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CHAPTER I
 
GENERAL INTRODUCTION
 
The study of marine natural products, at its current level of 
development, is a relative newcomer in the scientific arena. Nevertheless, 
tremendous strides have been made in describing and cataloging the 
abundant chemical structures represented in the marine environment. The 
establishment of a Gordon Research Conference dedicated to the subject is 
tribute to the level of scientific interest marine natural products chemistry 
has evoked. Natural products isolated from marine organisms have 
provided a plethora of new and exciting chemicals with unique properties 
which are only now being exploited for pharmaceutical and agrichemical 
applications. Within this framework, the marine algae offer a wealth of 
opportunity as sources of novel chemistry. 
Concomitant with the isolation and structure elucidation of natural 
products is a natural curiosity about the pathways utilized for their 
biosynthesis. Knowledge of these pathways is of utility in determining some 
of the details of structure and stereochemistry of novel compounds. And, in 
addressing these aspects of natural products chemistry, more in-depth 
questions on the bio-organic chemistry involved in their production are 
raised. 
Although the structural chemistry and pharmaceutical aspects of 
marine secondary metabolites has developed into a mature science, the study 
of their biosynthesis and the characterization of the enzymes involved is an 2 
area largely unexplored. Most of the studies on marine natural product 
biosynthesis have been in the form of in vivo feeding experiments. 
Although these studies are of interest and certainly provide insight into 
metabolic routes, they rely on analogy to known biosynthetic pathways for 
interpretation. The true novelty of many biosynthetic mechanisms can only 
be fully appreciated by working with isolated enzymes. For example, the 
occurrence of a number of isocyano containing natural products (e.g. 1-3) 
found in marine organisms, particularly sponges, (Chang & Scheuer, 1990) 
exemplifies one of the more perplexing questions in biosynthetic research. 
Unlike terrestrial isocyano containing metabolites in which the nitrogen is 
derived either directly from its amino acid precursor or another amino acid, 
the source of nitrogen for this functionality in the marine metabolites is 
unknown. Virtually all of the marine isocyano compounds have an 
isoprenoid skeleton (Cheng & Scheuer, 1990) and biosynthetic studies indicate 
the immediate nitrogen precursor is molecular cyanide (Carson, 1986; Karuso 
& Scheuer, 1989). Molecular cyanide is extremely toxic and occurs only in 
very low concentrations in sea water. How it is cycled into the pathway is 3 
unclear. It may be that bacterial processing is involved (Garson, 1986). 
Another dilemma for investigators of this metabolic pathway is the identity 
of the producing organism. While isocyanoterpenes are isolated exclusively 
from sponges, symbiosis with various microalgae and bacteria is ubiquitous 
among these life forms. Although there is some experimental evidence to 
support the sponge as the producing organism (Garson et al., 1992), the 
question still remains. 
In Chapter I of this thesis I will present a brief overview of marine 
natural products, with examples of those I consider the most interesting. A 
more detailed examination of the oxylipins found in marine algae will 
follow. I will then review the status of research related to enzymes involved 
in marine secondary metabolism. 
In the subsequent chapters I will address the biosynthetic mechanisms 
employed by particular macrophytic marine algae in the synthesis of 
conjugated polyunsaturated fatty acids. This dissertation will advance the 
thesis that by examination of the enzymes utilized in the biosynthesis of 
marine natural products new insights into the bio-organic chemistry of 
enzyme catalyzed reactions can be attained and that these enzymes can be 
applied to the synthesis of novel compounds applicable to investigations in a 
wide range of research areas. 
MARINE NATURAL PRODUCTS 
There is a wealth of literature on the natural products chemistry from 
marine sources which has been reviewed periodically by Faulkner (1984, 1986, 
1987, 1988, 1990, 1991, 1992) and in Scheuer's series, Marine Natural Products 
vol. I-V (1973, 1978, 1980, 1981, 1983). However, to illustrate the exceptional 4 
chemistry found in the marine environment and to describe the application 
of these compounds in pharmacological and biomedical research, it is 
worthwhile to point out a few examples. 
One of the first success stories in the pharmacological application of 
marine natural products is that of ara-A (4) and ara-C (5). The former is a 
clinically useful anti-viral agent for Herpes simplex infections of the eye and 
the latter an anti-tumor agent (Scheuer, 1989). Both of these pharmaceuticals 
were developed after the discovery of spongothymidine (6) and 
spongouridine (7) from the Caribbean sponge Cryptotethia crypta in the early 
1950's (Bergmann & Burke, 1956). The development of these drugs required 
decades from the time of the original structural elucidation; ara-C was 
approved by the FDA in 1969 and ara-A in 1980 (Rinehart, 1988). This effort 
NH2 
N 
OH  HO 
OMe 5 
illustrates the application of multidisciplinary research required to fully 
exploit natural products and the time scale often encountered in developing 
drugs for clinical use. 
Didemnin B (8) is arguably the most promising candidate for 
pharmacological development recently found in the marine environment.  It 
is produced by the tunicate Trididemnum solidum and is currently 
undergoing Phase II clinical trials in Canada as an anti-tumor agent. 
Didemnin B has also shown impressive bioactivity against Herpes simplex 
type I and II. In in vitro tests concentrations as low as 0.05 1.1.M have proven 
effective. Similar results have also been observed against the viral agents of 
Rift Valley fever, Venezuelan equine encephalomyelitis, yellow fever, 
sandfly fever and Pichinde virus (Davidson, 1993). 
Bryostatin 1 (9) represents a class of compounds which have shown 
considerable promise as anti-tumor agents. Originally isolated from the 
bryozoan Bugula neritina (Pettit et al., 1982) bryostatin 1 has been shown in in 
vivo tests to extend the life of mice with NCI M531 murine ovary sarcoma by 
31-68% over controls at levels as low as 5 mg/Kg (Pettit et al., 1985). The 
OH
 
9 6 
isolation and characterization of this and similar compounds has entailed the
 
extraction of hundreds of kilograms of the producing organisms to isolate 
milligram quantities of the pure substance. Owing to the trace amounts 
available from natural sources and the structural complexity of the chemical 
(which has so far eluded total synthesis), progress in developing these natural 
products has been slow. Efforts are currently underway to culture the 
producing organisms. 
HO 
Manoalide 10, isolated from the sponge Luffariella variabilis (deSilva, 
E.D., & Scheuer, P.J., 1980), and luffariellolide 11, from Luffariella sp. 
(Albiazati et al., 1987), are potent inhibitors of secretory phospholipase A2 
(PLA2) and are used as tools for investigating inflammatory responses (Glaser 
& Jacobs, 1986, Jacobs et al., 1985). Investigations on the structure activity 
relationship of manoalide and related compounds have indicated the 
importance of the 7-hydroxybutenolide (A) ring in forming imines with 
specific lysine residues in PLA2 (Potts et al., 1992). Moreover, it was found 
that binding of luffariellolide is reversible in the presence of hydroxylamine, 12 
suggesting the use of this inhibitor as an affinity chromatography ligand for 
PLA2 purification. 
One of the most striking examples of the structural complexity to be 
found in marine natural products is that of palytoxin 12. This isolate of the 
zoanthid coelenterate Palytoa toxica has an LD50 of 0.025 µg /kg in rabbits, 
making it the most potent non-proteinaceous toxin known (Ireland et al., 
1988). With a chemical formula of C129H223N3054 and no repeating structural 
subunits, the structure determination of this molecule was a daunting task, 8 
requiring the efforts of dozens of investigators over a period of decades 
(Moore, 1985). 
Work in our laboratory has unveiled another promising anti-cancer 
lead from the cyanobacteria Lyngbya majuscula (Gerwick et al., 1994). This 
compound, curacin A (13), has shown excellent anti-proliferative activity 
against several cell lines in the NCI 60 cell line assay, with IC50 values as low 
as 7.0 nM. It is currently undergoing whole animal test. Curacin A appears to 
act through the inhibition of tubulin polymerization, interacting at the 
colchicine binding site (Hamel et al., 1995). The original isolation effort was 
guided by brine shrimp toxicity assays where it proved to be extremely toxic. 
Curacin A is expressed as a major lipid component of the alga where it 
represents approximately 8-10% of the total lipid (Gerwick et al., 1994). 
OXYLIPINS FROM THE MARINE ENVIRONMENT 
The role of fatty-acid derived secondary metabolites is an area of 
interest to a broad range of biochemists and physiologists. In mammals the 
eicosanoids play key roles in numerous critical autocoid functions (Smith et 
al., 1991). Release of arachidonate from membrane phospholipids through 
the action of phospholipase A2 (Ghomashchi et al., 1991) initiates metabolism 
through one of three principal pathways: the prostaglandin H synthase 
(cyclooxygenase) pathway, the lipoxygenase pathway or the cytochrome P450 9 
Membrane Phospholipid 
PLA2 
Arachidonic Acid 
PGH Synthase  Cyto­
(Cyclo- chrome
 5-LOX  12-LOX  15-LOX oxygenase)  P450 
PGG2  5-HPETE  12-HPETE  15 -HPETE  epoxides 
1 \  / \ PG's  HHT's
 
15-HETE  diHETE's
 5-HETE  diHETE's  HETE's  diHETE's 
TX's 
Leukotrienes 
Hepoxilins  Leukotrienes  Lipoxins 
1 
Trioxilins 
Figure I.1. Generalized scheme for the arachidonate cascade in mammals. 
PG, prostaglandins; TX, thromboxanes; HHT, hydroxy-heptadecatrienoic acid; 
HETE, hydroxyeicosatetraenoic acid; HPETE, hydroperoxyeicosatetraenoic 
acid, 
pathway. Figure 1.1 presents a generalized scheme for the arachidonate 
cascade. 
Each of these three major metabolic routes results in a myriad of 
oxygenated and otherwise substituted products whose physiological effects 
include immunoregulatory activities such as chemotaxis for 
polymorphonuclear lymphocytes (PMNLs), smooth muscle contraction, 
platelet aggregation and a host of others, many of which are not well 10 
described. This is a rapidly evolving field of biomedical research with new 
developments occurring daily. 
Interest in oxylipin metabolites in marine organisms was sparked by 
the discovery of 15R-PGA2 (this compound is epimeric at the 15 position to 
the prostaglandins found in mammals) and15R-acetoxy-PGA2 in the 
gorgonian coral Plexaura homomalla in 1969 (Weinheimer & Spraggins, 
1969). It was later demonstrated that careful collection and rapid freezing (in 
liquid N2) of the corals resulted in only the acetoxy compounds being isolated. 
It is now generally accepted that the natural products are the acetate form 
and that the free PGA2 is the result of hydrolysis. Because of the potent 
physiological activities of the prostaglandins in mammals, the finding that 
they are found in life forms as far removed evolutionarily as the corals has 
stimulated tremendous excitement. 
In the decade following Weinheimer and Spraggins initial discovery 
an intense effort was mounted to find other prostanoids in the corals. 
Numerous examples of this class of chemistry have now been isolated from 
these organisms including 15S-PGA2. There are several recent reviews on the 
subject (Coll, 1992; Gerwick, 1994; Gerwick et al., 1993c). 
The success in finding prostanoids and other eicosanoids in the corals 
naturally resulted in efforts to find this class of chemistry in other marine 
organisms. As will be discussed, numerous oxidized metabolites of 
arachidonate and eicosapentaenoic acid (EPA) as well as fatty acids of 16, 18, 
and most recently 22 carbon lengths have been isolated from the marine 
environment. To facilitate discussion, the term oxylipin has been introduced 
to include all fatty acid metabolites, regardless of chain length, which have 
undergone at least one enzymatic oxidation in the course of their biosynthesis 
(Gerwick et al., 1991; Gerwick et al., 1993c). 11 
Sponges have long been a favorite subject for natural products 
investigators. Accordingly a number of interesting oxylipins have been 
isolated from these animals. Perhaps the most unusual found to date is 
halicholactone 15, isolated from Halichondria okadai (Niwa, 1989). Niwa 
proposed a biogenesis as illustrated in Scheme 1.1. An alternative and 
perhaps more feasible biogenesis has been proposed by Gerwick et al. (1993c) 
based on their work with the cyclopropyl containing lactones from the red 
alga Constantinia simplex. In this mechanism, depicted in Scheme 1.2, 
arachidonate is first peroxidized by a putative 15R-lipoxygenase. The 15­
hydroperoxyeicosatetraenoic acid (15-HPETE) is subsequently dehydrated to 
the epoxide intermediate which then rearranges to form the cyclopropyl 
lactone. Epoxide ring opening produces the diol. Although workers in the 
Gerwick group have demonstrated the biosynthesis of constanolactones 16 
and 17 in vitro, using acetone powder preparations of the alga, direct 
experimental evidence for this mechanism is still lacking. 
Invoking a lipoxygenase initiated biosynthesis for the oxylipins found 
in marine algae is, however, well founded. Lipoxygenases in terrestrial plants 
have been recognized for over four decades. Indeed, soybean lipoxygenase is 
HO lulu',,.... 
16 R=H, R'=OH 
17 R=OH, R'=H 12 
15 
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unquestionably the best characterized of this class of enzyme; its crystal 
structure has recently been deduced (Boyington et al., 1993). However, the 
physiological function of the peroxide and hydroxyl products is not so well 
understood. There is some evidence that they may be involved in senescence 
and in systemic defense against bacterial and fungal pathogens (Hamberg & 
Gardner, 1992) and the role of lipoxygenase in the biosynthesis of jasmonic 
acid is well established (Hamberg, 1993a). Interestingly, lipoxygenase activity 
was not recognized in mammals until 1973 as a result of Swedish 
investigators Mats Hamberg and Bengt Samuelsson's interest in the 
mechanism of this enzyme (Hamberg & Samuelsson, 1974). Work in our 
laboratory resulted in the first demonstration of lipoxygenase activity in 
marine algae (Moghaddam & Gerwick, 1990). 
The first oxylipins found in algae were PGE2 and PGF2a (Gregson et al., 
1979). Since then scores of algal oxylipins have been discovered, many from 
research in this laboratory. Marine algae, in fact, represent a rich source of 
oxylipins and this has become a central focus of our laboratory. There are 
several recent reviews on the occurrence of oxylipins in marine organisms 
(Gerwick, 1993; Gerwick & Bernart, 1993; Gerwick et al., 1993b; Gerwick et al., 
1993c). Here I will present a few relevant examples from the marine algae. 
The Rhodophyta (red algae) produce a wide variety of oxylipins, many 
structurally identical to the mammalian eicosanoids such as 12(S)­
hydroxyeicosatetraenoic acid (12S-HETE), a potent mediator of smooth muscle 
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migration. This eicosanoid, originally found in mammalian platelet cells 
(Hamberg & Samuelsson, 1974), has been isolated from Gracilariopsis 
lemaneiformis (Moghaddam & Gerwick, 1990), Murreyella periclados, 
Platysiphonia miniata, and Cottoniella filamentosa (Gerwick & Bernart, 1993). 
Another important mammalian autocoid of the lipoxygenase pathway, 
hepoxilin B3, has been isolated from P. miniata and C. filamentosa 
(Moghaddam et al., 1990). Numerous unusual oxylipins have also been 
found in this division. Some examples are ptilodene 18 from the Ptilota 
filicina (Lopez & Gerwick, 1988) and the dihydroxyeicosanoids 19, 20 and 21 
from Farlowia mollis (Solem et al., 1989). 
The Chlorophyta tend to be less rich in C20 fatty acids; nevertheless 
they have provided us with several examples of novel C18 oxylipins such as 
22 and 23 from Acrosiphonia coalita (Bernart et al., 1993). These metabolites 
are proposed to result from a 9- and a 16-lipoxygenase acting on a-linolenic 
acid (Scheme 1.3). Experimental evidence to substantiate this mechanism is 
lacking. However, incubations of the microsomal fractions of A. coalita 
homogenates with oc-linolenic acid have shown the development of a triene 15 
COOH
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like chromophore by UV spectroscopy (unpublished data). The biosynthesis 
of the branch chained fatty acid 23 represents a unique metabolic pathway for 
fatty acids, the enzymology of which warrants further exploration. 
Proteau (1994) has recently completed a survey of the oxylipins in 
several species of Pacific Northwest Phaeophyceae (brown algae). These 
efforts have revealed several new and exciting oxylipins exemplified by 
cymathere ether A (24) from Cymathere triplicata and the divinyl ethers 25 16 
and 26 from Laminaria sinclarii. In the case of cymathere ether A, a 
biogenetic pathway involving a 10-lipoxygenase has been proposed (Proteau 
& Gerwick, 1992). 
HO um-
COOH 
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Among the Cyanobacteria (blue-green algae) there are only a few 
notable examples of oxylipins, e.g. the triol, malyngic acid 27 from 
L. majuscula (Cardillina & Moore, 1980). The blue-green algae have not 
revealed as wide a variety of oxylipins as their macrophytic counterparts. 
This may be, in part, due to the difficulties in collecting and identifying these 
organisms; they have not been systematically examined. 
COOH 
OH  27 
Examination of the oxylipins found in the marine algae have also 
revealed a trend in the regiospecificity of the putative lipoxygenases. This is 
illustrated graphically in Figure 1.2; the large arrows indicate the predominate 
points of peroxidation as a function of major algal division and chain length 17 
of substrate, smaller arrows indicate minor peroxidation sites (Gerwick et al., 
1993b). 
Although it is apparent from the preceding discussion that 
lipoxygenase pathways are prevalent in the marine algae, to date no 
lipoxygenases have been purified from a marine alga. However, cell free 
work in our laboratory and in collaboration with Dr. Mats Hamberg at the 
Karolinska Institute have provided incontrovertible evidence of a 12(S)­
lipoxygenase in G. lemaneiformis (Gerwick, 1993). In the Appendix, I will 
report my own efforts at purifying this lipoxygenase. 
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Figure 1.2 Trends in lipoxygenase catalyzed peroxidation in the marine 
macrophytic algae. 18 
ENZYMOLOGICAL STUDIES OF MARINE NATURAL PRODUCT
 
BIOSYNTHESIS 
Detailed investigations of the mechanistic enzymology involved in the 
biosynthesis of marine natural products is scarce. In this section the literature 
pertaining to biosynthetic research using cell free systems will be reviewed. I 
will begin with probably the most thoroughly studied enzymes from marine 
sources, the haloperoxidases. This will be followed by work on steroid 
biosynthesis in sponges. I will then describe the work, to date, elucidating 
prostanoid biosynthesis in corals and continue with the biosynthetic 
mechanisms of oxylipin biosynthesis in algae. 
Marine organisms produce a variety of halogenated metabolites. These 
are thought to be principally for the purpose of chemical defense. Some, such 
as halomon from the red alga Portiera hornemannii, have shown promise as 
anti-tumor and anti-viral agents (Fuller et al., 1992). Haloperoxidase activity 
has been recognized in marine algae since the early 1900s (Butler & Walker, 
1993). These enzymes catalyze the general reaction: 
Org-H +  + H202 + H+  X-Org + 2H20 
Haloperoxidases are also found in terrestrial organisms, including 
mammalian cells such as eosinophiles and neutrophiles (Butler & Walker, 
1993). The first haloperoxidase to be purified was chloroperoxidase from the 
fungus Caldaromyces fumango (Hager at al., 1966). 
Using a cell free homogenate of the red alga Odonthalia floccosa 
Manley and Chapman (1978) were able to convert tyrosine to 3-bromo-4­
hydroxybenzaldehyde. Ensuing efforts in a number of laboratories resulted in 
partial purification of bromoperoxidases from several red algae including 19 
Cystoclonium purpureum, Bonnemaisonia haminifera, and Delsea fimbriata 
(Barrow, 1983). Baden and Corbett (1980) purified bromoperoxidases from 
three species of green algae, Penicillus lamourouxii, Penicillus capitatus, and 
Rhipocephalus phoenix. These enzymes appeared similar in many respects 
to fungal chloroperoxidase except that they could only brominate 
monochlorodimedone; they could not chlorinate this substrate. They were 
also approximately 20-40 times more active than chloroperoxidase. Another 
remarkable feature of these findings is that halogenated metabolites have 
never been isolated from Penicillus. It was later determined that the 
bromoperoxidase from P. capitatus is a heme-iron containing enzyme 
(Manthey & Hager, 1981). 
A novel bromoperoxidase isolated from the marine brown alga 
Ascophyllum nodosum has been shown to require vanadium for activity 
(Vilter, 1984). De Boer et al. (1986a, 1986b) used electron paramagnetic 
resonance spectroscopy, in concert with vanadium reconstitution of the 
apoenzyme, to demonstrate that vanadium is required in the active site. This 
represents the first enzyme characterized to use vanadium as a prosthetic 
group. 
More recently a unique chloroperoxidase has been isolated from the 
marine polychaete Notomastu lobatus (Chen et al., 1991). The enzyme has an 
Mr = 174,000 and a a4B272 quaternary structure which readily dissociates into 
two subunits, neither of which is catalytic alone. The a4 moiety is a flavin 
(tentatively identified as FAD) containing protein and the B272 moiety is a 
heme-iron containing protein. This is the first haloperoxidase purified from 
a marine polychaete and the first flavin containing haloperoxidase. 
A substantial body of knowledge has accumulated on the mechanism 
and characteristics of the haloperoxidases from marine organisms. These are 20 
certainly the best characterized of all the enzymes emanating from marine 
sources. The current status of research on these enzymes has recently been 
reviewed (Butler & Walker, 1993). 
Marine organisms, particularly sponges, produce an enormous variety 
of sterol secondary metabolites. The novelty of the steroids range from 
unusual nuclei to a vast array of structurally unique side chains. These 
include the occurrence of cyclopropane and cyclopropenes as well as a 
number of oxygenated forms. The chemistry and biosynthesis of these 
unusual steroids has been the subject of several recent reviews (Baker & Kerr, 
1993; D'Auria et al., 1993; Giner, 1993). Most of the research on sterol 
biosynthesis has been in the form of precursor feeding. With sponges this can 
be problematic in that they are often difficult to culture, necessitating field 
experimentation. Sponges also tend to be rather slow growing, requiring 
lengthy (and expensive) experiments. Giner and Djerassi (1990) have 
pioneered the use of cell free methods in studying the enzymology of these 
organisms. Djerassi and coworkers were the first to unequivocally 
demonstrate the de novo biosynthesis of steroids in sponges, using cell free 
preparations incubated with 2,3 oxidosqualene (Silva et al., 1991). 
Because of the large quantities of prostaglandins found in the coral P. 
homomalla several research groups thought this organism might provide a 
plentiful source of prostaglandin H synthase, notable among them E.J. Corey 
(Nobel laureate, chemistry 1990). However, it soon became apparent that 
prostaglandin biosynthesis in marine invertebrates is mechanistically quite 
different from that in mammals. Using a detergent solubilized microsomal 
fraction from buffer extracted homogenates of P. homomalla, Corey and his 
coworkers were able to demonstrate the enzymatic synthesis of PGA2 (Corey 
et al., 1973). This preparation of the coral required 1 M NaCl for its activity 21 
and the transformation of tritiated arachidonate produced three radiolabeled 
products, as determined by thin layer chromatography (TLC). PGA2 only 
represented a 10% conversion of substrate; the other two products represented 
20% and 40% conversion of substrate but were not identified. Surprisingly 
the synthesis was not inhibited by the well known inhibitors of prostaglandin 
H synthase: aspirin, indomethacin and eicosatetrayenoic acid (ETYA). 
Furthermore, feeding radioisotope labeled PGE1, an intermediate in the 
biosynthesis of PGA2 in mammals, did not result in radioisotope labeled 
PGA2. In follow-up experiments Corey et al. (1975) showed that neither PGH2 
or PGG2 were intermediates in the P. homomalla PGA2 synthase. 
Unfortunately, the microsomal preparations were highly unstable, losing 
100% activity after 24 hours at 0° C. Ammonium sulfate precipitation, 
acetone precipitation or column chromatography were all ineffective in 
stabilizing the activity. 
In 1982 a 15-lipoxygenase activity was reported in the marine coral P. 
porosa (Doerge & Corbett, 1982). A crude (1.6 fold) purification of the enzyme 
was effected by ammonium sulfate precipitation and dialysis. This 
preparation was used to determine the kinetic parameters, Km = 3.8 p.M and 
Vmax = 0.163 1.tmol min-1 mg-1. This was the first reported lipoxygenase from 
an invertebrate source. In a later investigation (Bundy et al., 1986), acetone 
powder preparations as well as buffer extracts of this same coral species 
yielded only 8R-hydroperoxyeicosatetraenoic acid (8R-HPETE) upon 
incubation with exogenous arachidonate. Oddly, this metabolite is not found 
as a natural product. These experiments also failed to demonstrate any 15­
lipoxygenase activity as previously described. It was proposed that in the 
earlier study the 8R-LOX was denatured during purification; hence, only the 
more stable 15-lipoxygenase was observed. 22 
From the observation that acetone powders of P. porosa and another 
coral, Clavularia viridis, both convert exogenous arachidonate to the 
cyclopentenone, preclavulone-A 28 Corey and Matsuda (1987) suggested that 
the prostanoid biosynthetic pathway in marine invertebrates occurs though 
an allene oxide 29 intermediate in a manner analogous to jasmonic acid 
biosynthesis in plants (Hamberg & Gardner, 1992). Scheme 1.4 illustrates a 
mechanism proposed by Brash et al. (1987) to explain the fact that incubations 
of arachidonate with homogenates or acetone powders from a variety of coral 
species typically result in racemic mixtures of 8,12 cis preclavulone-A 28 or 
8,12 trans preclavulone-A, with the preponderance being the cis isomer. By 
this scheme, after peroxidation by an 8R-lipoxygenase and during conversion 
to 8,9 epoxy-5Z, 9Z,11Z,14Z eicosatetraenoic acid, the intermediate cation at 
C10 (not shown) allows rotation about the C9-C10 bond resulting in the allene 
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COON 
rotation about the  29
C9-C10 bond  epoxide ring opening 
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C8-C9 bond 
C0011 
28
 
+
 
28 
Scheme 1.4 23 
oxide 29. Upon epoxide ring opening, a 90° rotation about the C8-C9 bond 
allows the carbocation at C8 to delocalize though the conjugated it system. 
Ring closure via a concerted (4nit) mechanism is a conrotary process, with 
either positive or negative rotation, resulting in the racemic mixture of 8,12 
cis isomers 28. 
Following on this line of research, Brash (1989), in an ingenious 
experiment to demonstrate the existence of the putative allene oxide 
intermediate, used an acetone powder extract of P. homomalla in a 
buffer/pentane emulsion with 8(R)-HPETE as a substrate. By vortexing the 
mixture as it reacted, the highly unstable allene oxide was immediately 
extracted into the pentane phase and protected from hydrolysis. The results 
unequivocally demonstrated the occurrence of the allene oxide. 
There are still several unanswered questions regarding the biosynthesis 
of prostaglandins in the marine corals. The inability to synthesize a chiral 
8,12 trans product from these acetone powder systems is problematic. 
Moreover, the racemic products are not likely the result of a completely 
enzymatic process as Brash and co-workers have pointed out with the 
chemical process illustrated in Scheme I.4 (Brash et al., 1987). Additionally, 
the preclavulone-A found in the in vitro studies has never been isolated 
from a natural source. How this putative "intermediate" is isomerized to the 
chiral prostaglandins is not clear. Better resolution of the specific enzymes 
involved is certainly needed. 
Oocytes of the starfish (Orthasterias koehleri and Evasterrias troschelii) 
have also been shown to produce 8-HETE as well as 9-,12- and 15-HETE from 
incubations with exogenous arachidonate (Meijer et al., 1986). In more 
detailed studies Brash et al. (1991) used the microsomal fraction of 
homogenized oocytes (from a variety of starfish species) to explore the 24 
enzymology of arachidonic acid metabolism in this life form. They found 
that arachidonate was converted to 8R-HETE through an intermediate 8R­
HPETE. They also observed an allene oxide product and products of a 
putative hydroperoxide lyase. 
In addition to the 12(S)-HETE from lipoxygenase activity in G. 
lemanetformis, this alga also produces a 12R,13S-diHETE (change in priorities 
at the 12 position in the diHETE). Using buffered tissue homogenates of this 
plant, Gerwick et al. (1991) were able to demonstrate a hydroperoxide 
isomerase activity. Reaction in the presence of 1802 resulted in both hydroxyl 
oxygens being labeled. It was further demonstrated, by incremental trapping 
of the hydroperoxide with glutathione and glutathione peroxidase, that the 
12(S)-hydroperoxide was an intermediate in the reaction. Partial purification 
of the 12(S)-lipoxygenase and the hydroperoxide isomerase was effected by 
100,000 X g centrifugation, ammonium sulfate precipitation and size 
exclusion chromatography (Hamberg & Gerwick, 1993). The lipoxygenase was 
found to be a cytosolic protein eluting at a molecular weight of approximately 
84-89,000. The hydroperoxide isomerase was found distributed equally in the 
cytosolic and the microsomal fraction. On gel filtration it eluted in two bands 
at molecular weights of 40-45,000 and >220,000. It appears that the algal 
hydroperoxide isomerase may exist in mono and multimeric forms. It was 
also discovered that the lipoxygenase activity was enhanced approximately 20 
fold in the presence of 1.0 M NaCl. The classic lipoxygenase inhibitors ETYA 
and nordihydroguaiaretic acid were shown to be effective against the 
lipoxygenase (Hamberg & Gerwick, 1993). 
Cell free and partially purified extracts of Lithothamnion corallioides 
were used to investigate the biosynthesis of 13-hydroxyarachidonic acid 
(Gerwick et al., 1993a). This unusual hydroxylation of a bisallylic group does 25 
1802 
not fit the typical oxidation pattern of a lipoxygenase. By incubating the 
100,000 X g supernatant of the homogenized tissue in the presence of either 
or H2180 , it was shown conclusively that the hydroxyl oxygen 
originated from water. However, the enzymatic transformation did have a 
requirement for molecular oxygen. It was hypothesized that the oxygen is 
involved either in a proton abstraction or in regeneration of the oxidase-like 
enzyme (Gerwick et al., 1993a). Hamberg (1992) also found that the 
metabolism of 6Z, 9Z, 12Z-octadecatrienoic acid by homogenates of L. 
corallioides resulted in a bisallylic hydroxyl product, 11(R)- hydroxyl -6Z, 9Z, 
12Z-octadecatrienoic acid and a conjugated tetraene 6Z, 8E, 10E, 12Z­
octadecatetraenoic acid. In addition to the conjugated polyenoic fatty acids 
from L. corallioides and Bossiella orbigiana (discussed in Chapter II) several 
hydrocarbon compounds with conjugated olefins such as finavarrene 30, 
giffordene 31 and the cyclic hydrocarbon ectocarpene 32 have been isolated 
from brown algae (Stratmann et al., 1993). 
The physiological role of these metabolites as female sex pheromones 
is well established (Jaenicke & Boland, 1982; Muller & Schmid, 1988). 
Biosynthetic studies of these metabolites have been conducted in vitro with 
female gametophytes of Ectocarpus siliculosis, Sphacelaria rigidula and 
Giffordia mitchellae. Unlike the terrestrial plant Senecio isatideus, which 
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produces substantial quantities of ectocarpene 32 and finavarrene 30, and uses 
a C12 trienoic fatty acid as a substrate (the product from (3-oxidation of a­
linolenic acid) (Boland & Mertes, 1985), the algal cells only metabolized 
arachidonate and EPA (or a synthetic C19 homologue) into the hydrocarbon 
products. Moreover, from the incorporation of regiospecfically labeled 
substrate it was established that the Cii pheromones derived from the C10­
C20 portion of the substrate (Stratmann et al., 1993). From these results it was 
postulated that the biosynthetic pathway in the algae is completely different 27 
from that in terrestrial plants and involves a 9-HPETE intermediate. Scheme 
1.5 illustrates the proposed biogenesis of giffordene. 28 
CHAPTER II
 
CHARACTERIZATION OF POLYENOIC FATTY ACID ISOMERASE, A NOVEL
 
ENZYME FROM THE MARINE RED ALGA
 
PTILOTA FILICINA
 
INTRODUCTION 
There are numerous reports on the occurrence of conjugated dienoic, 
trienoic and tetraenoic fatty acids in plants (e.g. Morris & Marshall, 1966; Spitzer 
et. al., 1991; Takagi & Itabashi, 1981), most of which are eighteen carbon 
compounds originating from oleic (9Z -octadecenoic acid), linoleic (9Z, 12Z­
octadecadienoic acid), linolenic (9Z, 12Z, 15Z-octadecatrienoic acid) or 
stearidonic (6Z, 9Z, 12Z, 15Z-octadecatetraenoic) acids. However, the 
biosynthesis of these conjugated polyenes from their fatty acid precursors is still 
poorly understood. One of the more thorough investigations to date, regarding 
the biosynthesis of conjugated polyenes in plants, was by Crombie and Holloway 
(1985) who examined the conversion of oleic acid and linoleic acid to calendic 
acid 33 (8E, 10E, 12Z -octadeca-trienoic acid) by cell free homogenates of 
germinating marigold seeds. Using combinations of regiospecifically labeled 
oleic and linoleic acids, they were able to demonstrate that the conversion of 
linoleic acid occurred via removal of two hydrogens, one each from the C8 and 
C11 positions. There appeared to be no involvement of an oxygenated 
intermediate. 
Burgess et al. (1991), studying arachidonic acid metabolism in cell free 
preparations of the red marine alga Bossiella orbigniana, produced 
5Z,8Z,10E,12E,14Z-eicosapentaenoic acid 34 to which they assigned the trivial 
name bosseopentaenoic acid (BPA). They speculated that the biosynthetic 29 
33 
34 
0 
35 
pathway involves a 12-lipoxygenase or cytochrome P450 catalyzed oxygenation 
because the cell free biosynthesis of BPA from arachidonate required molecular 
oxygen. Gerwick et al. (1993), working with a related red marine alga, 
Lithothamnion corallioides, found this same conjugated tetraene to be produced in 
cell free homogenates incubated with arachidonic acid. Subsequently, Hamberg 
(1992), using C18 polyunsaturated fatty acid precursors, showed that L 
corallioides possesses a unique oxidase-type activity which forms the conjugated 
tetraene functionality without production of oxygenated intermediates. The 
enzyme requires molecular oxygen or some form of electron acceptor for its 
activity. (It was found to catalyze the reaction under anaerobic conditions if p­
benzoquinone, phenazine methosulfate or 2,6-dichlorophenol-indophenol were 
included in the incubation.) Using stereospecifically deuterated 7-linolenic acid 
(6Z, 9Z, 12Z -octadeca-trienoic acid) it was shown that the enzyme oxidatively 
removes the pro-S and pro-R hydrogens at C8 and C11, respectively, resulting in 
the formation of 6Z,8E,10E,12Z-octadecatetraenoic acid 35. Stoichiometric H202 30 
evolved from the aerobic reaction although the addition of NAD or FAD had no 
significant effect on observed rates. 
My interest in this area of metabolism stems from findings in our 
laboratory over the past several years that many marine algae metabolize 
polyunsaturated fatty acids (PUFAs) to a wide range of unusual and structurally 
unique oxylipins (Gerwick et al., 1993b), as well as known eicosanoids such as 
12S-HETE (Gerwick & Bernart, 1993) and hepoxilin B3 (Moghaddam et. al., 1990). 
In addition to oxidized fatty acid products containing oxygen derived from 
molecular oxygen, several metabolites with conjugated polyene systems have 
also been isolated. For example, during the course of earlier investigations in the 
Gerwick laboratory on the natural products chemistry of Ptilota filicina (a 
temperate red alga from the Oregon coast), a previously undescribed conjugated 
eicosanoid, 5Z, 7E, 9E, 14Z, 17Z-eicosapentaenoic acid 36 was discovered (Lopez 
& Gerwick, 1987). I was interested in examining the mechanisms of the 
isomerization reactions leading to its formation from a proposed EPA (37) 
precursor. This conversion of EPA (or arachidonate) involves, in essence, a 
double isomerization in that the C8-C9 double bond is transferred to the C7-C8 
position and the C11-C12 double bond migrates two carbons to form the C9-C10 
double bond (Scheme 11.1). I have successfully isolated the enzyme responsible 
for this novel isomerization, which has been termed polyenoic fatty-acid 
isomerase (PFI). In this chapter I will provide evidence for the regio and 
stereochemistry of the proton transfers involved in catalysis, analyze features of 
the binding/catalytic site and describe some of the characteristics of the protein. 31 
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MATERIALS AND METHODS 
Enzyme isolation. Ptilota filicina was collected during low tide at Devil's 
Punchbowl on the Oregon Coast on 26 Aug 1991. The freshly harvested plants 
were immediately frozen on dry ice and transported back to the laboratory 
where they were stored at -70° C. To prepare the enzyme, the frozen tissue, 
approximately 50 grams, was ground in a stainless steel Waring blender with 
liquid nitrogen. The powdered tissue was slurried with approximately two 
volumes of extraction buffer (100 mM NaH2PO4, 5 mM EGTA, 5 mM DTT, and 5 
mM MgC12, pH 6.5) and homogenized with an Ultraturrex followed bya Potter-
Elvehjem tissue homogenizer. The homogenate was then filtered through 
Miracloth (Calbiochem) and centrifuged at 12,000 X g for 20 minutes. The 
supernatant was centrifuged at 100,000 X g for 60 minutes. This high speed 32 
supernatant was then precipitated with ammonium sulfate and the material 
precipitating between 55% and 90% saturation resuspended in a minimal volume 
of 100 mM NaH2PO4, pH 6.5 (approximately 5 mL). This material was passed 
down a 2.5 X 91 cm Pharmacia Sephacryl S-300 size exclusion column and eluted 
with 20 mM NaH2PO4, pH 7.2. The fractions showing enzyme activity were 
pooled and concentrated to approximately 2.0 mL using an Amicon Centriprep 
concentrator with a 30 K molecular weight cutoff. The concentrated protein from 
size exclusion chromatography was then subjected to preparative isoelectric 
focusing (IEF) using a Rainin RF-3 Protein Fractionator and Pharmacia 
Pharmalyte ampholytes pH 4.0-6.5 (1% ampholytes in H2O with 10% glycerol). 
The active fractions off IEF (pH 4.4-4.8) were pooled and the buffer exchanged 
with 20 mM NaH2PO4, pH 7.2 by three cycles of concentration and dilution with 
ice cold buffer using an Amicon Centriprep 30 K concentrator (see Table II.1). 
To effect the final purification of PFI the concentrated material from IEF 
was subject to hydrophobic interaction chromatography (HIC). The IEF material 
was brought to 30% ammonium sulfate saturation by slowly adding an equal 
volume of a 60% ammonium sulfate saturated solution in 20 mM NaH2PO4 
buffer, pH 7.2 (pH adjusted after adding the ammonium sulfate). This solution 
was then loaded to a small (0.7 X 5 cm) column of phenyl sepharose pre-
equilibrated with 30% ammonium sulfate in 20 mM NaH2PO4 buffer, pH 7.2. 
The column was washed with approximately 15 mL of the 30% ammonium 
sulfate solution then the protein was eluted with a 20-0% ammonium sulfate 
saturated phosphate buffer gradient and collected in 1.0 mL fractions. The active 
fractions were pooled, concentrated and the buffer exchange as described above. 
Enzyme assay.  Activity was assayed spectrophotometrically on a Hewlett 
Packard 8452A diode array spectrophotometer by a modification of the method 
for lipoxygenase (Ben-Aziz et al. 1970). To a mixture of 100 mM NaH2PO4, pH 33 
7.2 with 0.02% Tween 20 (reaction buffer) an appropriate amount of enzyme 
solution (5-100 !IL) was added and the spectrophotometer blanked. Reaction was 
initiated by adding 40 gg of arachidonic acid in 10111_, of ethanol to make a final 
volume of 1.0 mL with 131 I.EM arachidonate. Product formation was measured 
by monitoring absorbance at 278 nm. Unless stated otherwise, all assays were 
conducted at 22° C. A unit of activity is defined as the amount of enzyme 
catalyzing the formation of one mol of triene product per minute, using an 
extinction coefficient E = 57,000 L/Mol-cm (Lopez & Gerwick, 1987). Under 
appropriate conditions the reaction is essentially linear for several minutes. 
Protein determinations were performed using the Bradford method (Bradford, 
1976); lipid free BSA fraction V was used as the standard. 
Kinetic analyses.  Kinetic analyses were performed for the various 
substrates using purified enzyme unless otherwise stated. A preliminary 
analysis was conducted to approximate the Km then duplicate independent 
experiments were performed using substrate concentrations ranging from (at 
least) 0.2 to 5.0 fold Km. At least five, and usually six, substrate concentrations 
were used for each analysis. Unless otherwise stated, assays were performed in 
100 mM NaH2PO4, with 0.02% Tween-20. Data analysis was performed using 
either EnzfitterTM software by Biosoft, Cambridge U.K. or Enzyme KineticsTM by 
Trinity Software. 
To determine the effect of pH on the kinetic parameters of PFI a series of 
reaction buffers was made up from pH 5.0 to 10.0. In order to provide buffering 
capacity over this pH range a buffer composed of 50 mM NaH2PO4, 50 mM 
NaCitrate and 25 mM NaB7O3 with 0.3 M NaC1 to make a final ionic strength of 
0.9 M and 0.02% Tween-20 (termed triple buffer, (TB)) was used. Values for Km 
and Vmax were calculated from Lineweaver-Burk plots; all plots had a coefficient 
of correlation ?. 0.90. 34 
Ionic strength optimum. The following salts were examined for their effect 
on PH activity and to determine the optimum ionic strength: NaH2PO4, 
NaCitrate, KH2PO4, NaC1, (NH4)2SO4, KC1, KI, and NaBr. Initially sodium 
phosphate buffer solutions were made at 10, 50, and 100 mM strengths 
representing ionic strengths of 0.03, 0.15 and 0.30 M respectively. Duplicate 
assays were performed with partially purified PFI (0.19 X le units per assay). 
EPA was used as the substrate at 131  Each buffer/salt solution was made 
up to the appropriate ionic strength and the pH adjusted using concentrated 
H3PO4 (14.6 M) or 5 M NaOH as required. 
pH and buffer effects. To determine the effects of various buffers and pHs 
on the observed velocity of the enzyme a series of neutral acid buffers as well as 
zwitterionic and cationic buffers were evaluated including: NaH2PO4, NaCitrate, 
Glycine, Bis-Tris, (bis(2-hydroxyethyl) imino-tris(hydroxymethyl) methane), and 
the "Good"1 buffers: PIPES, (piperazine- N,N' -bis[2 -ethane sulfonic acid]) and 
HEPES, (N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid). All buffers 
were made at 50 mM concentrations. Each buffer was made at the appropriate 
molar concentration and then the pH adjusted using 5 N HC1 or 5 N NaOH. 
Reaction solutions were made by adding sufficient Tween-20 to make the final 
concentration 0.02% (vol/vol). Assays were initiated with 1.4 X 10-3 units of 
partially purified (purified through the gel filtration step) enzyme and the 
change of absortion at 276 nm was directly compared as a measure of apparent 
velocity. Each pH point was assayed in triplicate. 
Detergent effects. The following commercially available biological 
detergents were examined: Tween-20 (sorbitan polyethlyester), CHAPS, Brij-35, 
cholic acid, digitonin, Lubrol PX, NP-40, Triton X-100, and SDS (sodium dodecyl 
1 Good buffers refer to the N-substituted taurine and glycine buffers developed by N.E. Goodet 
al. (1966). 35 
sulfate). An initial screening was performed by making up 0.02% detergent 
solutions (vol/vol) in 25 mM Citrate/ 25 mM NaH2PO4, pH 4.5 and assaying the 
reaction of a partially purified PH preparation (0.7 X le units per assay) with 
131 µM arachidonic (0.04 µg in 10 tit EtOH). Each assay was performed by 
preincubating the substrate in the reaction solution approximately three minutes 
and then adding the enzyme (in 10 pL) to initiate reaction. Each detergent was 
assayed in triplicate. 
14C labeled Aaachidonate. 1414q-arachidonate (10 I.LCi) was obtained from 
New England Nuclear and diluted with EtOH and cold arachidonate to make a 
working solution of 0.1 mg/mL arachidonate with an activity of 1 X 107 
dpm/mL. Liquid scintillation was performed on a Beckman LS 6800 Scintillation 
Counter using Scintillene scintillation fluid (VWR) in 5 mL vials. Thin layer 
chromatography (TLC) was performed on silica gel 60; F-254 plates (VWR) and 
was analyzed with a Bioscan 400 imaging system interfaced to an Apple 
computer. 
Molecular weight determinations. The mass of the native enzyme was 
determined by size exclusion chromatography using Sephacryl S-300 
(Pharmacia) on a 1.5 X 33 cm column. The following molecular weight standards 
were employed: apoferritin (443 kDa.), alcohol dehydrogenase (150 kDa.), bovine 
serum albumin (66 kDa.) and cytochrome C (12.4 kDa.) (Sigma). The Elution 
buffer was 100 mM NaH2PO4 pH 7.2, with and without 100 mM NaC1 (both gave 
the same results). The PFI preparation used for these analyses had been 
subjected to ammonium sulfate precipitation, S-300 gel filtration and 
concentration with a centriprep 30K concentrator. 
Analytical ultracentrifugation was performed on a sample of pure PFI 
(HIC purified, showing a single band on SDS-PAGE) using a Beckman Optima 
XL-A analytical centrifuge equipped with scanner optics and an AN60 Ti rotor. 36 
The material was subjected to an equilibrium sedimentation routine for 56 hours 
at 21° C with a rotor speed of 6700 RPM for the first 27 hrs then at 9000 RPM for 
the remaining 29 hrs in 20 mM NaH2PO4 buffer pH 7.2. The concentration 
gradient of the protein was analyzed using software developed specifically for 
this instrument (Dem ler, 1992). A partial specific volume of 0.73 mg cm -3 was 
assumed for the enzyme. 
Subunit mass of the IEF purified material was determined by two 
methods, SDS -PAGE and matrix assisted laser desorption/ionization mass 
spectrometry (MALDI/MS). Discontinuous gel electrophoresis was performed 
by the method of Laemmli (1970) on a 10% running gel and a 3% stacking gel 
with 0.6 M Tris in the running gel to reduce the spread of high salt fractions. 
Sigma mark VIII, molecular weight standards were used. The gel was silver 
stained (Wray et al., 1981). MALDI/MS with time of flight detection was 
performed using sinapinic acid as the matrix (Karas and Hillenlcamp, 1988; 
Jenson et al., 1993). Bovine serum albumin (Mr = 66.4 kDa) served as an internal 
standard. 
Amino acid composition and N-terminal sequencing. To analyze the amino 
acid composition of PH an aliquot, containing approximately 27.2 gg (468 pmol 
of subunits), of highly purified enzyme was speed vacuum dried in a 1.5 mL 
Eppendorf tube and sent to the University of California at Davis, Protein 
Structure Laboratory. Half of the sample was subjected to overnight acid 
hydrolysis in HC1 for routine amino acid analysis and the other half subjected to 
performic acid hydrolysis in order to estimate the cysteine composition. N-
terminal sequencing was performed at the Oregon State University Central 
Services Laboratory on an Applied Biosystems 475A sequencer. An aliquot of 8.5 
gg (146 pmol of subunits) of pure PFI was provided for the analysis. The 37 
sequencer was allowed to run until quantification of N-terminal cleavage 
products no longer gave analytically significant results. 
Reaction under anaerobic conditions. A 5.5 mL volume of the reaction buffer 
plus 5% glucose was placed in a 15 mL three neck flask with 1.4 X 10-3 units of 
PFI (in 20 pi, NaH2PO4 buffer) and capped with serum bottle septum. The flask 
was then subjected to 3 X 15 minute cycles of vacuum and purging with dry N2. 
Under a positive pressure of dry N2, 0.5 units of glucose oxidase (Sigma G6125) 
was injected with a syringe through the septum for an additional 30 minutes to 
remove any residual 02. The reaction of PFI was initiated by adding 0.2 mg of 
arachidonate in 50 !IL EtOH, again using a syringe and keeping the reaction 
vessel under pressure with N2. At timed intervals, 0.5 mL aliquots of the 
solution were removed, the reaction quenched with 1.0 mL Me0H and the 
absorbance at 272 nm measured (the triene Amax in Me0H). A control reaction 
was performed in an identical manner but without sealing the vessel. Both 
reactions were stirred constantly at 23° C. 
Lipid extraction. In experiments where reaction products were examined by 
NMR or GC/MS the lipid material was extracted in the following manner. The 
reaction was quenched with five volumes of Me0H, then sufficient H2O was 
added to make a final solution of Me0H/H20 (1:1). This Me0H/H20 solution 
was extracted with an equal volume of diethyl ether; the remaining aqueous 
phase was acidified to approximately pH 4.0 (determined with pH paper) by 
dropwise addition of 10% HC1. The acidified aqueous methanol solution was 
extracted three more times with diethyl ether. The ether extracts were pooled, 
washed twice with approximately 0.1 volumes of H2O, and reduced under 
vacuum using 100% ethanol as an azeotrope as necessary. The extracted lipids 
were resuspended in a small (1-3 mL) volume of Me0H and methylated by 
reaction with ethereal diazomethane for approximately one minute. 38 
Isolation of the triene methyl esters was accomplished by HPLC using 
two, in line, Alltech Versapak 101.1m, 30 cm X 4 mm silica columns with a Waters 
M-6000 Chromatography pump and a model 480 LC spectrophotometer detector 
set at 272 nm. Elution was accomplished with 2% EtOAc in hexanes at a flow 
rate of 4.0 mL/minute (3000 psi). The triene methyl ester eluted just after the 
arachidonate methyl ester in a volume of 40-45 mL. 
GC/MS analysis. All GC/MS analyses were performed on the methyl 
esters of the fatty acids. These were suspended in hexanes at a concentration of 
20-50 ng/pt and 1-2 ttL injected onto the column. Gas chromatography was 
performed on a Hewlett Packard 5890 Series II GC with a HP 5971A quadrupole 
mass selective detector interfaced with the Hewlett Packard Chemstation using 
G1034B software for data analysis. An 11.5 meter Ultra-1 open capillary column 
was used, initial temperature at 70° C with a 20° C/minute ramp to a final 
temperature of 250° C. Helium was used as the carrier gas. 
Inhibitor studies. The following lipoxygenase, prostaglandin H synthase 
and cytochrome P-450 inhibitors were evaluated for their inhibitory activity with 
the enzyme at the concentration(s) indicated: acetylsalicylic acid, 330 jiM; 
baicalein, 12 AM; dipyridamole, 1011M and 100 µM; eicosatetraynoic acid 
(ETYA), 10011M; esculetin, 50 givI; indomethecin, 56 RM; naproxen, 100 p.M; 
NDGA, 15 ii.M; SKF 525A, 50 ttM and 100  Each inhibitor was made up in 
EtOH to allow introduction of the appropriate amount into a 1 mL reaction 
vessel in 51..t,L (or less). The enzyme was pre-incubated with the inhibitor at least 
5 minutes before adding arachidonate (in 5µL EtOH, final concentration 131 
p,M). The rate of change in absorbance at 278 nm was compared to a control 
assay using 5µL EtOH instead of inhibitor. Each assay was performed two or 
three times. 39 
Analysis of metal content. EDTA and o-phenanthroline were used as 
chelating agents to remove exchangeable or loosely bound divalent cations 
associated with the enzyme. Aliquots of the partially purified PFI were 
incubated for 2.5 hr at RT in 100 mM NaH2PO4 (pH 7.2) with 5 mM EDTA. 
Comparisons of enzyme activity were by triplicate assay. For o-phenanthroline, 
the enzyme was incubated in a 1 mM solution of the chelator and 100 mM 
NaH2PO4 at RT and assayed at timed intervals for 17 hours (single assay per time 
point). Control incubations were treated likewise, however, without EDTA or o­
phenanthroline. In addition, the PFI was incubated with 5 mM EDTA at pH 4.2 
in a 50 mM citrate/50 mM NaH2PO4 buffer and assayed at timed intervals (one 
assay at t = 0, 15, 30, 60, 120, 240 minutes). 
To further evaluate for covalently or otherwise tightly bound metal co­
factors, a sample of highly purified PFI was analyzed by inductively coupled 
plasma mass spectrometry (ICP/MS). A Fisons PQ+ PlasmaQuad ICP equipped 
with a Meinhard nebulizer and interfaced to a SX300 quadrupole mass selective 
filter was used (Oceanography Department, Oregon State University). This 
instrument has a lower sensitivity level of 20,000 counts per second per ppb for 
indium. Approximately 47 [tg of protein, 810 pmol of subunits, in 0.13 mL 20 
mM NaH2PO4 buffer was diluted to 2.0 mL with H2O containing 10 ppb Indium 
115 as an internal control. The mass filter was programed for selective ion 
monitoring to optimize detection of the following ions: Mg 24, V 51, Fe 54, Fe 56, 
Fe 57, Mn 55, Co 59, Ni 60, Zn 66, Cu 65, Zn 66, Mo 95 and In 115. 
To further evaluate the efficacy of the instrument and methodology for 
detecting metal ions, a commercially available metalloenzyme, soybean 
lipoxygenase (Sigma L-7395), as well as BSA (to serve as a non-metal containing 
control) were prepared. These samples were dissolved in 50 mM NaH2PO4 
buffer containing 5 mM EDTA. They were then passed through three cycles of 40 
concentration and dilution with 20 mM NaH2PO4 buffer which had been filtered 
through a column of Chelex resin (Biorad) to remove trace residues of divalent 
ions. All glassware and containers were acid washed with 1.0 M HC1. 
The H2O used in these experiments was prepared by passing distilled 
water (house) through a Barnstead B water purifier equipped with a mixed bed 
ion exchange cartridge and an activated charcoal filter. This treatment provided 
water with a minimum of 17.8 megOhm-cm resistance (and proved to be 
relatively ion-free by ICP/MS). 
Neutron activation analysis (NAA) was also used to determine the metal 
content of PH. A 97 gg aliquot of pure PFI in 0.25 mL chelex treated water was 
irradiated in a TRIGA Mark II research reactor for 10 hours in a neutron flux of 
3.2 X 1012 neutrons cm-3s-1. The sample was irradiated on 22 November 1994 
and then transferred to a non-irradiated polyethylene vial for 'y-ray emission 
counting on 10 December 1994. 7-ray emission was counted for a total of 2.0 X 
105 seconds. National Bureau of Standards standard reference material (SRM) 
1577a (bovine liver) was used as an external standard. 
NMR, IR, UV analyses. All NMR experiments were performed on a Bruker 
ACP 300 instrument, and chemical shifts assigned relative to an internal TMS 
standard. IR spectra were obtained on a Nicolet 510 FT-IR. UV/VIS spectra 
were made on a Hewlett Packard 8452A diode array spectrophotometer. The 
following data were obtained for the C20 methyl ester tetraene product 39: 1H 
NMR (300 MHz, CDC13) 8 0.89 (3H, t, J=6.8 Hz, H3-20), 1.33 (6H, m, H2-17,18,19), 
1.45 (2H, tt, J=7.4, 7.4 Hz, H2-12), 1.73 (2H, tt, J=7.4, 7.4 Hz, H2-3), 2.01 (4H, m, H2­
13, 16), 2.11 (2H, m, H2-11), 2.23 (2H, bdt, J=7.5, 7.5 Hz, H2-4), 2.33 (2H, t, J=7.5 Hz, 
H2-2), 3.66 (3H, s, H3-1'), 5.33 (3H, m, H-5,14,15), 5.71 (1H, dt, J=14.1, 7.1 Hz, H­
10), 6.04 (1H, bdd, J=11.0, 11.0 Hz, H-6), 6.10 (1H, m, H-9), 6.16 (1H, m, H-8), 6.35 41 
(1H, dd, J=13.7, 11.1 Hz, H-7); IR (neat) Dm  2953, 2926, 2856, 1741, 1457, 1436, 
1243, 1199, 1170, 992, 966 cm-1; UV (EtOH) 262, 272, 282 nm. 
The C18 methyl ester triene product obtained from y-linolenate gave the 
following 1H NMR (300 MHz, CDC13) data: 8 0.89 (3H, t, J=6.7 Hz, H3-18), 1.24 
(8H, m, H2-14,15,16,17), 1.42 (4H, m, H2-4,13), 1.66 (2H, tt, J=7.4, 7.4 Hz, H2-3), 
2.09 (2H, dt, J=7.2, 7.2 Hz, H2-12), 2.20 (2H, dtd, J=7.5, 7.5, 1.0 Hz, H2-5), 2.32 (2H, 
t, J=7.4 Hz, H2-2), 3.66 (3H, s, H3-11), 5.37 (1H, dt, J=10.9, 7.5 Hz, H-6), 5.71 (1H, dt, 
J=14.4, 7.2 Hz, H-11), 6.00 (1H, bdd, J= 10.9,10.9 Hz, H-7), 6.07 (1H, tn, H-10), 6.16 
(1H, m, H-9), 6.36 (1H, bdd, J=13.4, 10.9 Hz, H-8). 
The C22 methyl ester hexaene product 48 from DI-IA gave the following 
1H NMR (300 MHz, CDC13) data: 8 0.97 (3H, t, J=7.5 Hz, H3-22), 1.47 (2H, tt, 
J=7.5, 7.5, H2-14), 2.09 (6H, m, H2-13,15,21), 2.39 (4H, m, H2-2,4), 2.77 (2H, bdd, 
J=5.9, 5.9 Hz, H2-18), 2.95 (2H, bdd, J=6.6, 6.6 Hz, H2-6), 3.67 (3H, s, H3-1'), 5.27­
5.43 (7H, m, H-4, 5, 7, 16, 17, 19, 20), 5.72 (1H, dt, J=14.2, 7.2 Hz, H-12), 6.01 (1H, 
bdd, J= 10.9,10.9 Hz, H-8), 6.11 (1H, bdd, J=14.2, 10.0 Hz, H-11), 6.19 (1H, bdd, J= 
13.1, 10.0 Hz, H-10), 6.40 (1H, bdd, J= 13.1,10.9 Hz, H-9). 
Deuterated substrates. The stereospecifically deuterated y-linolenic acids 
((11R) and (11S)411-21-1]-y-linolenic acid and (8R) and (8S)8-21-1]-y-linolenic acid) 
were generously provided by Professor M. Hamberg, Karolinska Institute, 
Stockholm Sweden. The synthesis has previously been described (Fahlstadius & 
Hamberg, 1990; Hamberg & Samuelsson, 1967; Schroepfer & Bloch, 1965). 
Briefly, the synthesis entailed the following: 11R or 11S 2H stearate was 
synthesized from 3R-hydroxy-decanoic. The 3R-hydroxy-decanoic acid was 
acetylated by refluxing in acetyl chloride. The decanoic acid was elongated by 
anodic coupling with monomethyl sebacate (HOOC-(CH2)8-COOCH3) and the 
ether extractable material hydrolyzed by treatment with 10% KOH in 50% 
aqueous Me0H to form 11R-hydroxystearic acid. The hydroxystearic acid was 42 
methylated with ethereal diazomethane and reacted with p-toluenesulfonyl 
chloride in pyridine to form the 11R-tosylstearate methyl ester which was 
purified by silicic acid chromatography, eluting with ether-hexane, 10:90. 11S­
stearic acid was produced by reflux of the tosylate with LiAl2H in 
tetrahydrofuran for 20 hours to form the 1,11(S) 2H stearyl alcohol. This product 
was treated with 10% methanolic KOH at reflux temperature to remove all traces 
of exchangeable labeled protons. Finally the stearyl alcohol was treated with 
Cr03 in glacial acetic acid for one hour at 50°C to produce (11S-)-stearic acid. 
To form (11R)-stearic acid, (11R)-tosylstearate methyl ester was treated 
with sodium acetate in glacial acetic acid to form (11S-)-acetoxystearate. This 
material was hydrolyzed with 25% KOH in aqueous methanol, esterified with 
diazomethane and purified by silicic acid chromatography to obtain (11 S)­
hydroxystearate methyl ester. The (11R)-stearic acid was formed from the (11S)­
hydroxy-stearate methyl ester essentially as described above for the (11R) 
enantiomer. 
The (11R) and (11S )42H] stearic acids were fed to separate cultures of 
Tetrahymena pyriformis to effect biological desaturation to form (11R) and (11S)­
[
21-1]-y-linolenic acid. The fatty acids were isolated and separated by argentation 
TLC. Owing to dilution by endogenously produced y-linolenic acid, the isolated 
material ranged from 25%-33% monodeuterated. 
The (8R) and (8S)42M-y-linolenic acids were produced similarly 
(Fahlstadius & Hamberg, 1990); however, (3R)-acetoxytridecanoic acid was 
anodically coupled to hydrogen methyl pimelate (HOOC-(CH2)5-COOCH3) to 
form (8R)-acetoxystearate methyl ester. Again, the final (8R) and (8S)-(2HH­
linolenic acid products were approximately 32% monodeuterated. 
Protein modification reagents. To explore the role of specific amino acid 
residues on the catalytic function of the enzyme several chemical modification 43 
reagents were employed. Inactivation of nucleophilic residues was attempted 
by incubating the enzyme in a 50 mM solution of iodoacetamide in 100 mM 
triethanolamine (TEA) buffer (pH 7.5) for two hours (Meens & Feeney, 1971, 
Coleman, 1968). Lysyl residues were modified by incubation of the enzyme in 
1.0 mM pyridoxal in 100 mM NaH2PO4 buffer, pH 6.5 for two hours (Price & 
Stevens, 1989, Dumas & Raushel, 1990). 
EDC [1- ethyl- 3- (3- dimethylaminopropyl )carbodiimide] has been shown to 
activate carboxylate residues to nucleophilic attack by the amine group of 
reagents such as glycine methyl ester (Hoare & Koshland, 1966, Yamada et al., 
1981). To screen for the ability of EDC coupled with glycine methyl ester to 
inactivate PFI, the enzyme was incubated in the presence of 5 mM EDC with 50 
mM glycine methyl ester in 50 mM MES buffer, pH 5.0 for 60 minutes. Because 
the substrate has a carboxylate group, it was necessary to quench any unreacted 
EDC. Therefore, the reaction solution was brought to 10 mM glycine by adding 
an equal volume of a 20 mM glycine solution. After an additional 30 minutes 
incubation, duplicate assays of the EDC/glycine methyl ester treated enzyme 
were compared to a control treatment of enzyme in MES buffer with 10 mM 
glycine. 
Diethyl pyrocarbonate (DEPC) is an effective modifier of histidine and 
tyrosine residues (Miles, 1977). To evaluate this reagent, a 0.7 M solution of 
DEPC was made by diluting the stock reagent 1:10 in acetonitrile. A 1 !IL aliquot 
of the DEPC solution was added to a 100 µL solution of NaH2PO4 buffer, pH 6.5 
containing approximately 1 X le unit PH, making a final concentration of 6.9 
mM DEPC. Control reactions were made by adding 1µL acetonitrile to an 
identical enzyme solution. Control and treatment solutions were assayed by 
diluting them with 900 pl reaction buffer in a quartz cuvette and assaying in the 
standard manner. 44 
Modification of cysteinyl residues was explored with Ellrnan's reagent 
(5,5'-dithio-bis(2-nitrobenzoic acid)) (DTNB)  (Coleman, 1969). A 250 
preparation of PH containing 16 X le unit in 100 mM TEA buffer, pH 8.0 was 
made up to 0.5 mM DTNB by adding an equal volume of a 1 mM DTNB  solution 
in TEA. A control treatment was made in an identical manner. However, the 
control was diluted with an equal volume of TEA without DTNB. At timed 
intervals, over a period of two hours, an aliquot of each solution was assayed for 
PFI activity using 131 µM arachidonate. 
RESULTS 
Protein Characterization 
Enzyme Isolation. Frozen (-70° C) tissue of P. filicina (50 g) was 
homogenized as described in materials and methods and subjected to high speed 
centrifugation (100,000 X g RCF) for 60 minutes. The high speed supernatant (S­
100) fraction as well as the resuspended pellet from the high speed centrifugation 
were assayed for activity with arachidonate. Incubation of arachidonate with the 
S-100 fraction resulted in the development of a chromophore indicative of a 
conjugated triene. Figure 11.1 illustrates the conjugated triene spectrum. The 
microsomal fraction showed no such activity. 
The supernatant from the S-100 fraction was evaluated for the effect of 
ammonium sulfate in precipitating PH activity. A series of ammonium sulfate 
"cuts" was performed to determine an appropriate level of saturation to effect the 
second crude purification step. The results are illustrated in Figure 11.2. 
Precipitation with 55% ammonium sulfate saturation consistently 
removed the majority of the highly colored phycoerytherins, resulting in a 
translucent, creamy brown solution without significant loss of PH activity. The 0.60 
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Figure 11.1 Development of a conjugated triene chromophore during the incubation of PFI with arachidonate. 46 
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Figure 11.2 Ammonium sulfate precipitation of PFI activity. The abscissa 
represents the percent ammonium sulfate saturation at 4° C, the ordinate 
represents the percent of the initial PH activity found in the precipitated 
material. 
proteins precipitating with 90% ammonium sulfate were subject to gel filtration 
on Sephacryl S-300, Figure II.3 shows the profile of PFI activity and absorbance at 
280 nm as a function of elution volume. 
Typically only about 45-60% of the total activity in the S-100 fraction was 
recovered in the 55-90% ammonium sulfate cut. However, despite the fact that 
some of the low activity fractions from gel filtration were discarded, the pooled 
fractions of PFI usually represented from 95-110% of the total activity placed on 
the column. Apparently the ammonium sulfate or some other low molecular 
weight compound in the 90% ammonium sulfate precipitant has an inhibitory 
effect on the enzyme. 47 
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Figure 11.3 Profile of PFI activity and absorbance at 280 nm vs. elution volume 
for 55-90% ammonium sulfate precipitant after sephacryl S-300 chromatography. 
Following gel filtration the active fractions were pooled, concentrated and 
subject to isoelectric focusing. Results from the preparative isoelectric focusing 
experiments indicate that PFI has an isoelectric point at pH=4.5 (Fig. 11.4). 
As a final purification step the pooled, active fractions from IEF were 
brought to 30% ammonium sulfate and fractionated by HIC (Fig. 11.5). Table 11.1 
summarizes a typical purification from 50 grams wet weight of frozen Ptilota 
filicina. 
Molecular mass determination. SDS-PAGE of the enzyme isolated through 
the IEF step shows a single major band, likely to be PFI, with an electrophoretic 
mobility corresponding to a molecular weight of 61,000 Da. That this is the 
bandcorresponding to the subunit of PFI was confirmed when the enzyme was 48 
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Figure II.4 PH activity of fractions off IEF superimposed on the pH of the 
fractions. Arrows indicate the pH of the fraction containing the highest PFI 
activity, hence the approximate pI of the enzyme. 
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Figure 11.5 Fractionation of PFI on phenyl sepharose HIC. Proteins eluted with a 
gradient of 20-0% ammonium sulfate saturated NaH2PO4 buffer, pH 7.2. 49 
Table II.1. Representative purification of PFI from approximately 50 g 
wet weight of frozen tissue. 
Fold 
Purification Step  Sp. Act.  %Recovery  Purification 
100K X g Supernatant  10.4  100  1 
55-90% (NH3)2SO4  34.4  47  3.3 
S-300 Gel Filtration  312  44  30 
IEF  1062  27  102 
HIC Chromatography  3580  25  344 
subject to HIC chromatography and SDS-PAGE of this material showed a single 
band with a relative electrophoretic mobility identical to that of the major 
fraction from IEF (Fig. II.7). 
To better assess the mass of the subunit, the enzyme was subjected to 
MALDI/MS using a time-of-flight detector and BSA as an internal standard (Fig. 
II.8). By this technique, the mass of the subunit was determined to be 58,119 Da 
with a standard deviation of 50 mass units (four replicate experiments). 
To determine the mass of the native enzyme, size exclusion 
chromatography was employed using Sephacryl S-300. By plotting the logic of 
the molecular weight of the protein standards against the elution volume, 
expressed as the Kay where: 
VeVo
Kay =  Where:  Ve = elution volume of sample 
Vt = total volume of column 
Vo = void volume of column 
the molecular weight of the unknown protein can be empirically determined 
from its elution volume (Price & Stevens, 1989). By this method a mass of 174,000 
Da was determined for PH (Fig. 11.6). 50 
While in most cases gel filtration has proven to be a rapid and effective 
method for determining the mass of native proteins, it is subject to a number of 
drawbacks. This method presumes that the protein has a globular conformation 
in solution and that there are no unusual interactions between the gel matrix and 
the protein (Cantor & Schimmel, 1980). Proteins with peculiar overall 
conformations, glycoproteins, or proteins with particularly high hydrophobicity 
will give anomalous results by size exclusion chromatography. Because PH 
showed a mass of 174 kDa by gel filtration and has only one subunit, as 
determined by SDS-PAGE, with a mass of 58.1 kDa this would indicate that the 
enzyme is a homotrimer. Although not unknown (Wood, 1977), homotrimeric 
enzymes are somewhat unusual. Analysis of the native protein by analytical 
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Figure II.6. Molecular weight determination of PH by size exclusion gel 
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centrifugation was, therefore, used as a more definitive technique for mass 
determination. 
Figure II.9 illustrates the fit of the data for the protein concentration (as 
determined by absorbance at 280 nm) as a function of radial position, where R2 is 
2 the square of the distance from the axis of rotation (in cm) and Rm s the square i
of the distance of the meniscus from the axis. This data is plotted over a 
theoretical curve for a molecule of molecular weight 125,686 (Dem ler, 1991). The 
inset shows the linear relationship of the log of the concentration (Log (C-
Baseline)) versus R2. A straight line plot of this data provides strong evidence for 
the homogeneity of the protein species under investigation ( Hansen et al., 1994; 
Van Ho 1de, 1985;). In cases where there are more than one species of 
macromolecule (e.g. a combination of monomers, dimers and/or trimers), one 
will observe a non-linear relationship by this analysis. Hence, by sedimentation 
equilibrium ultracentrifugation a mass of 125,686 ± 743 Da was determined for 
PFI, indicative of a homodimeric quaternary structure. 
Amino acid analysis. Results from the amino acid composition analysis are 
presented in Table II.2. The cysteine composition of PH was calculated as 
follows: the values for the performic acid digest were adjusted to correspond to 
the HC1 digest by calculating the ratio between them. The average ratio of the 
Arg, Lys, Phe, Leu and Ile residues was used (= 0.992). (These residues are the 
most stable to performic acid digestion.) By multiplying the performic acid value 
for cysteine by this factor and subtracting the 'background" of cysteic acid in the 
HCL digest, the relative cysteine composition of the HCL digest was determined 
to be 0.281 nmol. The amino acid composition for a PFI subunit was then 
determined by normalizing all of the residues to the lowest relative residue 
(cyteine) and assigning it a value of one. Then, by calculating the molecular 
weight contributed by each residue a.minimum molecular weight of 8602.15 was 55 
determined for this normalized unit. Taking the mass of the subunit to be 58,119, 
it is divisible by the minimum normalized unit by six. This leaves a mass of 6506 
which is attributed to 35 tryptophan residues (tryptophan is destroyed in both 
Table 11.2. Amino Acid analysis of PFI. 
Amino Acid 
Cysteic 
Aspartate 
Threonine 
Serine 
Glutamate 
Pro line 
Glycine 
Alanine 
Valine 
Methionine 
Isolucine 
Leucine 
Norleucinea 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
nmol
 
(HCL Digest)
 
0.073 
3.707 
2.385 
1.857 
2.689 
1.39 
2.013 
2.584 
2.255 
0.415 
1.100 
2.277 
2.027 
1.037 
1.574 
0.470 
1.431 
0.925 
nmol 
(Performic Acid Digest) 
0.357 
4.108 
2.443 
1.913 
2.837 
1.40 
2.134 
2.689 
2.298 
N/D 
1.116 
2.290 
2.026 
N/D 
1.541 
0.459 
1.397 
0.984 
a Norleucine was included as an internal standard. 56 
Table II.3 Calculated amino acid composition of PFI per subunit. 
Amino  Normalized  Molec  Mass per  Residues  Mass 
Acid  value  Wt  Normalized  Per  Per 
Subunit  Subunit  Subunit 
Ala  7.23  71  513.91  43  3083.46 
Arg  1.59  156  248.20  10  1489.20 
Asp/Asn  10.38  115  1194.13  62  7164.78 
Cys  1.00  103  103.00  6  618.00 
Glu/Gln  7.53  129  971.66  45  5829.96 
Gly  5.63  57  321.40  34  1928.40 
His  1.31  137  180.36  8  1082.16 
Ile  3.08  113  348.18  18  2089.08 
Leu  6.37  113  720.73  38  4324.38 
Lys  4.00  128  513.08  24  3078.48 
Met  1.79  131  235.58  11  1413.48 
Phe  4.40  147  648.12  26  3888.72 
Pro  3.89  97  377.68  23  2266.08 
Ser  5.20  87  452.55  31  2715.30 
Tip  - 186  34a 
0.00 
Thr  6.68  101  674.75  40  4048.50 
Tyr  2.90  163  473.48  17  2840.88 
Val  6.31  99  625.34  38  3752.04 
I = 8602 Da  I = 51613 Da 
aThe number of tryptophan residues is estimated from the difference in the knownmass of 
the subunits (58,115) and the mass calculated from the amino acid composition excluding 
tryptophan (51612). No allowance is made for the mass of any cofactors hence 34 is the 
upper limit for tryptophan. 
the HCl and the performic acid digest). Although this represents a relatively 
high trytophan composition, it is consistent with the calculated E280 = 26 found in 
preparations of highly purified enzyme. It should be noted that the amino acid 
composition analysis does not take into consideration the presence of any 
cofactors. As shown below, metal ions (and possibly a flavin) are, in fact, 57 
associated with the enzyme. As the quantification of these cofactors has not been 
rigorously determined, the number of tryptophan residues cannot be firmly 
established. It will be necessary to subject the purified protein to NaOH 
hydrolysis or methanesulfonic acid hydrolysis to definitively determine the 
trytophan content (Lundblad & Noyes, 1984). With these caveats, the calculated 
amino acid composition per subunit of PR is presented in Table 11.3. 
Because acid hydrolysis of the protein also results in hydrolysis of the 
amine functionalities of glutamine and aspartamine, it is not possible to 
quantitatively determine the number of glutamates versus glutamines or 
aspartates versus aspartamine. However it is clear from the relatively low pI of 
the enzyme that there are a substantial number of acidic residues present. 
N-terminal sequencing. N-terminal analysis of the enzyme resulted in the 
following determination: Asp(?)-Asp-Phe-Asp-Asp-Thr-Ile-Ala-Val-Val-Gly-Ala-
Gly-Tyr-Ser-Gly-Leu-Ser-Ala-Ala-Phe-Thr-Leu-Val-Lys-Lys-Gly-Tyr-Thr-Asn-
Val-Glu-Ile-Tyr-Ser-Gln-Gln-Tyr(?). The question marks after the Asp at position 
one and the Tyr at position 38 indicates that there is some ambiguity concerning 
the identity of these two residues. There was a substantial concentration of 
histidine detected in the first round of hydrolysis and at position 38 the signal-to­
noise ratio became significant. Otherwise, the sequenced residues appear as 
dominant peaks in the chromatogram at each cycle of the sequencer. In fact, the 
calculated quantity of residues in the initial five cycles ranged from 120 to 153 
pmol, in close agreement to the concentration of PFI subunits submitted for 
analysis. 
Cofactors. As the enzyme reached higher levels of purification it was 
observed that, upon concentration, a distinctive green-yellow coloration was 
discerned. Efforts to obtain UV/Vis absorption data of the purified enzyme 
usually resulted in weak, poorly defined spectra due to insufficient amounts of 0.10 
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Figure 11.10 UV spectrum of purified PFI. The PFI was at a concentration of 200 p.g/mL. 59 
protein. However, one preparation of PH contained sufficient enzyme to show 
an absorbance spectrum (Fig. 11.10) strikingly similar to published spectra of 
flavin containing proteins (Massy & Ganther, 1965). Moreover, taking an 
E=14,100 Ne cm-1 (Ghisla at al., 1974) for the putative flavin cofactor, the 
adsorbance at 452 nm corresponded closely with the calculated molar 
concentration of the protein at a ratio of one flavin per subunit. This material 
was examined by fluorescence spectroscopy in an effort to elicit a fluorescence 
spectrum characteristic of a flavin. Unfortunately, this was not observed (as is 
often the case with protein bound flavins (Beinert, 1960)). 
ICP/MS Analysis. Analysis of the metal content of an aliquot of PFI 
containing 47 p.g of protein (810 pmol of subunits) was performed by ICP/MS. 
For comparison, a sample of soybean lipoxygenase and BSA were prepared at a 
50 p,g/mL concentration. In addition, a preparation of lipoxygenase at 336 
p.g/mL concentration was analyzed to evaluate the effect of increasing the 
amount of the metalloprotein. Table 11.4 shows the results of these experiments. 
These data indicate the presence of relatively high levels of iron in PH; there also 
appears to be significant amounts of zinc, copper and magnesium. 
The control experiments with lipoxygenase and BSA clearly differentiated 
the presence of iron in the lipoxygenase versus BSA; however, the concentrations 
were surprisingly low. In the 50 p.g/mL lipoxygenase sample, we expected to 
see approximately 29 ppb Fe 57 and at 336 p.g/mL approximately 195 ppb; 
instead we saw 1.7 and 26 ppb respectively. The activity of the soybean 
lipoxygenase was determined when the lyophilized powder was brought up in 
buffer and again immediately prior to ICP/MS analysis (after treatment with 
EDTA and buffer exchange). It had lost approximately 50% of its activity during 
preparation; possibly some of the iron content was lost during this treatment. 
We also observed a substantial amount of manganese in the lipoxygenase. The Table II.4 Concentration of selected ions in preparations of lipoxygenase (LOX), Bovine Serum Albumin (BSA) and
Polyenoic Fatty Acid Isomerase (PFI) as determined by ICP/MS. 
Isotope  LOX a  LOXb  LOXb  BSA c  PFI  PFIc 
(50 pg/m1)  (50 pg/m1)  (336 lig/m1)  (50 lig/m1)  (corrected) 
Mg 24d  4.1  0.0  11.9  0.0  340.1  337.8 
V 51  0.1  0.1  0.5  0.0  0.8  0.7 
Fe 55  70.2  5.5  30.7  0.0  308.4  271.2 
Fe 57e  83.2  1.7  26.0  0.0  446.1  406.4 
Mn 55  3.6  3.3  21.4  0.0  7.6  7.5 
Co 59  0.1  0.0  0.1  0.0  1.3  1.3 
Ni 60  1.5  0.0  0.0  0.2  13.6  13.4 
Zn 64  2.4  0.8  7.1  0.0  104.7  103.8 
Zn 66  1.9  1.1  8.4  0.6  79.6  79.0 
Cu 65  2.2  0.2  2.0  0.0  101.7  101.0 
Mo 95  0.3  0.0  0.0  0.0  2.0  1.9 
a No background subtraction. b LOX spectra with 50 gg/m1 BSA spectra subtracted. C Phosphate buffer spectra 
subtracted. d Interference by C2+ ions can occur. e Fe 56 data was not included because of extensive interference by 
ArO ions. 61 
purity of the lipoxygenase preparation was not assessed; contaminating proteins 
could be the source of these other metals. 
In comparison, PH showed dramatically higher Fe 55 and Fe 57 content 
than expected. Assuming one iron molecule per subunit we expected to see 
approximately 22.5 ppb in the aliquot assayed. After subtraction of the buffer 
background we observed 406 ppb iron. Although the magnesium content 
ions i appears to approach that of iron, interference by C2 ons s frequently observed 
from organic compounds upon ionization with inductively coupled plasma and 
is likely responsible for much of the Mg 24 count. Without further evaluation of 
the precision of the instrument or our methodology for quantitative analysis it is 
difficult to derive more from these results. Certainly, interpretation 
of these data suggests that there are metals associated with the enzyme, in 
particular iron. It is possible that there may be several residues of iron, as well as 
other metals, per subunit. Unfortunately, limited access to the ICP/MS 
instrument precluded further experimentation. 
Neutron activation analysis. Results from NAA showed a significant 
intensity of radiation at the 1291 keV energy level 18 days after neutron 
bombardment. This y-emission pattern is characteristic of Fe59 decay (Laul, 
1979). Quantitation, by comparison to the external standard, showed the PFI 
solution to contain 37 ppm in 0.192 g of solution. This calculates to 0.12 innol of 
Fe59. The protein solution contained 1.67 X 10-3 innol of subunits, i.e. 
approximately 75 iron atoms per subunit. 
pH and ionic strength optimum. The optimum buffer and pH conditions for 
the enzyme was explored using a series of buffers over a range of pH from 2.0 to 
8.0. As illustrated in Figure 11.11 the effective range of each of these buffers was 
overlapped in order to directly compare the different buffers at a fixed pH. 62 
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Figure 11.11. Comparison of observed velocity of PH with various buffers over a 
range of pH. All reactions were performed under substrate saturating conditions 
(± S.E.M., n=3). 
Results from these experiments indicate that the activity of PFI is relatively 
unaffected by the type of buffer used. However, there is approximately a 2.4 fold 
increase in observed velocity at pH 4.5 relative to the velocity observed at pH 7.5 
under the reaction conditions employed. 
To directly compare the effect of buffer composition on the observed 
velocity the following buffers were made up at pH 4.5: 50 mM NaH2PO4, 50 mM 
Citrate, 50 mM BisTris, 25 mM BisTris/25 mM Citrate, and 25 mM NaH2PO4 /25 
mM Citrate. Each buffer was evaluated by triplicate assays of PFI with 131 11M 
arachidonic acid. The results are presented graphically in Figure 11.12 as the rate 63 
BisTris  Citrate NaHPO4  BisTris/ Citrate/
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Figure 11.12. Comparison of observed velocity in various buffers at pH 4.5 (± 
S.E.M., n=3). 
of increased absorbance at 276 nm ± S.E.M. Again there appeared to be little 
difference in the observed velocity due to different buffer components. A 
moredetailed analysis of the pH effects on the kinetic parameters of PFI is 
described in a following section. 
Detergent evaluation. To facilitate solubilization of the fatty acid substrates 
for PH and to reduce turbidity, thereby improving the spectrophotometric assay, 
it is necessary to use a detergent. A series of detergents (see experimental) were 
evaluated for their efficacy in this regard. Triton X-100, NP-40, CHAPS, and 
cholic acid all resulted in unacceptably high levels of turbidity. Results of the 
other detergents are presented graphically in Figure 11.13 as the rate of increased 
absorbance at 276 nm per minute ± S.E.M. Although Brij-35 appeared to be the 
best detergent it was found that routine use of this detergent was unpredictable, 64 
Tween-20 Brij-35 Lubrol-PX Digitonin  SDS 
Figure 11.13 Comparison of detergent effect on observed velocity of PFI (± 
S.E.M., n=3). Detergent concentrations were 0.02% (vol./vol.) except SDS which 
was at 0.02% (wt./vol.). All experiments were under substrate saturating 
conditions using arachidonate. The same enzyme preparation was used for all 
assays. 
at times causing unacceptably high levels of turbidity; hence, Tween-20 was 
chosen as the detergent for all subsequent assays. SDS appeared to denature the 
enzyme, as a distinct rate decrease was observed during the course of the three 
minute assay. 
Ionic Strength Optimum. In addition to pH and buffer, an important 
consideration in optimizing enzyme reaction conditions is the ionic strength of 
the reaction solution. The lipoxygenase from Gracilariopsis lemaneiformis has a 
requirement for high (>1M) NaC1, with the Na+ ion being specifically required 
(Hamberg & Gerwick, 1993). To evaluate the ionic strength requirements for PFI 
and to determine if any specific ion was necessary, a series of experiments was 
performed with NaH2PO4 buffer and NaCl. Figure 11.14 shows the different 65 
buffer and NaC1 concentrations used and their effect on reaction velocity (as the 
rate of increase in absorbance at 276 nm). There is a clear enhancement of 
activity at higher ionic strengths, with a maximum reached at an ionic strength of 
1.0. The concentration of Na+ also appears to play a role, as evidenced by the 
significant difference in activity between the 100 mM NaH2PO4 reaction mixture 
and the 10 mM NaH2PO4 with 0.27 M NaC1 reaction mixture. Both of these 
solutions have ionic strengths of 0.30; however, the 0.27 M NaC1 solution showed 
approximately a 36% increase in reaction rate. Although not as dramatic as the 
effect seen with G. lemanieformis lipoxygenase, these results indicate an 
enhancement of PFI activity in a high ionic strength environment and point to a 
specific role for Na+. 
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Figure 11.14. Effect of ionic strength and NaC1 concentration on PFI (± S.E.M., 
n=3). 66 
To further evaluate the specificity of the Na+ ion, another series of 
experiments was performed using 50 mM NaH2PO4 buffer with KI, KC1, NaBr at 
0, 0.15, and 0.85 M concentrations representing ionic strengths of 0.15, 0.30 and 
1.0 respectively. Also included in this experiment was ammonium sulfate at 0.05 
and 0.28 M, corresponding to ionic strengths of 0.3 and 1.0 M respectively. The 
results are presented in Figure 11.15. Here again, a clear relationship is seen 
between ionic strength and reaction velocity and the dependence on Na+ for 
maximum effect. The inhibitory effect of ammonium sulfate should also be 
noted. 
Ionic  Strength 
Figure 11.15 Effect of various salts over a range of ionic strengths on the apparent 
velocity of PFI (± S.E.M., n=3). EPA was used as the substrate under saturating 
conditions. 67 
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n=3). 
Finally, to evaluate the effect of PO4 2 on PFI activity, an experiment was 
conducted using sodium citrate buffer at concentrations ranging from 8 mM to 
280 mM representing ionic strengths from 0.05 to 1.7 M. The pH of each solution 
was adjusted to 6.5 with citric acid or NaOH as required. As illustrated in Figure 
11.16, increased velocity was observed with increasing ionic strength, reaching a 
plateau at an ionic strength of about 0.9. There appears to be no specific 
requirement for P042. Comparison of the rates of reaction shown in Figure 11.16 
to those in Figure 11.14 (performed under identical conditions of substrate 
concentration and enzyme used) illustrates that they are approximately thesame, 
indicating that P042 has no inhibitory effect (a problem in some metal cofactor 
requiring enzymes (Stoll & Blanchard, 1990)). 68 
Enzyme Mechanism 
Characterization of reaction product with arachidonate. To establish the 
chemical nature of the product formed from incubation of the enzyme with 
arachidonate 38, a large scale incubation was performed. A preparation of 
enzyme from Sephacryl S-300 size exclusion chromatography was diluted to 100 
mL with reaction buffer to which 10 mg of arachidonate in 100pL EtOH was 
added (328 1.1.M final concentration). After approximately 40 minutes, the 
reaction was quenched with 5 volumes of Me0H and the lipid material 
extracted. The methyl esters of the products and unreacted arachidonate were 
separated by HPLC. By a combination of 1H NMR, 1H-1H COSY, GC/MS and 
UV spectroscopy, the major product of arachidonate incubation was identified as 
a new conjugated triene metabolite 39, 5Z,7E,9E,14Z-eicosatetraenoic acid. 
Low resolution mass spectral analysis of the methyl ester derivative of 39 
indicated a molecular ion with a m/z = 318, in agreement with a molecular 
formula of C21143402. 1H-1H COSY (Fig. 11.17) analysis readily demonstrated 
coupling from the C2-methylene at 82.33 through the aliphatic chain to the C5 
olefinic proton at 85.33. Coupling from the C20 methyl at 80.89 through the 
aliphatic protons to the C15 olefinic proton at 85.33 was also clearly evident. The 
proton band at 85.33 was further coupled to a deshielded olefinic spin system 
descriptive of the conjugated triene. The UV spectrum of this product showed 
three maxima (Fig. 11.1) characteristic of a conjugated triene with Xmax (EtOH) 
262, 272, 282 nm. Additionally, the 85.331H NMR band showed coupling to one 
end of three sequentially coupled methylene groups (C11, C12, C13). Because the 
C2-C4, C16-C20 and C6-C13 spin systems all coupled to the signal at 8 5.33 
(representing the protons at C5, C14 and C15) it was not clear if this arachidonate 
metabolite was 5, 7, 9, 14-eicosatetraenoic acid or 5, 10, 12, 14-eicosatetraenoic 69 
acid. The question of the regiochemistry of the double bonds was resolved by a 
selective proton decoupling experiment. Irradiation of the C4 protons at 8 2.23 
collapsed the broad doublet of doublets at 8 6.04 (H-6) to a sharp doublet of 
doublets (Fig. 11.18), reflecting the loss of the long range allylic coupling between 
these protons, thereby establishing the position of the conjugated double bonds 
occurring between C5 and C10. Coupling constants of 3J5_6=11.0 Hz, 3J7-8=13.7 
Hz and 3J9 -10 =14.1 Hz defined the geometry of these three olefins as 5Z, 7E, 9E. 
We could not definitively determine the relative stereochemistry of the C14-C15 
olefin in 39, however, it is reasonable to expect this bond to be unchanged from 
the cis configuration of the substrate, as found in the naturally occurring EPA-
derived conjugated triene metabolites (e.g. 36, Lopez & Gerwick, 1987). 
Reaction with Alternative Substrates. The substrate specificity of PH was 
evaluated with several alternative fatty acid substrates. In experiments to 
determine the suitability of y-linolenate as a substrate, a comparison of the kinetic 
parameters of y-linolenate, arachidonate and EPA was performed. As shown in 
Figure 11.19, eicosapentaenoate is the best substrate and the following parameters 
were determined: EPA, (Kar = 32.8 ± 7.7 pM and Vmax=14.0 timol min4mg-1), 
ap p
arachidonate (Km = 39.9 ± 27 pM and Vmax = 7.0 pmol min-1 mg-1) and y­
linolenate (Kr = 150 ± 35 pM and Vmax = 4.0 pmol mirilmg-l)2. The values are 
given as apparent Kms and Vmaxs because the assays were performed at a pH 
above the optimum (see below), the effects of Tween-20 on the enzyme and the 
critical micelle concentration for the substrates were not determined, and the 
enzyme was not demonstrably pure. 
2A Km this high likely reflects the unavailability of the fatty acid due to insolubility. 70 
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To further probe the nature of the substrate binding and catalytic site, a 
series of experiments was performed using the following fatty acids: 4Z, 7Z, 10Z, 
13Z, 16Z, 19Z docosahexenoic acid 40; adrenic acid 41 (7Z, 10Z, 13Z, 16Z, 
docosatetraenoic acid; docosatrienoic acid 42, (13Z, 16Z, 19Z docosatrienoic acid; 
eicosatrienoic acid 43, (5Z, 8Z, 11Z, eicosatetraenoic acid); dihomo-y-linolenic 
acid 44 (8Z,11Z, 14Z, eicosatrienoic acid); a-linolenic acid 45 (9Z, 12Z, 15Z 
octadecatrienoic acid); linoleic acid 46 (9Z, 12Z octadecadienoic acid) and 
anandamide 47 (arachidonyl-N-ethanolamide). These substrates were first 
examined by incubating them with PFI in the standard reaction buffer (100 mM 
NaH2PO4, pH 7.2 with 0.02% Tween-20) and observing the development of a 73 
chromophore over time. All of these proved to be substrates for PFI (showing 
the development of a triene chromophore) with the exception of linoleic acid 46, 
which showed a chromophore with a single UV maximum at 238 nm, 
characteristic of a conjugated diene. Docosahexenoic acid 40 and adrenic acid 41 
appeared to be reasonably good substrates, as their chromophores developed 
rapidly. Somewhat surprisingly, eicosatrienoate 43 proved to be a poor 
substrate, showing relatively slow chromophore development. 
Substrate limiting studies were performed on the docosahexenoic acid 40, 
adrenic acid 41, EPA 37, arachidonic acid 38, eicosatrienoic acid 43 and 
anandamide 47 to quantify their kinetic parameters; the results are presented in 
Table 11.5. 
Note that the kinetic parameters for EPA and arachidonate presented in 
Table 11.5 differ somewhat from the initial experiments. The values in the table 
reflect experimental conditions with a more appropriate range of substrate 
concentrations, hence, they are considered more accurate. 
In the initial experiments to evaluate the pH optimum of the enzyme, a 
number of buffers ranging from pH 2.0 to 8.0 were examined. Observation of a 
maximum velocity at pH 4.5 suggests that the enzyme recognizes the protonated 
form of the substrate. This hypothesis was addressed by assaying PFI with the 
methyl ester of arachidonate. Although the enzyme utilizes the methyl ester, the 
rate appears to be approximately 10 fold slower than that of the free acid at pH 
7.2. Because of the low solubility of the methyl ester in aqueous solution, it is 
difficult to interpret these results unequivocally. However, using the methyl 
ester, a 2.4 fold increase in velocity between pH 7.2 and 4.5 was again observed. 
I have also discovered that PFI will utilize another non-ionizable analog of 
arachidonate, arachidonyl-N-ethanolamide 47, as a substrate (see Chapter 111). 
The enzyme shows an apparent velocity maximum at pH 4.5 with this 74 
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compound as well; hence, it appears that an ionized carboxylate is not absolutely 
required for binding and that the pH optimum, at least partially, reflects 
characteristics of the enzyme. A more detailed investigation of the pH effects on 
the enzyme is described below. 
Reaction of PH with DHA 40 and adrenic acid 41 produced a triene 
chromophore as evidenced by UV spectroscopy. However, because DHA is a 22 
carbon, 0 -4 fatty acid the regiochemistry of the conjugated triene system was not Table 11.5. Kinetic parameters of PFI with various substrates (± S.E.). 
Docosa- Adrenate  EPA  Arachidonate  Eicosatrienoate  Anandamidea 
hexaenoate 
Vmax  1.84 ± 0.11  1.10 ± 0.035  6.0 ± 0.32  2.78 ± 0.16  0.31 ± 0.021  0.80 ± 0.09 
(Ith4 min-lmg-1) 
Km (RM)  1.9 ± 0.36  17.0 ± 1.5  9.61 ± 1.2  25.5 ± 3.9  52.8 ± 9.2  17.5 ± 5.0 
Vmax/Km  0.97  0.065  0.62  0.11  0.006  0.045 
a All experiments performed at pH 7.0 in NaH2PO4 buffer except anandamide which was performed in TB. 
Values calculated from non-linear regression analysis using EnzfitterTM software. 76 
clear. One might assume that the product has the conjugated system starting at 
the first olefinic group as is the case with the 20 carbon fatty acids examined, 
resulting in 4Z, 6E, 8E, 13Z, 16Z, 19Z docosahexenoic acid 49. However, the 
possibility of the 4Z, 7Z, 9E, 11E, 16Z, 19Z, 48, the 4Z, 7Z, 12E, 14E, 16Z, 19Z; or 
the 4Z, 7Z, 9E, 15E, 17Z, 19Z isomers could not be discounted. Indeed, the 4Z, 
7Z, 9E, 11E, 16Z, 19Z isomer 48 would be the expected product if the enzyme 
recognizes the methyl terminus in positioning the substrate within the catalytic 
pocket. 
To determine which isomer was produced, a large scale incubation of 
DHA 40 with PFI was performed using 10 mg DHA in 50 mL reaction buffer (100 
mM NaH2PO4, pH 6.5 with 0.02% Tween-20) final concentration 60811M and 18.5 
X 10-3 unit of pure PFI. After eight hours the increase in absorbance at 276 nm 
plateaued at 7.35 A.U., representing 2.12 mg triene product (21% conversion). 
The reaction was quenched with five volumes of Me0H and the lipids were 
extracted, methylated and the methyl esters separated on HPLC using the 
standard protocol. The isolated triene product (0.89 mg total) was analyzed by a 
combination of UV/Vis spectroscopy, GLC/MS, 1H NMR, 1H-1H COSY, and 
nOe difference experiments. In CDC13, signals at 2.77 and 2.95 ppm (Fig. 11.20), 
showing a broad doublet of doublet pattern characteristic of bisallylic protons, 
were observed, each integrating for two protons. The H2-2 and H2-3 signals 
appeared as a broad multiplet at 82.39 integrating for four protons. The H-22 
protons appeared as a sharp triplet at 0.97 ppm. However, the co-2 protons (H­
21), characterized by a quadruplet at 2.11 ppm in DHA, were buried in the 
complex signal from the H-13 and H-15 methylenes. 
To confirm the connectivity of the proton signals a 1H-1H COSY 
experiment was conducted in d6-benzene (Fig 11.21). In benzene the broad 
multiplet observed at 82.39 in CDC13 separated into distinct signals at 82.30 and 77 
52.11 ppm. The 1H-1H COSY experiment showed coupling from the A-2 
methylene at 52.30 through the methylene at 52.11 (H2-3) to the olefinic protons 
at 55.28 -5.50. The terminal methyl protons at 50.92 coupled to a cluster of 
methylene protons at 82.02 (integrating for six protons), these coupled to a 
methylene at 81.39 as well as the olefinic protons at 55.28 -5.50; demonstrating 
that the H2-21 signal is buried in the peak attributable to the H2-13 and H2-15 
methylenes. The bisallylic methylenes (appearing at 52.81 and 82.91) both 
showed crosspeaks with the cluster of olefinic protons at 85.28-5.50 (and nothing 
else). The lowfield olefinic spin system showed couplings from the cluster at 
85.28-5.50 through the proton at 86.08 to the proton at 85.59 then to 86.13 , 86.21 
and finally to the signal at 86.51. In benzene H-8, 9, 10 and 11 are shifted slightly 
down field and H-12 shifted slightly up field relative to the spectrum in CDC13. 
Proton decoupling experiments in CDC13 (Fig. 11.20) demonstrated a long 
range allylic coupling between the bisallylic group at 82.95 and the olefin at 
86.01. Irradiation at 2.39 ppm showed no effect on any of the low field signals 
and irradiation of the bisallylic signal at 2.77 ppm only resulted in an abstruse 
alteration of the signal at 85.17-5.43. In d6-benzene, irradiation of the bisallylic 
signal at 82.91 resulted in a sharpening of the lowfield signal at 86.08. This 
spectrum could only result if two bisallylic groups are present and one is 
allylically coupled to the conjugated triene system. Hence the product of 
reaction of DHA with PH is neither the 4Z, 6E, 8E, 13Z, 16Z, 19Z isomer nor the 
4Z, 7Z, 9E, 15E, 17Z, 19Z isomer. 
To differentiate the two remaining possibilities (the 4Z, 7Z, 12E, 14E, 16Z, 
19Z versus the 4Z, 7Z, 9E, 11E, 16Z, 19Z isomer) a series of nOe difference 
experiments was performed. By irradiating the conjugated triene 48 in CDC13 at 
2.39 ppm (H2-2, 3) a slight, though distinct enhancement of the signal at 82.95 
(H2-6) was observed. When the sample was irradiated at 2.95 ppm (H2-6) an nOe 78 
decoupled at 2.77 ppm (H2-18) 
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Figure 11.20. 1H NMR spectra of docosahexaenoate conjugated triene methyl 
ester 48 in CDC13. Bottom, standard proton spectrum; middle, decoupled at 2.95 
ppm (H2-6); top, decoupled at 2.77 ppm (H2-18). 79 
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Figure 11.21. 1H-1H COSY of docosahexaenoate conjugated triene methyl ester 48
 
in d6-benzene.
 80 
nOe at 2.06 irradiated at 2.77 ppm 
nOe at 2.95  irradiated at 2.39 ppm 
irradiated at 2.95 ppm	  nOe at 2.39 
a--/ 
6.5  6.0  5.5  5.0  4.5  4.0  3.5  3.0  2.5  2.0 
PPM 
Figure 11.22. NOe difference spectra of docosahexaenoate conjugated triene 
methyl ester 48 in CDC13. Bottom spectrum, irradiation of bisallylic protons at 
2.95 ppm with enhancement at 2.39 ppm (H2-2,3). Middle spectrum, irradiation 
at 2.39 ppm (H2-2,3) with enhancement at 2.95 ppm (H2-6). Top spectrum, 
irradiation of bisallylic protons at 2.77 ppm with enhancement at 2.06 ppm (H2­
21). 
1.5 81 
was observed to signals at 82.39 (H2-2, H2-3), 85.40 and 86.40 (H-9). Finally, 
irradiation at 2.77 ppm (H2-18) resulted in an nOe to 80.97 (H3-22), 82.06 (H2-21) 
and 85.40 (H-17, H-20) (Fig 11.22). These "through space" dipole-dipole couplings 
of the bisallylic methylene at 82.95 (H2-6) with the aliphatic methylenes at 82.39 
(H2-2, H2-3) as well as the bisallylic methylene at 62.77 (H2-18) with the col 
methyl and the co2 methylene at 60.97 and 82.06 respectively firmly establish the 
double bonds at the 4,7,9,11,16 and 19 positions. The relative stereochemistry of 
the conjugated system is based on coupling constant analysis as in the conjugated 
triene 39 from arachidonate. Again, the relative stereochemistry of olefins at the 
4, 16, and 19 positions could not be defined from this data; they are presumed to 
be unchanged from the substrate. The product of the isomerization of DHA by 
PFI is 4Z, 7Z, 9E, 11E, 16Z, 19Z docosahexenoic acid 48 (Scheme 11.2). 
DHA 
PFI 
o' 
48 
Scheme II.2 
The reaction with dihomo-y-linolenic acid also provided insight into the 
mechanism of PFI. Although the reaction was slow relative to other substrates 
the reaction products showed the simultaneous development of two 82 
chromophores, one with the characteristic triene absorption pattern and another 
with a single maximum at 238 nm (Fig. 11.23). This appeared to represent the 
production of both a diene and a triene, in concert. To further investigate this 
phenomena a large scale incubation was performed using 33 X le unit of 
enzyme in 50 mL reaction buffer (100 mM NaH2PO4, pH 6.5 with 0.02% Tween­
20) with 5 mg dihomo-y-linolenic acid (final concentration = 327 gM). The 
reaction was allowed to run at room temperature and monitored with periodic 
spectra. After nine hours, when the triene chromophore appeared to reach a 
maximum, the reaction was quenched with five volumes of Me0H, the lipids 
extracted and methylated for GLC/MS analysis. At the time the reaction was 
quenched the UV spectrum showed a A.238 = 1.81, representing 1.0 mg diene and 
A.276 = 1.02, representing 0.24 mg triene (using e = 24,000 M-1cm-1 (Smith & 
Lands, 1972) and e = 57,000 M-lcm-1 (Lopez & Gerwick, 1987) respectively), i.e. 
approximately a 4:1 ratio of diene to triene in the products. GLC/MS analysis of 
the methylated reaction products showed three distinct peaks on the 
chromatogram, all with a Mobs =320, corresponding to the methyl esters of 
dihomo-y-linolenic acid, the conjugated diene 50 and the triene 51 (Fig. 11.24). 
A similar reaction was performed with a-linolenic acid. In 50 mL of 
reaction buffer 5 mg cc-linolenic acid (final concentration = 36011M) was 
incubated with 16.5 X 10-3 unit of enzyme overnight (23.5 hours). The reaction 
was quenched with Me0H and the lipids extracted and methylated. Although 
the diene chromophore did not appear as rapidly, appearing only as a shoulder 
to the triene chromophore during the first 14 hours of the reaction, it was clearly 
present prior to termination of the reaction. The UV spectra showed A.238=1.03 
and A.276=1.07, representing 0.51 mg diene 52 and 0.26mg triene 53. Again, the 
GLC/MS analysis of the methyl esters showed three distinct peaks, all with Mobs 
= 292 corresponding to a C19H3202 molecular formula. These likely 0.75 
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Figure 11.23. UV spectrum of products from incubation of PFI with dihomo-y-linolenic acid, 50 putative conjugated
diene, 51 conjugated triene. 84 
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Figure 11.24 GLC chromatogram of methyl esters of reaction products of PH with 
dihomo-y-linolenate. All three major peaks had M+=320 (the minor peaks 
accompanying each major peak showed a mass spectrum identical to the 
associated major peak, hence likely represent thermal isomerization). 85 
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represent the methyl esters of a-linolenate as well as the conjugated diene and 
conjugated triene isomers. 
Reaction in 2H20. To determine if either of the hydrogens involved in 
saturating the C11-C12 double bond of arachidonate originated from the solvent, 
the biosynthetic reaction was performed in deuterium oxide (99.8%) buffered 
with 100 mM NaH2PO4 at pH 7.2. The pH of the deuterium oxide was measured 86 
directly; no correction was made for the deuterium effect (approximately 0.4 pH 
unit). 
The reaction mixture consisted of 5.0 X 10-3 unit of partially purified 
enzyme, 5 mg of arachidonate (in 50 !IL EtOH), and 20 mL buffer with 0.02% 
Tween-20. The reaction was monitored by observing the UV spectra of aliquots 
taken at intervals. After approximately 27 hours, when no further increase in 
absorption at 278 nm was measured, the reaction was quenched with five 
volumes of Me0H, the lipids extracted and methylated. 
The UV absorbance (272 nm) of the conjugated triene 39 corresponded to 
2.2 mg (out of 3.9 mg total fatty acid methyl esters extracted). GLC/MS showed 
two major peaks, representing the methyl ester derivative of unreacted 
arachidonate and the conjugated triene product. The molecular ion of the 
product triene methyl ester had a m/z 319, demonstrating the incorporation of 
one deuterium atom from the solvent (ratio m/z 318/319 = 0.10). Unfortunately, 
the fragmentation pattern of the triene was not unequivocally diagnostic for the 
location of the incorporated deuterium atom, although this presumably occurred 
at either C11 or C12. 1H NMR analysis was used to resolve this question. 
The deuterium-containing triene product was separated from the 
arachidonate by HPLC of the methyl ester derivatives as described earlier and a 
1H NMR spectrum obtained. Figure 11.25 shows the spectrum of the deuterated 
triene with salient features of the normal protonated species superimposed above 
it. Collapse of the pentet at 5.7 ppm and the multiplet at 1.45 ppm representing 
protons at C10 and C12 respectively, as well as the diminution of the signal at 2.1 
ppm in the deuterated product, unequivocally demonstrated incorporation of 
one deuterium atom at C-11. 
Intramolecular hydrogen transfer in stereospecifically labeled y-linolenate. From 
the results of the incubation of the PFI with arachidonate in D20 it was 87 
clear that protonation of C12 results from transfer of a substrate derived proton 
(or hydrogen). This could occur either as an intermolecular transfer or an 
intramolecular transfer. The intramolecular mechanism was examined first. An 
allylic 1,3-proton shift from C10 was most easily envisioned. However, the 
possibility of transfer from C7 could not be ruled out. To test which of these two 
processes occurs, the enzyme was incubated in separate experiments with (11R)-, 
(11S)-, (8R)-, and (8S)-deuterio-y-linolenic acids. As indicated earlier, y-linolenic 
acid functions reasonably well as a substrate. With respect to the bisallylic 
methylene groups, C7 and C10 of arachidonate correspond to C8 and C11 of y­
linolenate. 
For these experiments the enzyme had been additionally purified by 
isoelectric focusing (Table 11.1, Fig. 11.7). Because it was determined that the 
conversion of arachidonate to the conjugated triene was approximately two to 
three times faster at pH 4.5  5.0 than at pH 7.2, all reactions with 2H-labeled y­
linolenate were performed at pH 5.0. As is clearly evident from Table 11.6, 
incubation of PH with (11S)411-21-1[-y-linolenic acid resulted in retention of 
deuterium in the product (19.4%) and a pronounced isotopic enrichment of the 
unreacted substrate (74.5%). Reaction with (11R)- [112H]- y- linolenic acid again 
showed retention of deuterium in the product (24.1%), however, no isotopic 
enrichment of the unreacted substrate was observed (23.9%). The ratios of the 
fragments at m/z 207 and 208 indicated the position of the 2H-label in the 
products (Table 11.6). Cleavage of the undeuterated and methylated triene 
product between the C-12,13 bond results in a methyl-C1 to C12 fragment with a 
nominal mass of 207 (Fig. 11.26). Transfer of deuterium from C11 to C13 results 
in a normal isotopic ratio for this fragment. The product formed from (11R)411­
2FIFy-linolenic acid gave a 208/(207 + 208) ratio of 0.36 while the methyl ester of 
the triene product formed from (11S)411-2M-y-linolenic acid showed a ratio of 11-10 
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Figure 11.25 1H NMR spectra of C20 conjugated triene methyl ester 39. Bottom, 1H spectrum of triene product formed in 
D20. Top. salient features of normal proton spectrum of 39. Note the collapse of signals from H2-12 and F1-10, H2-11 
signal is clearly diminished 89 
Table 11.6. Enrichment of deuterium in labeled y-linolenic acid and reaction 
products, including the ratios of the m/z 207 and 208 fragments from the 
products of reaction of PH with the two stereoisomers of [11-21-1.] -y­
linolenate. 
%2H Enrichmenta 
Product m/z 
Unreacted  208 
Substrate  Substrate  Substrate  Product  (207+208) 
(11 S)411-2I-1)-y­ 32.2  74.5  19.4  0.30 
lirtolenate 
(11R)411-
2
111-y­ 25.6  23.9  24.1  0.36 
linolenate 
(8 S)48­ 2 
FT-1-y­ 32.9  34.6  31.3 
linolenate 
(8R)-[8-
21-1] -y­ 32.4  69.2  4.7  -
linolenate 
y-linolenate control  0.25 
aThe % 2H enrichment is calculated as (M+1)-(13C abundance)/ M+[(M+1)-13C 
abundance]. 
0.30. The conjugated triene formed from unlabeled y-linolenic acid gave a ratio 
of 0.25. Hence, the deuterium enrichment in the product derived from (11 S) -(11­
2H]- y-linolenic acid is due to a deuterium transfer to C13 while that derived from 
(11R)411-21-11-y-linolenic acid is due to retention of deuterium at C11. 
When the enzyme was incubated in the presence of (8S)- [8- 2H]-y- linolenic 
acid or (8R)- [8- 2H]- y- linolenic acid under conditions essentially identical to those 
described for the [11-2H1-y-linolenic acids, a pronounced isotope effect was 
observed with the (8R)- [8- 2H]- y- linolenic acid resulting in enrichment of the 
unreacted deuterated substrate. The corresponding triene product showed only 
4.7% deuterium (due to a small enantiomeric impurity in the substrate 
(Hamberg, 1993b)). The deuterium enrichment of the unreacted (8S)- [8 -2H]-y­90 
linolenic acid was slightly increased over the starting material and a small 
decrease in deuterium was observed in the product (Table 11.6), again, reflecting 
a slight enantiomeric impurity of the substrate. These results clearly demonstrate 
that the pro 8-R hydrogen in ? linolenic acid, and by analogy the pro 7-R 
hydrogen in arachidonate, is lost to the solvent during the isomerization. 
Intermolecular proton (hydrogen) transfer. To explore the possibility of an 
intermolecular transfer of hydrogen, unlabeled arachidonic acid and labeled 
(11S)411-21-1]-rlinolenic acid were co-incubated with PH to observe if any of the 
deuterium label would be transferred to the C20 conjugated triene product. The 
(11S)411-21-1]-1-linolenic acid and unlabeled arachidonate were mixed in 
approximately 10:1 molar ratios (2151.1M rlinolenic acid with 21.5 pM 
arachidonate) to compensate for the higher affinity of the enzyme for 
arachidonate. The arachidonate was added 30 minutes after initiation of the 
0 Me 
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Figure 11.26. Fragmentation of deuterated conjugated triene from [112H] 
linolenic acid. 91 
reaction with y-linolenate and PFI to allow for several turnovers of the enzyme. 
After 3.75 hours the reaction was quenched with Me0H and the lipids extracted. 
The C20- derived conjugated triene product 39, isolated as its methyl ester, 
possessed a m/z 319/318 ratio of 0.28. This is identical to the M+1/M ratio found 
in the methyl ester of arachidonate as well as the triene product of arachidonate 
produced in the absence of deuterated y-linolenic acid. Therefore the hydrogen 
transfer must occur through an intramolecular mechanism. 
D(Vm/Km) KIE. Quantification of the magnitude of the KIE in the PH 
catalyzed isomerization was determined by reacting the (11S)411-41]-y-linolenic 
acid with PFI. Duplicate experiments were performed, one in which the reaction 
was allowed to go to 3% completion, the other was allowed to go to 5% 
completion before quenching with Me0H. The lipid extracts from the quenched 
reaction were methylated and the isotopic ratio of the product triene and 
unreacted substrate were quantified by GLC/MS. Using Northrop's (1975) 
equation (1) for the D(Vmax/Km); a KIE = 2.40 ± 0.05 (S.D.) was determined. 
(V/K)H  log(1-f )
D(Vmax/Km) = (v/K)D  Rf  (1)
log(1-f (--ko)) 
Where: f = the fractional conversion of substrate to product 
Ro = the isotopic ratio of the substrate initially 
Rf = the final isotopic ratio of the products 
Dependence of kinetic parameters on pH. The behavior of an enzyme under 
different pH conditions can provide insight to its mechanism. At the very least it 
is possible to determine the pH optimum for catalytic activity and in some cases 
it is possible to narrow the possibility of residues critical for binding and/or 
catalysis (Cleland, 1977). It is important, however, to examine both kinetic 
parameters (Km and Vmax) through substrate limiting studies in order to fully 
observe the pH effects (Knowles, 1976). 92 
To provide for a range of buffering capacity from pH 2.0 to pH 10, a buffer 
composed of 50 mM NaH2PO4, 50 mM NaCitrate and 25 mM NaB703 with 0.3 M 
NaC1, to make a final ionic strength of 0.9 M (termed triple buffer, (TB)) was 
used. Phosphate and citrate buffer had been evaluated previously for adverse 
effects on the enzyme. The effect of borate buffer was determined by direct 
comparison of the Km and Vmax of PFI with EPA at pH 7.0 in (A) 100 mM 
NaH2PO4, (B) 100 mM NaH2PO4, with 0.6 M NaC1, (C) TB, (D) TB diluted 1:3 (to 
make a final ionic strength of 0.3). The results are presented in Table II.7. 
From these data there is no significant difference in enzyme activity in the 
two high ionic strength buffers (B and C). The 100 mM NaH2PO4 buffer does 
show a somewhat higher Km and a reduced Vmax .  Certainly the borate shows no 
inhibitory effect. 
To evaluate the stability of the enzyme at the two extremes used in the pH 
dependence studies, an aliquot of partially purified enzyme (purified through 
the gel filtration step) was incubated in TB with 0.02% Tween-20 (reaction buffer) 
at pH 10 and at pH 4.0. At timed intervals of 5, 10, 15 and 30 minutes, aliquots 
were removed and adjusted to pH 7.0 by dropwise addition of either 5N HCL of 
Table II.7 The Vmax and Km of EPA with PFI under various buffer conditions. 
A  B  C  D 
Buffer:  NaH2PO4  NaH2PO4  Triple  1/3 Triple 
+0.6 M NaC1  Buffer  Buffer 
Vmax (iiM min-1 X 103)a  0.47  0.82  0.92  0.76 
Km (RM)  11.9  5.3  7.0  6.7 
aThe enzyme preparation used in these analyses was not pure, therefore the 
Vmax data is presented in terms of I'M/min. 93 
Time (min.) 
Figure 11.27 Activity of PFI (determined at pH 7.0) relative to control (treated as 
described in text) as a function of time of incubation at pH 10 and 4 (± S.E.M., 
n=3). 
5N NaOH as appropriate. This experiment was repeated in triplicate using 50 
11M EPA. The observed velocity of the reaction, as measured by the increase in 
absorbance at 276 nm per minute, was compared to the average activity of a 
control reaction of the enzyme in TB that had been subject to a single drop of 5 N 
NaOH or 5 N HCL followed by neutralization with the appropriate acid or base 
(maximum pH and minimum pH in the control reaction was 8.0 and 6.0 
respectively) and then immediately assayed. An additional control reaction 
demonstrated that the enzyme did not lose activity at RT in TB over a 30 minute 
period. As is evident from Figure 11.27 the enzyme loses some activity over time 
at these pHs, however, as will be shown, this loss is minor compared to the 
changes in activity observed as a function of pH. 
From these data it is clear that the Vmax/Km has a pH dependence, 
resulting in a logarithmic decrease as the pH goes from 7.0 to 9.0. This 
relationship appears to begin stabilizing above pH 9.0. The Vmax dependence is 2.5 
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Figure 11.28 Plot of the log of V/Km and log of Vmax as a function of pH3. 
displaced approximately 1.5 pH units higher. A duplicate experiment using pure 
PFI gave essentially identical results (but without as many data points). From 
these results it appears that two forms of the enzyme are catalytically active, with 
the protonated form having a greater catalytic efficiency (as reflected by the 
higher Vmax /Km at lower pHs). The proposed kinetic mechanism is depicted in 
scheme 11.5. 
Having discovered that PH is reactive with anandamide (arachidonyl-N­
ethanolamide) (see Chapter II1) it was of interest to determine if this substrate 
3Because the enzyme preparation used in these experiments was not pure the amount of enzyme 
per assay was estimated by comparison of the maximum observed velocity of the impure 
preparation to those of pure preparations at pH 7.0. Vmax values are expressed as 1.1.min-1 
mg-1. 
11 Table 11.8. Kinetic parameters of PFI using EPA as substrate over a pH range from 4.0 to 10.0. 
pH  5.0  6.0  7.0  7.5  8.0  8.5  9.0  9.5  10.0 
Vrnax(p.Mmin-1mg-1)a  4.1  4.27  4.78  4.69  3.19  2.11  1.23  0.796  0.607 
Km(1M)  1.64  1.8  3.09  8.5  13.17  21.88  21.3  23.7  21.7 
V/K  2.5  2.37  1.55  0.55  0.242  0.096  0.058  0.034  0.028 
log Vmax  0.613  0.630  0.68  0.67  0.503  0.323  0.090  -0.099  -0.217 
log V/K  0.398  0.375  0.189  -0.258  -0.615  -1.02  -1.24  -1.47  -1.55 
aThese data were calculated using an impure enzyme preparation. The enzyme concentration is approximated
hence the Vmax values cannot be interpreted as absolute. They are intended only for comparison between
pHs. 96 
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Scheme II.5 
showed the same pH dependency as EPA. Because anandamide does not have 
the carboxylate functionality of fatty acid substrates, thus does not carry a net 
negative charge at higher pH, the pH effect on the kinetic parameters of this 
substrate might provide some insight on substrate binding. To evaluate this, TB 
reaction buffers were made at pH 7.0 and 9.0 and duplicate substrate limiting 
analyses were performed using purified PFI (84 pg per assay, 1.9 X 10-3unit). 
Table II.9 shows the results of these experiments. From these data there is no 
significant difference in the kinetic parameters of PFI with anandamide as a 
substrate over a pH range where a 27 fold decrease in Vmax/Km was observed 
with EPA as the substrate. 
Inhibition by lipoxygenase, prostaglandin H synthase, or cytochrome P-450 
inhibitors. None of the nine inhibitors tested showed any significant inhibitory 
Table II.9. Effect of pH on kinetic parameters of PFI with anandamide. 
pH  7.0  9.0 
Vmax  0.80 ± 0.09  0.74 ± 0.09 
Km (tiM)  17.5 ± 5.0  15.2 ± 4.5 
Vmax/Km  0.046  0.049 97 
activity. Additionally, neither EDTA nor o-phenanthroline showed a significant 
effect on PR activity. 
Other Aspects 
02 requirement. Results from the anaerobic reaction of PFI demonstrate 
that the initial velocity of the reaction is unaffected by the lack of 02 (Fig. 11.29). 
It would appear that the enzyme does not require molecular 02, certainly not in 
stoichiometric amounts. Essentially identical results were obtained whether the 
reaction was run in the presence or absence of glucose and glucose oxidase. As a 
further check that anaerobic conditions were obtained by this procedure, a 
similar reaction was performed using Gracilariopsis lemaneiformis lipoxygenase 
(Moghaddam & Gerwick, 1990) and arachidonate. No hydroperoxide formation 
0  20  40 60 Time (min) 
Figure 11.29 Production of triene product as a function of time under aerobic 
(control) and anaerobic conditions. 98 
was observed (as determined from a spectrophotometric assay of diene 
formation i.e. increased absorption at 238 nm). It is of interest that the rate of 
triene formation under anaerobic conditions appears to slow (relative to the 
aerobic control) after a prolonged incubation. This phenomenon was observed in 
three replications of this experiment, but has not been further evaluated. 
Triene conversion to a putative diene. To examine if an equilibrium for the 
PFI catalyzed reaction could be determined, PH (2.5 X10-3 unit enzyme purified 
through the gel filtration step) was reacted with 0.08 mg arachidonate in a total 
volume of 2.0 mL (substrate concentration = 131 p,M) and spectra were obtained 
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Figure 11.30. Time course of triene production ( ; E = 57,000 M-lcm-1) and 
development of putative diene (A; e = 28,000 M -1cm-1) during long term 
incubation of arachidonate with PFI. 99 
at timed intervals. The results from these experiments were somewhat 
surprising; after approximately 90 minutes a chromophore with an absorption 
maximum at 236 nm began to appear. Moreover, the characteristic triene 
chromophore decreased in magnitude until at 240 minutes it appeared as only a 
shoulder on the predominate 236 nm peak. The results of this experiment are 
illustrated in Figure 11.30. From these data it would appear that the triene is 
being converted to another compound, probably with a conjugated diene 
functionality. 
It was not clear if the conversion of the triene to the putative diene was 
facilitated by enzymatic reaction (either a second function of the PH or perhaps 
another contaminating enzyme in the partially purified preparation) or possibly 
through a non-enzymatic chemical reaction (e.g. autoxidation). To test the 
involvement of enzyme catalysis an identical reaction was carried out with the 
Time (Min.) 
Figure 11.31. Effect of Me0H quenching on the development of triene and 
"diene" chromophores during reaction of arachidonate with PFI. 100 
following modification. After 90 minutes reaction the protein components were 
denatured by adding two volumes of Me0H and the development of 
chromophores monitored for another 150 minutes. As demonstrated in Figure 
11.31 the addition of Me0H effectively stopped any further PFI activity and the 
triene remained stable for the duration of the experiment. These results can be 
interpreted as showing that enzyme denaturation prevented conversion of the 
triene to the "diene". Nevertheless, it might be argued that the 2:1 Me0H 
solution could have a stabilizing effect on the triene by another mechanism, thus 
preventing the transformation. 
To test this hypothesis, 1.4 X le unit of the same enzyme preparation 
was incubated with 262 µM arachidonate in a total of one mL of reaction buffer 
for approximately 20 minutes at which time approximately half of the solution 
was centrifuged through a Microsep ultrafiltration membrane with a 30,000 
molecular weight cut-off (prewashed with reaction buffer). Both the filtrate and 
the retentate were allowed to react another three hours with stirring at room 
temperature and spectra obtained. The retentate (material not passing through 
the membrane) had a predominate chromophore with absorbance maxima at 232 
nm and a small three peaked spectra with maxima at 274 nm. The filtrate had no 
significant absorbance at 232 nm and contained a small, characteristic triene 
chromophore. These results unequivocally demonstrate that a macromolecule 
incapable of passage through a 30,000 molecular weight cut-off membrane is 
required for the development of the putative diene chromophore. 
Although there appears to be a clear correlation between the appearance 
of the putative diene and the disappearance of the triene during long term 
incubations one could reasonably argue that the diene was being synthesized 
from unreacted arachidonate and the appearance of one and the disappearance 
of the other is coincidental. To test this possibility an experiment was performed 101 
using 1114C] labeled arachidonate. A reaction vessel with enzyme (1.4 X 10-3 
units) and 0.05 mg 1414C] arachidonate containing 54 X 103 cpm (165 p,M) in a 
total volume of 2.0 mL was set up. After 90 minutes 0.5 mL was removed and 
quenched with 5 volumes of Me0H. The remaining reaction mixture was 
allowed to incubate another 90 minutes and then quenched in an identical 
manner. Spectra taken of these two Me0H quenched solutions showed the 
presence of a characteristic triene chromophore in the 90 minute reaction with a 
shoulder at the lower wavelengths. The 180 minute reaction showed a 
prominent peak with a maxima at 232 nm and a shoulder on the longer 
wavelength side (there was no characteristic three peaked triene chromophore). 
The two quenched solutions were extracted, methylated and then 
resuspended in minimal Et20, spotted onto TLC plates and developed with 20% 
EtOAc in hexanes. After drying, the plates were scanned for 14C activity. Figure 
11.32 shows the results of this experiment. Clearly, a second compound has been 
produced from the labeled arachidonate. The fact that it does not move from the 
origin indicates that it is either highly polar or subject to degradation on the TLC 
system. Unfortunately, the conjugated triene and the arachidonate methyl esters 
migrate with similar Rf values (0.67-0.78) in this system and are not clearly 
resolved on TLC; therefore it is not possible to unequivocally determine if the 
radioactivity at Rf z 0.75 represents unreacted arachidonate or residual triene. 
The slightly higher Rf of the mobile component in the 180 minute reaction 
products is consistent with this being unreacted arachidonate (arachidonate is 
slightly more mobile than the conjugated triene on normal phase silica TLC) and 
the distinct triene chromophore was absent in the extract of the 180 minute 
reaction. Efforts at isolating the diene chromophore have been unsuccessful. It is 
apparently quite labile. 11 
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Figure 11.32. TLC radiogram of reaction products from 14C labeled arachidonate and PFI. Top scan, reaction products
after 90 minutes reaction time. Lower scan, reaction products at 180 minutes reaction time. 103 
Effects of protein modification reagents. Of the five protein modification 
reagents used, only DEPC showed any significant effect on the enzyme relative 
to control reactions. Oddly, the effect of DEPC was to enhance the activity 
approximately 2.5 fold. To further evaluate this result, a time course study was 
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Figure 11.33. Time course of DEPC activation of PFI. 
performed to determine the rate at which the activity enhancement occurred. PFI 
was incubated in 1.0 mM DEPC and assayed at 0, 7,15, and 30 minute intervals 
(one assay at each time period). A control incubation with an aliquot of 
acetonitrile equivalent to the volume used in the treatment was assayed in 
duplicate at t = 0 and 30 minutes. The results are presented in Figure 11.33. As 
the time course experiment substantiated the original experimentno further 
repetition was performed (the time course of the DEPC effect on PH is 
comparable to reports of DEPC inactivation of other enzymes (Dumas & Raushel, 
1990; Melchior & Fahrney, 1970)). 104 
DISCUSSION 
Protein Char cterization 
SDS-PAGE analysis of the purified enzyme indicates that it is composed of 
similar or identical subunits of 61,000 Da. This was substantiated by 
MALDI/MS, which demonstrated a single subunit with a molecular mass of 
58,119 Da. While these techniques are highly reliable in assessing the mass of 
protein subunits, determining the mass of a native enzyme can be more difficult. 
It was apparent from the elution profile on gel filtration that the 
enzyme was fairly large. Initially, the mass of the native enzyme was determined 
by analytical gel filtration and found to be 174,000 Da, indicating a possible 
homotrimeric quaternary structure. Subsequent analysis by sedimentation 
equilibrium ultracentrifugation showed that the native enzyme has a mass of 
125,000 Da. Unlike gel filtration, results of which are a consequence of the size 
and shape of the molecule under investigation, ultracentrifugation is a direct 
measure of the effect of a centrifugal force on the mass of a solute (Cantor & 
Schimmel, 1980; Hansen et al., 1994; Van Holde, 1985), hence is a highly reliable 
technique for molecular weight determinations of multimeric proteins. The 
essentially linear relationship of log C vs R
2 
Rmeruscus (Fig II.9) seen in the 
sedimentation equilibrium experiment also shows that there are no anomalous 
subunit associations, i.e. all the protein exists as a dimer; there are no discernible 
monomers or other multimeric forms ( Hansen et al., 1994; Van Holde, 1985,). 
Interpretation of the MALDI/MS data, together with the results of the ultra-
centrifugation, suggests a dimeric quaternary structure for the enzyme and a 
mass of 125 kDa. This is slightly more than double the 58.1 kDa mass observed 
from the MALDI/MS analysis. Which technique offers a more accurate 
assessment of molecular mass is subject to debate, however, the 105 
ultracentrifugation analysis assumes a standard partial specific volume for the 
protein of 0.75 g cm-3. The MALDI/MS analysis makes no assumptions, 
therefore is probably a more reliable measurement. I propose that the molecular 
mass of the native enzyme is 116.2 kDa. 
Both ICP/MS and NAA show strong evidence of iron in the purified 
enzyme. Quantitative analysis indicates that there are from 20 to 75 iron atoms 
per subunit. Although these techniques are extremely sensitive, the very small 
quantities of enzyme available for analysis taxed the limit for adequate 
instrument response. Although it is unlikely that the enzyme contains this high 
of a level of iron, the data certainly shows that there is iron associated with the 
protein and perhaps other metals. The UV/visible spectrum of the purified 
enzyme also suggests that there is a cofactor. The similarity of the spectrum to 
that of a flavin is striking. Moreover, the N-terminal sequence data shows an 
amino acid sequence (val  17) homologous to the 
flavin binding motif (gly-x-gly-x-x-gly) found in a variety of flavoproteins 
(Lawton et al., 1990). To definitively establish the presence of a flavin it will be 
necessary to denature the enzyme with trichloroacetic acid and examine its 
fluorescence spectrum before and after performic acid oxidation (Singer & 
McIntire, 1984). 
The data from the ionic strength experiments show that the enzyme 
functions best in a relatively high ionic strength environment. Detailed analysis 
of this effect on kinetic parameters was not performed, therefore it is difficult to 
say if this is a reflection of an increase in Vmax or a decrease in Km. In part, it 
may simply reflect the hydrophobic interaction between the enzyme and 
substrate. However, this does not explain the specific role Na+ appears to play. 
Other PUFA metabolizing enzymes isolated from marine organisms have shown 106 
this same salt sensitivity (Hamberg & Gerwick, 1993; Song & Brash, 1991; Corey 
et al., 1973). 
Enzyme Mechanism 
One of the first hypotheses on the biogenesis of conjugated trienes in 
terrestrial plants (Gunstone, 1965) suggested that these metabolites result from 
the oxidation of the bisallylic methylene group of linoleic acid to form 11­
hydroxyoctadeca-9Z,12Z-dienoic acid followed by 1,4 dehydration to form either 
8,10,12- or 9,11,13-octadecatrienoic acid. Badami and Morris (1965) agreed that 
the fatty acid precursor for these conjugated trienes was linoleic acid; however, 
he proposed 9-hydroxyoctadeca-10E,12Z-dienoic acid and 13-hydroxyoctadeca­
9Z,11E-dienoic acid (likely products of lipoxygenase metabolism) as 
intermediates to these two conjugated trienes. Crombie and Holloway (1985) 
found, experimentally, that linoleic acid is the immediate precursor of calendic 
acid 33, a conjugated triene containing fatty acid from marigold seeds (Calendula 
officinalis). These experiments showed that regiospecific abstraction of the C8 
and C11 hydrogens from linolenic acid resulted in the formation of the 
conjugated triene product. No oxygenated intermediates appeared to be 
involved in the reaction, although a requirement for molecular oxygen was not 
assessed. This biosynthetic pathway may be analogous to the system in L. 
corallioides (Hamberg, 1992). Although the transformation in C. officinalis was 
presented as a radical mechanism, there was no direct experimental evidence to 
support this proposal. 
It is interesting that in the investigation by Gerwick et al. (1993) of oxylipin 
metabolism by L. corallioides, an enzyme catalyzed conversion of arachidonate to 
both 5Z, 8Z, 10E, 12E, 14Z-eicosapentaenoic acid and 13R­107 
hydroxyeicosatetraenoic acid was seen, in which the latter product was similar to 
the intermediate proposed by Gunstone (1965). While the L. corallioides  enzyme 
requires molecular oxygen, 180 labeling studies clearly revealed that the 13R 
hydroxyl oxygen originates from water (Gerwick et al., 1993a). Hamberg's (1992) 
continuing studies of the L. corallioides system have shown that although this 
alga can introduce a bisallylic hydroxyl group in a variety of polyunsaturated 
fatty acid precursors, this metabolic capacity is unrelated to its ability to 
oxidatively form conjugated tetraene products (e.g. metabolite 35). 
Another enzyme known to isomerize linoleic acid to a conjugated product, 
octadeca-9Z,11E-dienoic acid, has been isolated from the anaerobic bacterium 
Butyrivibrio fibrisolvins (Kepler & Tove, 1967). Detailed experiments with the 
isolated enzyme, linoleic acid Ancis, All trans isomerase, showed that the 
transformation of 9Z, 12Z -octadecadienoic acid into 9Z, 11E -octadecadienoic 
acid occurred through abstraction of a proton from the C11 methylene and 
stereospecific pro-R protonation at the C13 position from a solvent derived 
proton (Kepler et al., 1971). Kepler (Kepler et al.,1970) also demonstrated that the 
enzyme could be reversibly inactivated with EDTA and o-phenanthroline, 
suggesting an involvement of a metal cofactor in catalysis. 
More recently a new enzyme involved in unsaturated fatty acid 
metabolism has been isolated from rat liver and heart mitochondria (Chen et al., 
1994). This enzyme apparently provides an alternate route for the 0-oxidation of 
unsaturated fatty acids in which A2, 05 dienoyl-CoA is first isomerized to 03, 05 
dienoyl-CoA by 03, 6,2 dienoyl-CoA isomerase. This conjugated diene is then 
isomerized to trans-2, trans-4 dienoyl-CoA by the newly described enzyme A3,A5,­
t-2,t-4 dienoyl-CoA isomerase. 
Polyenoic fatty acid isomerase represents the first example, to my 
knowledge, of a single enzymatic isomerization of two double bonds, one 108 
allylically and one homo-allylically (for review see Schwab & Henderson, 1990). 
The sequence of these steps is not clear at present, although, I suggest that it 
occurs first with the formation of a conjugated diene followed by a second 
isomerization to form the conjugated triene. Hence, the enzyme performs a 
rather complex series of proton (or hydrogen) abstractions and transfers to 
accomplish this "double" isomerization, with apparently distinct mechanisms. In 
essence, it appears to combine the activities of both Ancis, Alltrans isomerase 
and A345,- t -2, t-4 dienoyl-CoA isomerase. 
To dissect the regio and stereochemical course of the PFI catalyzed 
isomerization stereospecifically labeled y-linolenic acids were used as substrates. 
The rationale for these experiments was that if a carbon hydrogen bond was 
broken in a partially rate limiting step, one would expect to see a kinetic isotope 
effect (ME) with the deuterated substrates. The KIE would manifest itself as an 
enrichment of the unreacted deuterated substrate. An increase of the M+1 
molecular ion over the normal isotopic abundance attributable to 13C in the 
product would result only upon deuterium retention. Observation of both a KIE 
and retention of deuterium in the product would indicate bond breakage and 
transfer of deuterium within the substrate. Conversely, if there is no KIE and the 
product is isotopically enriched then that hydrogen is not effected in the 
isomerization. And, of course, a KIE with no retention of deuterium in the 
product would indicate that the labeled hydrogen is lost to the solvent. Figure 
11.34 exemplifies the three possible outcomes of reaction of PFI with (11S) -[11­
21-11-y-linolenate. 
When (11 S)11-21-1]-y-linolenate was used as a substrate both a ME and 
isotopic enrichment of the product was observed. When (8R)- [8- 2H]-y- linolenate 
was used as a substrate, the reaction showed a pronounced ME but the product 
was essentially depleted in deuterium. This can only be interpreted as a result of 11(S)-2H-y-Linolenate 
(a) Transfer of pro-S-hydrogen from  (c) Transfer of pro-R-hydrogen 
C11 to C13.  from C11 to C13 
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Fig 11.34.  Rationale for the experiments using deuterium labeled substrates 110 
carbon-deuterium bond breakage in a partially rate limiting step for both of these 
substrates. In the case of (11 S)- [11- 2H]- y- linolenate the deuterium is transferred 
intramolecularly while in the case of (8R)18-21-1]-7-linolenate the deuterium label 
is lost to the solvent. The other two substrates showed little or no deuterium 
enrichment in the unreacted substrate and therefore did not undergo a carbon-
deuterium bond cleavage (in a partially rate-limiting step). 
The m/z 208, 207 fragments formed in the mass spectrometer by 
fragmentation of the C12,13 bond further substantiate the transfer of the C11 pro-
S hydrogen to the C13 position (Table 11.6). Although the 208/(207+208) ratio 
obtained from the methyl ester of the product from unlabeled y- linolenate (0.26) 
is higher than one would expect for a C13 compound, it is possible that some of 
the 208 peak intensity is due to a Mc Lafferty rearrangement. The slightly higher 
208/(207+208) ratio seen in the conjugated triene produced from (11S)411-21-1H­
linolenate (0.30) is attributable to a 4.6% enantiomeric impurity in the substrate 
(Hamberg, 1993b) (any (11R)411-21-1]-y-linolenate present in the (11 S)- [11- 2H]-y­
linolenate preparation would certainly be enriched in the product). The 
significantly higher ratio of 207/(207+208) ions (0.36) from the methyl ester 
product of (11R)411-21-11--y-linolenate incubation clearly indicates that the pro-R 
hydrogen at C11 remains at that position in the product (this substrate was only 
1.7% enantiomerically impure (Hamberg, 1993b)); therefore, it must be the pro-S 
hydrogen which is transferred. 
The transfer of protons or hydrogens during the isomerization of 
arachidonate or eicosapentaenoate to the corresponding 5E, 7Z, 9Z conjugated 
triene product is shown in Scheme 11.6. The pro-S hydrogen at C10 (Ha) is 
abstracted and transferred to C12 to form the proposed diene intermediate. The 
pro-R hydrogen at C7 (He) is then removed with subsequent electron migration 
and protonation at the C11 position by a solvent derived proton. I suggest that 111 
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the transfer of the C10 pro-S hydrogen (or proton) to C12 occurs as a 1,3 allylic 
shift, likely catalyzed by a single catalytic functionality. Determination of the 
stereochemistry of the proton addition at C12 would provide some insight into 
the involvement of one or more catalytic residues in this process. 
By this scheme, the enzyme bound diene intermediate (there is no 
evidence for a free diene in solution) is then subject to a second isomerization 
involving abstraction of the C7 pro-R hydrogen (or proton) and migration of the 
pi system to form the conjugated triene. Protonation at C11 occurs with a solvent 
exchangeable proton, the stereochemistry of which remains undetermined. The 
fact that only deuterium enriched substrate and undeuterated triene product 
were observed upon reaction with (8R)48-21-11-7-linolenate would suggest that if 
the reaction does proceed through a diene intermediate the first step must be 
reversible and the diene intermediate must be enzyme bound. If the diene 
intermediate were free to dissociate from the enzyme then it is this species which 
would become enriched with deuterium following reaction with (8R)48-211]-y­
linolenate. In the kinetic mechanism depicted in Scheme 11.5 the ES' complex 
represents this enzyme bound diene intermediate. 
While this reaction is drawn (Scheme 11.6) as an anionic mechanism, I 
emphasize that the nature of the electron transfers is uncertain. The ability of the 
enzyme to abstract a proton from the bisallylic C10 and C7 methylene groups 
poses some intriguing questions. The two best characterized classes of enzymes 
catalyzing this kind of reaction are the lipoxygenases and prostaglandin H 
synthase (Smith et a1.,1991). In both of these, the bisallylic hydrogens are 
removed in radical mechanisms with the resulting allylic radical being quenched 
by molecular oxygen to form a hydroperoxide. Frey (1990) has proposed that all 
enzymatic reactions involving C-H bond cleavage at unactivated or 
unfunctionalized sites involve radical mechanisms. 113 
Heterolytic cleavage (at least in the proposed first step, to form the 
conjugated diene) does not seem a likely mechanism. The pKa of a bisallylic 
methylene in an open chain fatty acid is about 31-36, based on literature values. 
The allylic proton of propene, for example, has a pKa = 43 and the methylene in 
cyclopentene has a pKa = 16 (March, 1992). These two species bracket the range 
of pKa values one might expect for a bisallylic proton. In the case of a bisallylic 
system, the presence of a second olefin will provide greater resonance stability 
than in the case of propene, therefore more acidity is expected in the methylene. 
Aromaticity of the cyclopentadienide anion, on the other hand, contributes 
greatly to the acidity of this methylene. Dibenzocyclohepta-1,3-diene (DCH) 54 
has a pKa = 31.2 and diphenylmethane (DPM) 55 has a pKa = 33.4 (Carey & 
Sundberg, 1990; Streitwieser et al., 1973). Of these model compounds DPM 
probably represents the closest parallel for a bisallyic methylene. Of course, 
extrapolation of these values to an enzyme mechanism is complicated by the 
effect of the microenvironment within the protein. 
54 
Enzymatic radical reactions always require some form of cofactor (Frey, 
1990). In the case of PH, passage of the enzyme down either Sephadex G-25 or 
Sephacryl S-300 results in quantitative recovery of activity, indicating that the 
addition of cofactors, such as transition metals or flavins, is not required. 
However, substantial evidence has been presented that iron and possibly a flavin 114 
are associated with PFI. The catalytic role of these cofactors is yet unknown. 
One might envisage the transition metals either playing a role in binding the 
substrate through pi-complexes with the olefinic groups (the presence of (0­
terminal olefinic groups appear to be critical for efficient substrate binding, see 
below) or the metals may be directly involved in the proton abstractions. Alper 
et al. (1969) have shown that iron pentacarbonyl complexes are able to isomerize 
the non-conjugated cyclohexa-1,4-diene to the conjugated cyclohexa-1,3 diene 
isomer with intramolecular transfer of the hydrogen. Similar systems have been 
described for iron carbonyl complexes with 1,4 pentadiene. A mechanism 
involving protein liganded iron in the active site of 09411 linolenic isomerase has 
been proposed (Seltzer, 1972). The electronic nature of the hydrogen transfers in 
PFI will require further investigation. 
Polyenoic fatty-acid isomerase does not appear to have a hydroxy or 
hydroperoxy intermediate formed (reaction in the presence of glutathione and 
glutathione peroxidase have no effect) and experiments under anaerobic 
conditions (Fig. H.29) have shown that stoichiometric quantities of oxygen are 
not needed. Moreover, under aerobic conditions, incubation of PH with 
arachidonate in the presence of horseradish peroxidase and o-dianisidine 
hydrochloride shows no evidence of H202 production. The results of the 
anaerobic incubations are enigmatic; we hypothesize that there may be some 
change in the conformation and/or function of the enzyme under reducing 
conditions, or possibly a side reaction involving a cofactor (still to be 
determined). 
The alternative substrate and pH dependence experiments provide an 
intriguing insight into the nature and requirements of the binding/catalytic site 
of PFI. From the relatively low Km of docosahexenoic acid and EPA (1.9 and 9.6 
ILIM respectively), it appears that an w-3 olefin dramatically increases the binding 115 
affinity of the substrate. The co-6 olefinic group in adrenic acid and arachidonic 
acid give an intermediate affinity (Km = 17.0 and 25.5 gM respectively) and 
eicosatrienoic acid with an co-9 olefinic group has a relatively low Km (52.8 gM). 
This is, in fact, lower than anandamide (Km = 17.5 gIvI). y-Linolenate had the 
lowest affinity of any of the compounds analyzed (Km = 152 gM). These results 
strongly suggest that the enzyme recognizes an olefinic group at the methyl end 
of the substrate. Although it is tempting to speculate that the charged 
carboxylate is of key importance in substrate recognition, the affinity of 
anandamide discounts this hypothesis. There is, however, a clear enhancement 
of catalytic efficiency associated with the presence of a carboxylate group. EPA, 
possessing both the carboxylate and the co-3 olefin, has the highest Vmax (6.0 
gmol min-1 mg-1) of any of the substrates tested (corresponding to a kcat =11.6 s-1, 
assuming one catalytic site per molecule and a molecular weight of 116 kDa). All 
of the fatty acids possessing either o.)-3 or co-6 olefins and a terminal carboxylate 
showed relatively high catalytic efficiencies. By comparison, eicosatrienoic acid 
had a V/Km ratio two orders of magnitude lower than EPA; anandamide was 
approximately one order of magnitude lower. Moreover, the pH dependency 
curve and the kinetic mechanism derived from it show that the enzyme is 
catalytic in both the protonated and unprotonated state. The protonated form is 
considerably more efficient, as reflected by the logarithmic decrease in V /Km at 
higher pH. This effect on the V/Km indicates that it must be one of the steps up 
to and including the first irreversible step that is affected by pH changes 
(Northrop, 1975). Additionally, when anandamide was reacted at pH 7.0 and 9.0 
there was virtually no difference in the V/Km. Although the identity of the 
protonated residue has not been established it is certainly reasonable to speculate 
that it might be a cationic acid (e.g. lysine-NH3 or histidine). In the protonated 
form this residue could hydrogen bond the carboxylate group on the fatty acids. 116 
Anandamide, lacking the charged carboxylate group, would be relatively 
unaffected by the state of protonation of the enzyme. 
I propose that the enzyme recognizes the olefin(s) at the methyl terminus 
for binding and that the carboxylate helps to position the substrate in the 
catalytic site for the most efficient alignment of catalytic moieties. Figure 11.35 
shows the C20 test substrates oriented with their methyl termini aligned. This 
figure illustrates how the abstracted protons on the substrates might line up 
when viewed in a linear fashion. The conformation of the substrate in the 
catalytic site will, of course, have a three dimensional aspect. Indeed, one would 
expect the substrate to be held in a conformation approaching that of the 
product. In this case the substrate molecule is held at either end and "twisted" 
into its transition state conformation. The catalytic residues in theenzyme would 
then be positioned to execute the complex series of proton abstractions and 
transfers and product release. In the case of EPA the combination of the oa-3 
olefin, the carboxylate group and the appropriate chain length allow for the most 
efficient positioning within the catalytic pocket. Docosahexenoic acid, on the 
other hand, is an excellent substrate in terms of binding, but, because of the 
additional two carbons, does not fit into the catalytic site as well as EPA. 
Moreover, the fact that the product of reaction of DHA with PFI is the 4Z, 7Z, 9E, 
11E, 16Z, 19Z isomer 48 provides concrete evidence that the enzyme recognizes 
the co- terminus of the substrate. Eicosatrienoic acid, by virtue of its 1,4,7 
heptatriene functional group is converted to the conjugated triene, but lacking an 
w-3 or co-6 olefin the binding efficiency is quite low (Km = 52.8) and the kcat is 
more than two orders of magnitude lower than EPA. a-Linolenate and T­
linolenate ostensibly seem to defy this trend. I suggest that because of the chain 
length, the primary binding mechanism for these two substrates is through the 
carboxylate group. From this orientation the protons at the C11 position in 'y­117 
linolenate would occupy a space close to the protons in the C10 position of 
arachidonate, allowing for catalysis. This would explain the relatively high Km 
determined for y-linolenate. a-Linolenate does not align so well, but, like 
dihomo-y-linolenate, it also resulted in a preponderance of conjugated diene 
products upon reaction with PFI. Again, this is consistant with a proclivity of the 
enzyme to first abstract a proton from the C11 position of C18 substrates. 
The evidence of a diene product, free in solution, from reaction of PH with 
dihomo-y-linolenic acid demonstrates that the overall reaction is likely not a 
concerted one. It is tempting to interpret this phenomena as proof that the diene 
is formed first, followed by conversion to the conjugated triene. It is more likely 
that the substrate simply lines up in the catalytic pocket in such a manner that a 
C10 methylene proton is transferred to the C12 position resulting in the 8Z, 10E, 
14Z stereoisomer. This product can not be further isomerized and is therefore 
released from the enzyme. However, there appears to be some latitude in the 
catalytic site, approximately 25% of the dihomo-y- linolenic acid is converted to a 
conjugated triene. This must result when one of the C13 methylene protons is 
abstracted first to form the 8Z, 11Z, 13E conjugated diene intermediate. This 
intermediate can then undergo subsequent isomerization, resulting in a 
conjugated triene product. Unfortunately, not enough of the reaction products 
were synthesized for NMR spectral analysis. Without concrete evidence of the 
structure of the diene these points can only be speculated. 
The observation of a free diene also raises the question of why no diene 
build up was observed when (8R)- [8- 2H]-'y- linolenic acid was used as a substrate. 
The presence of an olefin located between the formed diene and the carboxylate 
of the substrate in the enzyme bound intermediate might be a factor in product 
release. Neither 44 nor 45 would have this functionality. At this point there is 
insufficient data to give a definitive answer. 118 
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Figure 11.35. PUFA substrates for PH aligned with respect to the terminal methyl 
groups (except the C18 45 and 56). The large arrows indicate site of the putative 
initial hydrogen abstraction. The smaller arrow under dihomo-y-linolenic acid 
and a-linolenate reflects that these substrates yield a second, minor product. 119 
Unlike the well characterized aerobic reaction of lipoxygenases from plant 
and animal sources, or even the relatively new enzyme described by Hamberg 
(1992), which produces a conjugated tetraene, PH appears to have no 
requirement for molecular oxygen. Further, it is not inhibited by the 
conventional inhibitors of mono and dioxygenases. The enzyme is strictly an 
isomerase, i.e. no net desaturation occurs as is the case in calendic acid 33 or BPA 
34 biosynthesis. 
With the multitude of structurally novel oxylipins found in the marine 
environment, it is not surprising that these organisms are also rich sources of 
enzymes which catalyze unique biosynthetic reactions. It is our hope that further 
investigation into these pathways may simultaneously reveal unknown features 
of the physiology and ecology of the algae, extend the range of known enzymatic 
transformations of arachidonic acid and its congeners, and provide insight into 
the use of these enzymes as tools for the synthesis of novel bioactive compounds. 120 
CHAPTER III
 
CONJUGATED TRIENE ANANDAMIDE SYNTHESIS
 
INTRODUCTION 
Devane et al. (1992) have recently described the isolation of a candidate 
endogenous ligand for the cannabinoid receptor from porcine brain tissue. This 
compound, the N-ethanolamide of arachidonate, was termed anandamide (47, 
Scheme Ind) from the Sanskrit, "ananda", meaning bliss and "amide", the 
chemical class to which it belongs. Although the receptor for cannabinol (09­
tetrahydrocannabinol), the active ingredient in marijuana, had been cloned and 
overexpressed (Matsuda et al., 1990), anandamide represented the first high 
affinity ligand for the cannabinol receptor to be isolated from mammalian brain 
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tissue. Its discovery has marshaled an intense effort to characterize the structure 
activity relationship of the receptor ligand interaction as well as a search for other 
endogenous ligands and pharmacologically useful synthetic analogs. 
Because anandamide contains the arachidonate functionality and PFI has 
shown a broad specificity for PUFAs, it was of interest to react this compound 
with the enzyme. In so doing I hoped to synthesize a novel high affinity 
cannabinoid and to expand our understanding of the molecular characteristics of 
the enzyme binding site. In this chapter I will describe the enzymatic 
transformation of anandamide to conjugated triene anandamide (CTA) and 
report the cannabinoid receptor affinity of this novel cannabimimetic substance. 
MATERIALS AND METHODS 
Polyenoic fatty acid isomerase was isolated and purified as described in 
Chapter II. Anandamide was obtained from Cayman chemicals, Ann Arbor, MI. 
Gas Chromatography/Mass Spectrometry was performed on a Hewlett Packard 
5890 Series II GC with a HP5971A quadrupole mass selective detector interfaced 
with a Hewlett Packard Chemstation using G1034B software for data analysis. A 
Waters M-6000A pump and a Waters Lambda Max 480 UV detector were used 
for HPLC. NMR experiments were conducted on a Bruker ACP 300 instrument. 
Ultraviolet spectra were obtained on a Hewlett Packard 8452A diode array 
spectrophotometer. Lipid extraction of reaction products was performed as 
described in Chapter II, however, without acidification of the aqueous phase. 
GLC conditions were the same as described in Chapter II (Materials and 
Methods). 
Trimethylsilane derivitization of the alcohol group was accomplished 
using 1,1,1,3,3,3-hexamethyldisilazane and trimethylsilane chloride in pyridine 122 
(Evershed, 1993). An aliquot of the lipid material was dried under high vacuum 
then resuspended in a minimal volume of pyridine. To this solution was added 
3-4 drops of 1,1,1,3,3,3-hexamethyldisilazane followed by 3-4 drops of 
trimethylsilane chloride. After approximately 25 minutes the solution was again 
dried under high vacuum and resuspended in hexanes. This solution was 
centrifuged at low speed for 5-10 minutes on a table top centrifuge to remove any 
residual precipitated TMS and the supernatant decanted for analysis by 
GLC /MS. 
Spectral characterization of the reaction product 57 gave the following: 1H 
NMR (300 MHz) in CDC13 showed the following (shifts relative to internal TMS): 
8 0.90 (3H, t, J=6.81 Hz, H-20), 1.25-1.36 (6H, m, H-17,18,19), 1.45 (2H, tt, J=7.6, 7.6 
Hz, H-12), 1.77 (2H, tt, J=7.4, 7.4 Hz, H-3), 2.02 (4H, m, H-13, 16), 2.12 (2H, dt, 
J=7.8, 7.8, H-11), 2.19-2.28 (4H, m, H-2, 4), 3.42, (21-1, dt, J=5.0, 5.0, N-CH2), 3.73 
(2H, t, J=5.0, CH2 -O), 5.3-5.4 (3H, m, H-5,14,15), 5.72 (1H, dt, J= 7.1,14,3, H-10), 
6.05 (1H, m, H-6), 6.09 (1H, m, H-9), 6.17 (1H, m, H-8), 6.35 (1H, dd, J= 11.5,13.7, 
H-7). A 13C DEPT experiment in CDC13 (300 MHz) showed the following shifts 
relative to solvent at 77.00 ppm, assignments based on model compounds (Lopez 
& Gerwick, 1987): 813.89 (C-20; CH3), 22.48 (C-19; CH2), 24.85 (CH2), 25.10 (CH2), 
25.52 (CH2), 26.82 (CH2), 27.02 (CH2), 29.14 (CH2), 31.33 (C-12; CH2), 32.20, (C-11; 
CH2), 35.45 (C-2; CH2), 42.33 (N-CH2), 62.53 (CH2-0H), 125.48 (C-7; CH), 129.03 
(C-6; CH), 129.62 (C-14; CH), 130.24, 130.25, 130.41 (C-5, C-8, C-9; CHs), 133.21 
(C-15; CH), 135.23 (C-10; CH). The UV spectrum showed Xmax (EtOH) = 262, 
272, 282nm. [LR ELMS m/z (rel. intensity) obs.[M+] m/z 419 (11), 404 (20), 258 (15), 
218 (13), 214 (12), 204(15), 200 (10), 188 (18), 176 (13), 172 (11), 160 (14), 159 (12), 
135 (11), 134 (41), 133 (20), 132 (45), 131 (18), 119 (23), 118 (22), 117 (33), 116 (100), 
107 (10), 106 (14), 105 (24), 103 (19), 102 (11), 101 (20), 98 (23), 95 (12), 93 (21), 92 123 
(20), 91 (64), 86 (13), 85 (89), 81 (16), 80 (11), 79 (32), 78 (12), 77 (17), 75 (19), 73 
(50), 69 (11), 67 (22), 55 (23)1 
RESULTS 
An initial experiment was performed in which 1.6 X 10-3 unit of highly 
pure (IEF purified) PH was incubated with 0.1 mg of anandamide in 1 mL of 
reaction buffer (288RM final concentration). Spectra were obtained at timed 
intervals showing the development of a distinctive three peaked chromophore 
identical to that obtained from incubation of the enzyme with arachidonic acid. 
To obtain sufficient product for spectral characterization and to conduct 
receptor binding studies, a larger scale incubation was performed. In a 10 mL 
Erlenmeyer flask, 5 mg of anandamide (288 i.tM) was incubated with 6.3 X 10-2 
unit of PFI in 5 mL of 100 mM NaH2PO4 buffer, pH 6.5 with 0.02% Tween-20. 
The progress of the reaction was monitored by periodic spectra of 1:10 dilutions 
of the reaction mixture. After 10.5 hours the production of triene reached a 
plateau with an absorbance at 276 nm of 5.2 A.U., representing approximately 
33% conversion of substrate to product. A control reaction, identical to the test 
solution but without enzyme, showed a final absorbance at 276 nm of 0.01, i.e. no 
triene formed. The reaction was quenched with 5 volumes of Me0H and the 
lipids extracted. By UV spectral analysis a total of 1.16 mg of CTA was obtained 
(E = 57,000 L moricm-1)(Lopez & Gerwick, 1987). 
GLC/MS analysis of anandamide typically results in a substantial portion 
of the material dehydrating, resulting in two peaks, one with a M+= 347 and 
another with a M+= 329 (M+-18). To resolve this problem we found that the 
trimethyl silyl derivatives of anandamide and CTA were stable to GLC/MS. The 
TMS anandamide eluted in a single sharp peak withan Rt = 13.3 minutes 124 
whereas CTA eluted as dual peaks at Rt = 15.6 and 15.8 minutes (both of these 
peaks showed identical fragmentation patterns and, in all likelihood, represent 
thermal isomerization of the cif isomer to the ttt isomer while on the GC column, 
a phenomenon commonly observed with conjugated polyenoic fatty acids (Wolff 
& Miwa, 1965)). Both compounds showed a Mo+bs= 419, as expected for the TMS 
derivative. 
To separate the anandamide from the CTA several solvent/support 
systems were tested. Based on the protocol reported by Devane et al. (1992) both 
reverse phase system and normal phase systems were examined (using TLC). A 
reverse phase C18 plate with a 10% Me0H in H2O solvent system as well as a 
silica TLC plate with 4% Me0H in CHC13 were tried. After development, 
observation of the plates under a UV lamp revealed a single, strongly fluorescing 
band. Subsequent charring with H2SO4 showed two bands, one corresponding 
to the fluorescent band and another non-fluorescing band. Both bands charred 
distinctly different shades of brown; hence were easy to differentiate. Although 
separation was apparent with both systems, it was marginal. Several other 
systems were explored by TLC in an effort to better effect separation. These 
included: 40% EtOAc in hexanes, 60% EtOAc in hexanes on silica and 2% Me0H 
in CHC13 on an R1-NH plate. None of these proved particularly effective. The 
reverse phase system was tried first on HPLC. 
Reaction products were prepared for HPLC by passage through a C18 Sep­
pak preconditioned with 2 mL Me0H followed by 5 mL H2O. The material was 
loaded to the Sep-pak, washed with H2O then eluted with 2 mL 90% Me0H 
followed by 2 mL of 100% Me0H. When a small aliquot of the reaction products 
was applied to the RP HPLC and eluted with isocratic 90% Me0H in H2O only 
one major peak appeared on the chromatogram. A UV spectrum of this material 
demonstrated the presence of the triene chromophore as well as three other 125 
peaks at 234, 304 and 318 nm. A TMS ether derivative was analyzed by GC/MS. 
This sample showed a major peak with an Rt = 13.3 minutes and Mobs= 421; no 
peak with an Rt corresponding to the triene was observed. 
It appeared that little separation was accomplished with the reverse phase 
system and that some degradation (reduction) of the material resulted from this 
method. Therefore, the normal phase system, using two in-line 3.9 X 300 mm 10 
porasil columns, preconditioned with the mobile phase (4% Me0H in CHC13), 
was employed. The sample was prepared for HPLC by passage down a small 
silica column (glass pipette with a glass wool plug) using 5% Me0H in CHC13. 
After reducing under vacuum, the material was resuspended in 4% Me0H in 
CHC13 and subjected to HPLC. Compounds showing significant UV absorption 
at 280 nm eluted in one major peak centered at 28.8 mL and two minor peaks 
centered at 7.8 mL and 35.7 mL. The major peak contained both the anandamide 
and the CTA (the two minor peaks were not further characterized). By 
fractionating the peak at 28.8 mL into two approximately equal portions it was 
possible to separate the anandamide, eluting first, from the CTA. 
The TMS ether of the fraction eluting from 28.0 to 31.2 mL contained the 
characteristic triene UV chromophore and showed a single peak by GLC/MS 
with an Rt = 15.6 minutes and a Mo+bs= 419. This molecular ion corresponds to a 
molecular formula of C25H44NOSi. Using an E = 57,000 M-1cm-1 for the UV 
maxima at 272 nm, 0.23 mg of pure CTA 57 was isolated. 
With the exception of a small up-field shift of the H2-2 and H2-4 protons 
(due to the amide linkage) and the signals from the N-ethanol functionality, the 
NMR characteristics of CTA are essentially identical to those for the methyl ester 
of the 5Z, 7E, 9E, 14Z eicosatetraenoate metabolite 39 isolated from reaction of 
arachidonate with PH (Chapter II)  .  The UV spectra with Amax (Et0H)=262, 272, 
282 nm is characteristic of a conjugated triene system and the Mo+bs= 419, 126 
corresponding to a molecular formula of C25H44NOSi, for the TMS derivative, are 
all consistent with the determination of 5Z, 7E, 9E, 14Z eicosatetraenoate-N­
ethanolamide as the product (57). However, the possibility that the compound 
could be the 5Z, 10E, 12E, 14Z isomer was not precluded by this data. 
To establish the position of the conjugated triene functionality a proton 
decoupled experiment was performed. By irradiating the signals at 2.23 ppm the 
pentet at 1.77 ppm collapsed to a singlet and the multiplet at 6.05 ppm showed a 
distinct sharpening in its spectral line (Fig.  These results clearly 
demonstrate that the signals at 2.23 ppm represent the H2-2 and H2-4 methylenes 
surrounding the H2-3 methylene and that there is an allylic coupling to the 
olefinic proton at 6.05 ppm (H-6). The relative stereochemistry of the C14-15 
olefinic group could not be unequivocally determined; it is assumed to be 
unchanged from the substrate since this portion of the molecule is not affected by 
the enzymatic reaction (Chapter II). 
The CTA was evaluated for its ability to displace the high affinity 
cannabinoid receptor ligand [3H]CP- 55,940, f(-)-342-hydroxy-4-(1,1­
dimethylheptyl)phenyl]-4-[hydroxypropyl] cyclohexan-1-01} from binding to rat 
brain membranes. Results from these experiments showed CTA to be a relatively 
high affinity cannabinoid, Ki = 647nM (relative to anandamide Ki = 125 nM). 
These results are presented graphically in Figure 111.2. 
DISCUSSION 
Structure activity studies on several analogs of anandamide have shown 
that a number of polyunsaturated fatty acid ethanolamides exhibit cannabinoid 
agonist behavior. Felder et al. (1993), evaluated five fatty acid analogs of 
anandamide: [dihomo-y-linolenic acid 44, (8Z, 11Z, 14Z eicosatrienoic acid); Decoupled at 2.23 ppm (H2-2,4) 
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Figure III.1 1H and 1H decoupled spectra of Conjugated Triene Anandamide (CTA) 57. Bottom spectrum, standard proton spectrum; Upper spectrum, sample irradiated at 2.23 ppm (H2-2,4). Note the sharpening of the signal at 6.05 ppm (H-6) due loss of allylic coupling and the collapse of the tt at 1.77 ppm to a singlet (H2-3). 100 
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Figure 111.2 CTA (II) and anandamide (0) inhibition of the specific binding of [3E1]CP-55,940 (100 pM) to rat neuronal membranes. CTA showed a Ki = 647 nM and anandamide showed a Ki = 125 nM. Each data point is themean ± S.E.M. of two independent experiments performed in duplicate. 129 
adrenic acid 41, (7Z, 10Z, 13Z, 16Z docosatetraenoic acid); docosahexenoic acid 
40, (4Z, 7Z, 10Z, 13Z, 16Z, 19Z docosahexenoic acid); y-linolenic acid 56 (6Z, 9Z, 
12Z octadecatrienoic acid and palmitic acid] and four derivatives of the ethanol 
moiety of anandamide: [3- amino -1- propanol, R,S-2-amino-1-propanol, R,S-1­
amino-2-propanol, and arachidonamide] for their relative affinity to the 
cannabinol receptor, as determined by the competitive displacement of [3H]CP­
55,940 from plasma membranes of L. cells expressing the rat cannabinoid 
receptor and for their inhibition of forskolin stimulated cAMP accumulation in 
Chinese hamster ovary cells expressing the human cannabinoid receptor. Of the 
compounds tested, the adrenic acid, the dihomo -y- linolenic acid analogs and the 
3-amino-1-propanol derivative showed Ki values for binding and IC50 values for 
cAMP accumulation comparable to anandamide (Ki = 543 ± 83 nM and IC50 = 160 
± 13 nM (±S.E.M.)). The other fatty acid analogs showed Ki values > 12.2 p.M 
and IC50 values > 6.0 p,M; palmitic acid showed no activity up to 1mM. The 
three ethanolamide derivatives had Ki values ranging from 1.3 to 9.611M and 
IC50 values ranging from 507 nM to 10.1 JIM. It is noteworthy that both adrenic 
acid and the dihomo-i-linolenic acid ethanolamides have recently been isolated 
from porcine brain tissue and shown to be competitive inhibitors of [3H]HU-243 
( 11- hydroxyhexahydrocannabinol -3- yldimethylheptyl homolog) binding to rat 
synaptosomal membranes with Ki values comparable to z9- tetrahydrocannabinol 
(Hanus et al., 1993). 
These results indicate that the terminal aliphatic pentyl chain is critical for 
receptor binding. There also appears to be a requirement for an olefin group as 
evidenced by the inability of the palmityl analog to bind. The relatively low 
activity of the 'y- linolenate congener also points to the fact that there are other 
structural features involved, possibly a minimum chain length in the fatty acid 
moiety. 130 
The results from the binding studies with CTA clearly demonstrate that a 
degree of structural rigidity in the cannabinoid is permissible. The conjugate 
triene conformation in CTA will restrict the three-dimensional configurations 
allowed by the methylene interrupted polyolefinic fatty acids investigated by 
Felder et al. (1993). The CTA activity is also consistant with a requirement for an 
olefin in the (0-6 position. Although it is possible to model the possible low 
energy conformations of CTA, without some knowledge of the solvent/protein/ 
ligand interaction these are of dubious value. 
A number of exciting conclusions, in several arenas, can be made from 
these experiments. First, they demonstrate the utility of marine enzymes in the 
synthesis of novel compounds for use as pharmacological probes. CTA is a new 
cannabimimetic substance whose activity offers new insight into the structure 
activity of cannabinoids in general. They also present the possibility that new 
and pharmacologically useful cannabinoids may be present in nature, in 
particular in the marine environment. There is also the potential for the 
discovery of new enzymes capable of transforming anandamide or similar 
polyunsaturated ethanol amides into novel molecular probes of use in the study 
of cannabinoid pharmacology. Finally they provide some insight into the 
substrate binding characteristics of PFI, the enzyme responsible for the synthesis 
of CTA (as discussed in Chapter II). 1 3 1
 
CHAPTER IV
 
STRUCTURE AND BIOSYNTHESIS OF NOVEL CONJUGATED POLYENE
 
FATTY ACIDS FROM THE MARINE GREEN ALGA ANADYOMENE
 
STELLATA
 
INTRODUCTION 
At the most fundamental level, marine and terrestrial organisms share 
the same basic biological paradigm. However, there are differences at cellular 
and molecular levels to which a comparative approach has proven to be 
successful in the elucidation of many divergent physiological and 
biochemical processes. The oxidation of PUFAs, such as arachidonic acid, to 
biologically active compounds is one such process. The capacity to utilize this 
fatty acid and produce metabolites with structures similar to prostaglandin 
and leukotrienes, mediators of inflammation (among other functions), has 
been found in such marine organisms as corals, tunicates, and macrophytic 
algae (Jacobs et al., 1993; Gerwick et al., 1993b; Gerwick et al. 1993c; Gerwick, 
1994). The biological functions of these enzymatic cascades and resulting 
metabolites, along with the evolutionary implications of such similarities,  is 
one of our research interests. 
Not only do marine organisms provide us with unique models to 
study fatty acid metabolism and other biochemical pathways, but they provide 
us with new molecular probes with which to study the process of 
inflammation in mammalian systems. Compounds derived from some 
sponges and soft corals have been found to inhibit the signaling cascade 
involved in inflammation of mammalian models. A few examples include 
fuscoside, scalaradial, and manoalide which were isolated from the soft coral, 
Eunicea fusca, a sponge from the genus Cacospongia, and the  sponge, 132 
Luffariella variabilis, respectively (Jacobson & Jacobs, 1992; deCarvahlo & 
Jacobs, 1991; Glaser & Jacobs, 1986). One of the interests of our laboratory is to 
examine if this trend extends to the marine algae. 
Metabolites of arachidonic acid are found throughout the plant and 
animal kingdoms, suggesting that they possess important physiological roles. 
In the macrophytic marine algae, various chain length PUFAs and resulting 
oxylipins have been found in all of the major groups (Rhodophyta, 
Phaeophyceae, Chlorophyta)(Gerwick, 1994). Cyanobacteria, on the other 
hand, appear to metabolize shorter chain fatty acids of 14 to 18 carbons 
(Gerwick & Bernart, 1993). 
The ability of marine plants to produce polyunsaturated fatty acids 
(PUFAs), particularily 20- and 22-carbon omega 3 fatty acids, has long been 
recognized. In addition, enzyme(s) have been found that are capable of 
producing oxylipins via oxidation of 20-carbon PUFAs. The biochemical 
pathways involved have been considered to some extent in marine red algae; 
however, little work has been done with marine green algae (Gerwick, 1994; 
Gerwick & Bernart, 1993). Furthermore, the physiological significance of the 
metabolites produced in both groups of algae, as well as many other 
organisms, is largely unknown. It has been a frequent observation that 
marine algae possess enzyme systems capable of metabolizing 20-carbon 
PUFAs as well as 18- and 22-carbon PUFAs, resulting in the production of 
diverse chain-length oxylipins. In most cases the substrate preference and 
specific functions of the enzyme cascade(s) involved are still to be 
determined. 
In addition to our group, Professor Robert Jacobs at the University of 
California, Santa Barbara has been studying the red and green marine algae to 
determine the relative capacity of various organisms to metabolize 133 
arachidonate. Among the benthic marine algae collected in the Florida Keys 
by the Jacobs group, high levels of arachidonic acid metabolism have been 
detected in the species Anadyomene stellata. A. stellata is of interest because 
it is frequently found in habitats exposed to high herbivory, yet does not 
appear to be preyed upon. This observation has lead to the suggestion that 
this species is a fairly toxic among the Anadyomenaceae (Targett et al., 1979). 
In this chapter I will describe my efforts at characterizing some of the 
conjugated fatty acid constituents from this marine alga. These efforts 
resulted in the structure elucidation of a novel C22 heptaenoic acid. This 
compound has been given the trivial name stellaheptaenoic acid (SHA) and 
represents the first known 22 carbon oxylipin. 
MATERIALS AND METHODS 
Algae The green alga Anadyomene stellata was collected off the west 
coast of Long Key, Florida by Drs Robert Jacobs and Marina Mikhailova. The 
plants were immediately frozen in liquid nitrogen, transported to California 
on dry ice, and stored at -77° C. 
Lipid preparation The crude lipid extraction involved the following. 
protocol: batches of approximately 100 g of frozen algal tissue were ground in 
liquid nitrogen. The coarse powder was added to chloroform-methanol (2:1) 
and homogenized at 0° C with a Tekmar homogenizer. The homogenate was 
filtered through Buchner filters fitted with Whatman filter paper #1. For 
further purification, distilled water was added to the mixture along with 1 M 
NaC1 in a 1/10 final volume. The water phase was discarded and the organic 
phase dried with anhydrous Na2SO4, filtered, and reduced in vacuo. The dry 
sample was resuspended in 1 mL hexane and methylated with diazomethane. 134 
Gas Chromatography/Mass Spectrometry was performed on a Hewlett 
Packard 5890 Series II GC with a HP5971A quadrupole mass selective detector 
interfaced with a Hewlett Packard Chemstation using G1034B software for 
data analysis. A Waters M-6000A pump and a Waters Lambda Max 480 UV 
detector was used for HPLC. NMR experiments were conducted on either a 
Bruker ACP 300 or AM 400 instrument. Ultraviolet spectra were obtained on 
a Hewlett Packard 8452A diode array spectrophotometer 
A crude lipid extract of Anadyomene stellata was methylated with 
ethereal diazomethane and subjected to vacuum chromatography on silica 
gel (30 X 40 mm i.d.) using stepwise elution with EtOAc in hexanes, 0-2% in 
0.5% gradations. The fraction eluting with 1.0% EtOAc in hexanes, was 
further purified by HPLC on two 4 mm X 30 cm Alltech 10g silica columns 
connected in series. Purification was accomplished with isocratic elution (1% 
EtOAc in hexanes at 2.6 mL/min, 3000 psi). Compounds showing significant 
adsorption at 325 nm eluted in three fractions centered at 42, 48, and 54 mL; 
these were separated, reduced under vacuum and analyzed by GC/MS. An 
11.5 meter Ultra-1 (100% dimethylpolysiloxane) open capillary column was 
used in the splitless injection mode. Injector temperature was 250° C, oven 
temperature 100° C with a 10° C temperature ramp to a final temperature of 
240° C (detector temperature, 280° C). Helium was used as the carrier at 11 psi. 
RESULTS 
The crude extract of A. stellata was first fractionated by vacuum 
chromatography (VC). The VC fraction eluting with EtOAc /hexane (1:99) 
showed a UV spectrum characteristic of a conjugated tetraene (Burgess et al., 
1991) (see Fig. IV.1). This VC fraction was then subjected to HPLC where three 135 
distinct peaks, each having UV absorption at 325 nm, were observed. All 
three HPLC fractions showing significant UV absorption had spectra with 
maxima at 294, 306, and 322 nm (in hexanes), characteristic of conjugated 
tetraenes. The fraction eluting at 54 mL showed a single major peak by 
GLC /MS with a M+ = 340 corresponding to a molecular formula of C23H3202 
[LR ElMS m/z (rel. intensity)] obs.[M+] m/z 340 (6), 260 (18), 232 (30), 171 (10), 
157 (21), 145 (27), 131 (83), 117 (83), 105 (63), 91 (100), 79 (57), 67 (30)]. Assuming 
an E -a 72,000 M-lcm-1 (Burgess et al., 1991) for the UV maxima at 306 nm, 0.53 
mg of derivative 59a was isolated. The 1H NMR (300 MHz) in d6-benzene 
showed the following (shifts relative to solvent peak at 7.15 ppm): 8 0.90 (3H, 
t, J=7.51 Hz, H3-22), 1.99 (2H, m, H2-21), 2.11 (2H, t, J=7.45 Hz, H2-2), 2.30 (2H, 
dt, J=7.3,7.3 Hz, H2-3), 2.81 (2H, dd, J=5.0, 5.0 Hz, H2-18), 2.92 (4H, in, H2-6,15), 
3.32 (3H, s, OMe), 5.31-5.44, (8H, m, H-4,5,7,14,16,17,19,20), 6.10 (2H, m, H-8,13), 
6.24 (2H, m, H-10,11), 6.55 (2H, ttl, H-9,12). A 13C DEPT experiment (400 MHz) 
showed the following (shifts relative to solvent at 128.00 ppm), assignments 
based on model compounds (Burgess et al., 1991, Lopez & Gerwick, 1987): 
M4.44 (C-22; CH3), 20.89 (C-21; CH2), 23.09 (C-3; CH2), 25.92 (CH2), 26.51 (CH2), 
26.61 (C-6,15,18; CH2), 33.94 (C-2, CH2), 51.98 (-0CH3), 127.33 (C-9; CH), 128.49, 
(C-8; CH), 128.52 (C-12; CH), 128.54 (C-4; CH), 128.69 (C-7; CH), 128.98 (C-5; CH), 
129.19 (C-13; CH), 129.50 (C-19; CH), 129.51 (C-17; CH), 130.37 (C-16; CH), 130.41 
(C-20; CH), 132.18 (C-14; CH), 133.84 (C-10; CH), 133.86 (C-11; CH). Resolution 
of the low field signals was accomplished by Guassian multiplication of the 
DEPT spectra from 126 to 136 ppm. An HMBC experiment showed long range 
coupling from the H2-2 and the OMe protons to a quaternary carbon 
(carbonyl) at approximately M73 ppm and also confirmed assignments of C3 
and C21. 136 
From these data it is clear there are fourteen olefinic methines, six 
aliphatic methylenes, two methyl groups and one carbonyl carbon. Three of 
the methylenes are bisallylic groups as indicated by their chemical shifts, one 
at 82.81 and two at 82.92 (four protons by integration). The UV spectrum (Fig. 
IV.1) indicated that four of the double bonds are in conjugation. A 1H-1H 
chemical shift correlation spectroscopy (COSY) experiment (Fig. IV.2) 
demonstrated coupling from the C2-methylene at 82.11 through the aliphatic 
protons at 82.30 ppm to the C4 olefinic proton at approximately 85.3-5.4. 
Similarly, coupling from the terminal methyl at 80.90 through the methylene 
protons at 81.99 to the cluster of olefinic protons at 85.3-5.4 established that 
portion of the molecule. The relative positions in the conjugated tetraene 
functionality of the six low field proton signals at 86.10, 6.24, and 6.55 were 
assigned by comparison with methyl bosseopentaenoate 60 (Burgess et al., 
1991), and were consistent with the COSY data obtained for 59a. The large 
cluster of signals at 85.3-5.4 represented the protons in the three isolated 
olefinic groups as well as the first and last protons in the conjugated system. 
The 1H-1H COSY experiment also showed a long range coupling from the H2­
3 protons to a bisallylic signal at 82.92 as well as a long range coupling between 
the 82.92 signal and a low field olefinic proton at 86.10. A long range 1H-1H 
COSY experiment optimized for 1 Hz convincingly showed coupling from the 
co2 protons (81.99) to the bisallylic signal at 82.81. This was confirmed by 
decoupling the signal at 82.81 and observing a distinct sharpening of the co2 
signal. These data eliminated the possibility of the conjugated system starting 
at C4 or C13, leaving only one of two possible regioisomers; i.e. 4, 7, 10, 12, 14, 
16, 19 docosaheptaenoic acid 58a or 4, 7, 9, 11, 13, 16, 19 docosaheptaenoic acid 
58b. Resolution of these two possibilities was accomplished by a 2D nuclear 
Overhauser enhancement spectroscopy (NOESY) experiment in CDC13. As 137 
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evidenced by Figure IV.3 the NOESY experiment showed a distinct nOe 
between the bisallylic proton signals at 52.82 and 52.97. Because the proton 
spectra shifted slightly in CDC13 (bisallylic protons at 52.82 and 52.97) it was 
necessary to confirm that the signals at 52.08 and 52.82 were, in fact, H2-21 and 
H2-18, respectively. This was accomplished by selectively irradiating the 52.08 
signal and observing a distinct sharpening of the proton signal at 52.82, 
resulting from the loss of homoallylic coupling. Having established that the 
52.82 signal corresponds to H2-18 the nOe results could only be accounted for 
by structure 59a. 
The 4Z, 7Z, 9E, 11E, 13Z, 16Z, 19Z relative stereochemistry of the seven 
olefinic groups is based on the close similarity of the low field 1H NMR 
spectra of this compound with that of methyl BPA (Burgess et al., 1991), the 
13C NMR resonances (Lopez & Gerwick, 1987; Tulloch, 1982), and the UV/Vis 
spectrum (Husain & Devi, 1993). Although 4Z, 7Z, 9E, 11E, 13E, 16Z, 19Z; 4Z, 1 3 8
 
7E, 9E, 11E, 13Z, 16Z, 19Z, or 4Z, 7E, 9E, 11E, 13E, 16Z, 19Z configurations 
cannot be absolutely precluded from the evidence presented, these do not 
seem likely based on the above data, the symmetry of the tetraene system as 
observed by NMR, and the precedence of Z,E,E,Z configurations in naturally 
occurring conjugated tetraenes (Tulloch, 1982; Hamberg, 1992). 
The HPLC fraction eluting at 42 mL also showed only one major peak 
on GLC /MS with a molecular ion m/z = 316, corresponding to a molecular 
formula C21H3202 [LR EIMS m/z (rel. intensity) obs [Mt] m/z 316 (56), 245 (9), 
201 (14), 147 (11), 145 (18), 143 (13), 131 (52), 117, (73), 105 (52), 91 (100), 79 (44), 67 
(30, 55 (13); 1H NMR (300 MHz, d6-bz, shifts relative to the solvent peak at 7.15 
ppm): 8 0.86 (3H, t, J=7.35 Hz), 1.23 (4H, m), 1.31 (2H, m), 1.58 (2H, tt, J=7.4,7.4 
Hz), 1.96 (2H, bdt, J=7.3, 7.3 Hz), 2.09 (2H, t, J=7.4 Hz), 2.13 (2H, dt, J=7.6, 7.6 Hz), 
2.88 (2H, bdd, J=7.42, 7.42 Hz), 3.32 (3H, s, OMe), 5.27 (1H, dtt, J=8.34, 8.34, 1.51 
Hz), 5.36-5.47, (3H, m), 6.09 (1H, dd, J=11.0, 11.0 Hz), 6.14 (1H, dd, J =11.0, 11.0 
Hz)), 6.25 (1H, m), 6.31 (1H, m), 6.56 (2H, dd, J=11.4,13.7 Hz). The proton 
spectra of this compound was essentially identical to bosseopentaenoic acid 
(Burgess et al., 1991), however, to confirm that this compound was methyl 5Z, 
8Z, 10E, 12E, 14Z eicosapentaenoate 60, as opposed to methyl 5Z, 7E, 9E, 11Z, 
14Z eicosapentaenoate, we performed two additional proton decoupled 
experiments. First, irradiation of the signal at 81.91 collapsed the signals at 
81.61 and 5.27 ppm. In turn, irradiation at 81.61 collapsed the signals at 81.91 
and 82.09. These results clearly demonstrated that the unsaturation pattern in 
60 was 5Z, 8Z, 10E, 12E, 14Z, as previously assigned for methyl eicosa­
pentaenoate 60 (BPA). In the alternative isomer, 5Z, 7E, 9E, 11Z, 14Z, the 
signal at 81.91 would have been due to H16 and thereby possessed a 
completely different coupling pattern . 59a 
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Figure IV.1 UV spectrum of stellaheptaenoate methyl ester (SHA) 59a in hexanes. 140 
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Figure P1.3 NOESY spectrum of stellaheptaenoate (SHA) methyl ester 59a in 
CDC13. 142 
The third HPLC peak (eluting at 48 mL) contained a mixture of four 
compounds as determined by GLC/MS, having molecular ions with m/z 260, 
290, 314, 316. These molecular ions are consistent with the methyl esters of 
C16:5, C18:5, C20:5 and C20:6; however, they have not yet been purified to a 
degree sufficient for rigorous structural analysis. 
DISCUSSION 
Although relatively simple with respect to the number and types of 
functional groups, conjugated polyenoic fatty acids can present subtle nuances 
in their NMR spectra making characterization difficult. This was the case 
with SHA where overlap of proton signals presented difficulties in assigning 
their positions relative to other, better defined signals. Only through the 
NOESY experiment was it possible to define the position of the conjugated 
tetraene system in SHA. 
The fact that the crude extract had such a variety of conjugated 
tetraenes is intriguing. I would interpret this to mean that the organism 
either has several enzymes capable of oxidizing different chain length fatty 
acids to the different chain length conjugated tetraenes or, more likely, that 
there is a single enzyme which is promiscuous in its substrate recognition. 
The structures of these conjugated tetraenes are most readily 
interpreted as resulting from an oxidative pathway such as that described by 
Hamberg for the 6Z, 8E, 10E, 12Z-octadecatetraenoic acid from Lithothamnion 
corallioides (Hamberg, 1992). Comparing the positions of the conjugated 
systems in SHA 58a to BPA 34 it is tempting to hypothesize that, if it is a 
single enzyme, then it recognizes the carboxylate terminus of the substrate 
(Fig. IV.4). However, when the putative C18:5 structure is examined this does 143
 
OR 
Figure IV.4. SHA 58a, BPA 34 and the putative C18:5 (61), with the conjugated 
tetraene systems aligned. 
not seem likely. If these metabolites are the product of a single enzyme it may 
well be that the methylene interrupted olefins in the substrate are the 
functionalities being used to align the substrate within the catalytic pocket. 
Clearly more detailed examination of the enzyme(s) involved is needed to 
resolve this point. These efforts are currently underway in Dr. Jacobs' 
laboratory. 
These experiments have now demonstrated the occurrence of 
conjugated polyenoic fatty acids in the Chlorophyta. Furthermore, SHA 
represents the first C22 oxylipin (if, in fact, this is an oxidative pathway) from 
a marine alga. The widespread expression of these conjugated polyenoic fatty 
acids, both in phylogenetic and geographic terms, suggests that these 
metabolites play a fundamental role in the physiology or chemical ecology of 
marine algae of which we know very little. 144 
CHAPTER V
 
SUMMARY
 
Life on earth is generally believed to have originated in the oceans, the 
chemical and physical environment of which is ideal for the life process. The 
relatively warm waters provide a veritable soup of nutrients for any life form 
capable of extracting them. Movement is not required; dinner will float by. The 
buoyancy afforded by the aqueous surroundings obviates the need for more than 
a minimal amount of structural integrity. These features of sea life have allowed 
the evolution of a multitude of soft bodied, sessile or slow moving organisms. 
Although nature's plenty is readily at hand for these docile filter feeders and 
herbivores, they, in turn, serve as food for higher trophic levels; the competition 
for survival is enormous. Without armor or speed these soft bodied creatures 
depend on more subtle defense mechanisms. Chemical deterrence is a frequently 
employed strategy. Like terrestrial plants, which cannot run or hide from their 
enemies, the sessile algae, sponges, tunicates, and corals must discourage 
predation through the biosynthesis of secondary metabolites. Some of these 
organisms, such as the nudibranch Hexabranchus sanquineus or "Spanish dancer", 
appear to advertise their presence with bright, colorful pigmentation as a 
warning to would be predators that they are not a choice food item. 
An estimated 25-50% of the pharmaceuticals in clinical use are based on 
the natural proucts chemistry of terrestrial plants (Tyler et a1.,1988). In this 
regard the oceans represent a huge store of yet to be discovered drugs. It is 
estimated that more than 80% of the life forms on earth live in the oceans and 
although thousands of bioactive compounds have been isolated from this source, 
less than 1% have been examined for their pharmacological application 
(Marderosian & Liberti, 1988). 145 
From the perspective of a biochemist, marine organisms represent a vast 
array of unresolved biosynthetic pathways. As delineated in Chapter I, the 
examination of marine natural products biosynthesis has led to some startling 
discoveries. The enigma of prostaglandin biosynthesis in corals, the revelation of 
a vanadium containing enzyme (bromoperoxidase) and the utilization of cyanide 
in the biosynthesis of isocyano compounds by marine sponges are but a few. 
Because of the difficulties inherent in probing the oceans, the exploration of these 
phenomena has hardly begun. 
Relevant to this dissertation, the investigations on the biosynthesis of 
prostaglandins in corals illustrates two key points. First, it is clear that these 
compounds, as do all the oxylipins, play a much broader function in nature than 
originally thought. Interest in this class of chemistry originated from the 
discovery of their involvement in mammalian metabolism, particularly their 
immunoregulatory and vasoactive properties. To find prostaglandins in 
invertebrates, possessing only primitive immune systems and no vasculatory 
systems, points out that they have much broader roles in nature. At present, the 
biological function of prostanoids in coral is not entirely clear; although there is 
some evidence that they act as emetic agents against predatory fish and that they 
play a role in coral reproduction (Coll, 1992). 
Secondly, it was only through the use of cell free systems that the novelty 
of coral prostanoid biosynthesis was recognized. Without the ability to 
manipulate experimental conditions afforded by in vitro systems, such as 
introduction of inhibitors or putative intermediates, the recognition that 
prostaglandin H synthase is not involved would have been impossible. It is also 
of interest that Corey's original purpose in working with these organisms 
stemmed from his on-going research on prostaglandin biosynthesis in mammals. 146 
He considered the coral a potential source of abundant PGH synthase (Corey et 
al., 1973). 
Conjugated polyenoic fatty acids in the marine algae represent another 
metabolite produced through a variety of biosynthetic pathways. In the brawn 
algae conjugated olefins appear to be mediated through a lipoxygenase manifold, 
the green algae and some of the red algae appear to utilize oxidases in the 
production of these functionalities. Polyenoic fatty acid isomerase is strictly an 
isomerase. Recognition of this fact has only been possible by in vitro 
experimentation. 
The herein reported mechanistic investigations of PH have shown that 
this isomerase is capable of abstracting a proton from a non-activated carbon. 
Because there is no involvement of molecular oxygen in this reaction, there is no 
parallel to other enzymes in the arachidonate cascade. The only other enzymes 
with similar activities are the newly described 6,345,4-2J-4 dienoyl-CoA 
isomerase (Chen et al., 1994) and the Aucis, An trans linolenate isomerase 
described by Kepler and Tove (1967) two decades ago. And, like Aucis, A11trans 
linolenate isomerase, PFI contains metal ions, although it is not as easily 
inactivated by chelating reagents. The A345,4-2,t-4 dienoyl-CoA isomerase has 
not been characterized in sufficient detail to ascertain a metal prosthetic group. 
I suggest that PFI provides a biosynthetic precedent that may have 
parallels in other biological systems. Unfortunately, the mechanism of the Aucis, 
A11trans linolenate isomerase has never been fully determined. It is possible that 
it is quite similar to PFI. Although speculative, it is likely that the iron in PFI 
plays a pivotal role in the catalytic event. The use of electron paramagnetic 
resonance (EPR) to observe radical formation would prove insightful. We have, 
so far, been unable to isolate sufficient quantities of the enzyme to facilitate these 
kinds of investigations. It will be necessary to either scale up the isolation 147 
procedure or clone the PH gene into a system where it can be overexpressed. 
The former approach would be feasible with the purchase of additional 
laboratory equipment. With the sequence information from these studies, the 
second alternative is also possible, although it entails more development (and 
risks). 
The application of molecular biological techniques is almost completely 
lacking in the investigation of enzymes involved in secondary metabolism in 
marine organisms, particularly the algae. This is lamentable; as illustrated above 
and as will be discussed in the appendix, there is tremendous potential for this 
approach. 
Aside from the role of the conjugated polyunsaturated hydrocarbons in 
the brown algae, the biological function of these metabolites in algae is 
completely unknown. Recently, the nutritional and pharmacological properties 
of conjugated fatty acids in mammals have received increased interest, 
particularly with respect to their potential anti-cancer activities. In whole animal 
studies Ip et al. (1991) have shown that feeding mice high levels of conjugated 
dienes (mixed geometric isomers of octadecadienoic acid) significantly reduced 
the occurrence of mammary tumors induced by dimethylbenz(a)anthracene 
(DMBA). At the cellular level Cornelius et. al. (1991) examined the cytotoxicity of 
the conjugated tetraene, cis-parinaric acid (9Z, 11E, 13E, 15Z-octadecatefraenoic 
acid) to undifferentiated leukemic U-937 cells. These experiments showed that 
parinaric acid was selectively toxic to the cancer paradigm but not so to normal 
cell cultures. Moreover, the cytotoxic effect of the conjugated tetraene on the 
malignant cells was not duplicated by oleic acid or the methylene interrupted 
polyunsaturated fatty acids linolenic acid or moroctic acid (stearidonic acid18:4 
06,9,12,15), suggesting a critical role for the conjugated olefin functionality. The 
mode of action of this selective cytotoxicity is not known, although it has been 148 
suggested that they serve as anti-oxidants (Ip et al., 1991); possibly these 
compounds serve the same function in the red and green algae. More research is 
needed. 
One of the postulates of this thesis is the applicability of novel enzymatic 
transformations, using enzymes from marine algae, to produce pharmaceutically 
useful products. The synthesis of CTA from anandamide is but one example. 
Previous work in our laboratory resulted in the enzymatic synthesis of 
radioisotope labeled 12(R), 13(S)-diHETE, which was used to evaluate its effect 
on ovine luteal function (Orwig et al., 1992). 
Chirality is a critical aspect in the synthesis of pharmaceuticals. The use of 
racemic thalidomide as a therapy for morning sickness in the late 1950s tragically 
illustrates this point. The benefits of the R-isomer of thalidomidewere 
drastically overshadowed by the teratogenic effects of the S-isomer (Kean et al., 
1991). The inherent chirality of enzyme catalyzed reactions ideally suit them for 
use in the synthesis of pharmaceuticals. Although organic chemists have, in the 
past, been reticent to use enzymatic transformations, this trend appears to be 
waning and there are increasing applications of enzymes in organic synthesis 
(Wong & Whitesides, 1994; Farber, 1992). 
With the ever present need for more effective drugs to combat newly 
emerging diseases, old ones with new found drug resistance, cancer and the 
processes of aging, innovative approaches must be developed. In view of the 
success of molecular biological techniques in the pharmaceutical industry, 
coupled with constant improvements in the technology of enzyme catalyzed 
synthesis, the identification, characterization and exploitation of enzymes from 
marine organisms has tremendous potential. 149 
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INTRODUCTION
 
The first lipoxygenase to be isolated was that from soybeans and it is the 
best characterized of all the lipoxygenases (Boyington et al., 1993). The discovery 
of a lipoxygenase activity in human platelet cells (Hamberg & Samuelsson, 1974) 
stimulated considerable interest in this enzyme as it relates to human physiology. 
In 1990 the 12-lipoxygenase from human platelet cells was cloned (Funk et al., 
1990). Most of the lipoxygenases characterized to date, including the plant 
lipoxygenases, have a requirement for a non-heme iron (Boyington et al., 1993). 
This iron moiety, critical for catalytic activity, is tightly bound by the 
lipoxygenase and is not readily removed by treatment with cation chelating 
reagents such as EDTA or 1,10 o-phenanthroline. 
The physiological function of this metabolite in plants is not completely 
understood. In several plant species it appears to be instrumental in the 
elicitation of secondary metabolites involved in chemical defense from 
pathogenic microorganisms and herbivores (Gunlach et. al, 1992). Another role 
for lipoxygenase products in plants is the biosynthesis of jasmonic acid 
(Hamberg & Gardner, 1992), a well known phytohormone. Only recently has an 
algal species, Gelidium latifolium, been shown to produce jasmonic acid (Krupina 
& Dathe, 1991). 
In 1990 Mehran Moghaddam, working in William Gerwick's marine 
natural products laboratory at Oregon State University, clearly demonstrated the 
presence of a 12(S)-lipoxygenase in acetone powder preparations of Gracilariopsis 
lemaneiformis (Moghaddam & Gerwick, 1990). Subsequent efforts by Gerwick et 
al. (1993a) have shown that the 12(S)-lipoxygenase activity is extractable into 
aqueous buffers and that the enzyme utilizes molecular oxygen and is inhibitable 
by several well characterized inhibitors of mammalian lipoxygenase (Hamberg & 161 
Gerwick, 1993).  The enzyme has been partially purified by ammonium sulfate 
precipitation and size exclusion chromatography (Hamberg & Gerwick, 1993). 
To purify the enzyme to homogeneity was the first project I undertook in my 
graduate studies. Unfortunately these efforts have been largely unsuccessful; 
however, some insight into the nature of the enzyme has been obtained. In this 
appendix I will describe the results of my investigation of G. lemaneiformis 12(S)­
lipoxygenase. 
MATERIALS AND METHODS 
Enzyme extraction. The plants used for these experiments were collected 
on the south side of Yaquina Bay (under the bridge). The freshly harvested 
plants were either immediately frozen on dry ice or placed on ice, with a layer of 
newspaper for insulation. They were transported to the laboratory where they 
were either stored at -70° C or immediately processed. To prepare the enzyme, 
the tissue was ground in a stainless steel Waring blender with liquid nitrogen. 
The powdered tissue was slurried with approximately two volumes of extraction 
buffer (100 mM NaH2PO4, 5 mM EGTA, 5 mM DTT, and 5 mM MgC12, pH 7.2) 
and homogenized with an Ultraturrex followed by a Potter-Elvehjem tissue 
homogenizer. The homogenate was then filtered through Miracloth 
(Calbiochem) and centrifuged at 12,000 X g for 20 minutes. The supernatant was 
centrifuged at 100,000 X g for 60 minutes. This high speed supernatantwas then 
precipitated with ammonium sulfate and the material precipitating between 40% 
and 80% saturation resuspended in a minimal volume of 100 mM NaH2PO4, pH 
7.2 (approximately 5 mL). Polyvinylpyrolidone (PVP) and polystyrene (XAD-4) 
were used at various stages of the extraction, either batchwise or as a column fill, 
to remove any contaminating polyphenolic compounds. Fractionation with 162 
sephacryl S-300, DEAE ion-exchange, and phenol-sepharose was attempted. 
Preparative isoelectric focusing on a Rainin RF-3 fractionator using pH 3.0-10 
ampholytes from Protein Technologies was also tried. 
Enzyme assay. Lipoxygenase activity was assayed spectrophotometrically 
as described in Chapter II. An extinction coefficient E= 28,000  cm 
-1 (Smith & 
Lands, 1972) was used to calculate the production of conjugated diene product. 
With this technique it is not possible to discern between hydroperoxy (12(S): 
HPETE) and hydroxyl (12(S )-HETE) production. As a lag phase is typically 
encountered with this enzyme, activity was calculated from the portion of the 
spectrogram giving the maximum rate of increase. 
Dialysis .  Dialysis was performed against various buffers using SpectraPor 
dialysis tubing with a molecular weight cut-off of 12-14,000 Da. The tubing was 
pretreated with a warm EDTA solution, then washed exhaustively with distilled 
H20. In each experiment 1.0 mL of a resuspended 40-80% ammonium sulfate cut 
was dialyzed against the indicated buffer. An aliquot of this ammonium sulfate 
cut was kept in the cold room for the duration of the dialysis experiment as an 
untreated control. 
Western Blot Analysis. A sample of the ammonium sulfate precipitated G. 
lemaneiformis extract was sent to the laboratory of Professor Colin Funk, 
Vanderbilt University, Nashville where a western blot for human platelet 12­
lipoxygenase was used to probe for homology (Funk et al., 1990). 
Seasonal expression of lipoxygenase by G. lamaneaformis. During the summers 
of 1992 and 1993, collections of G. lamaneaformis were made from Yaquina Bay at 
approximately two week intervals throughout the summer (April-October). The 
alga was transported to the laboratory where 4-6 replicate samples were 
processed to extract the lipoxygenase in a quantitative manner. For each 
replicate, 10 g of tissue was ground in liquid nitrogen using a mortar and pestle 163 
until a fine powder was achieved. Each replicate was then slurried with 20 mL 
extraction buffer and treated for 2 X 1 minute with an ultra-turrex tissue 
homogenizer at a speed setting of 80. Each sample was then ground for 2 
minutes in a 55 mL Potter & Elvehjem homogenizer. The samples were filtered 
though a layer of Miracloth and centrifuged for 20 minutes at 12,000 X g. The 
supernatants were then centrifuged at 100,000 X g for 60 min. The volume of 
each supernatant from this high speed centrifugation was determined. The 
activity of each sample was determined by triplicate assays using 50 ill aliquots. 
Assays were conducted at 22° C in 100 mM NaH2PO4, pH 7.2 with 0.02% Tween­
20 and 0.1 mg arachidonate in 10 mL EtOH for a final substrate concentration of 
329 p,M. Activity per mL was calculated as follows: 
AA .U.238nm /min
Act/mL (iMol/rrun)  (28.0)(0.05 mL) 
Multiplying the act/mL by the volume of the sample and dividing by 10 g, gave 
the activity per gram of tissue (wet weight). 
RESULTS 
Enzyme extraction. Extraction of lipoxygenase activity into a buffer 
solution from the tissue of G. lemaneiformis was accomplished in a routine and 
predictable manner. This activity could be precipitated between 40-80% 
ammonium sulfate saturation with reasonably high recoveries (>80% total 
activity). The ammonium sulfate precipitate was resuspended in a minimal 
volume of NaH2PO4 buffer (100 mM, pH 7.2) and stored at -20° C until used. I 
found that the LOX activity remained stable under these conditions for periods 
of weeks to months. In an experiment to assess the stability of the enzyme, the 
activity of the stored enzyme actually increased as much as two fold after 3 
months at -20° C. 164 
During the course of extraction the UV spectra of the homogenate as well 
as the resuspended ammonium sulfate precipitate typically showed a maxima at 
260 nm (rather than the 280 nm expected of proteins). Because plants often have 
large amounts of phenolic and polyphenolic compounds which, in concert with 
phenol oxidases, can form covalent bonds at numerous sites on proteins it is a 
common practice to adsorb these contaminates with either insoluble 
Polyvinylpyrolidone (PVP) or polystyrene (XAD-4)(Loomis, 1974). Both these 
materials were tried, either separately or together, by batch loading into the 
crude homogenate (after P&E homogenation) and stirring for 10 to 60 minutes. 
The crude homogenate was also treated by passage through a 1.5 X 15 cm 
column packed with XAD-4 at a flow rate of approximately 1.0 mL/min. The 
adsorbent treatments did not result in significant increases in activity compared 
to untreated controls. Polyphenolic contamination of the lipoxygenase in 
extracts of this alga is not a significant concern. 
Efforts at purifying the lipoxygenase from G. lemaneiformis after 
ammonium sulfate precipitation were largely unsuccessful. Hamberg and 
Gerwick (1993) were able to recover lipoxygenase activity after fractionation of 
an ammonium sulfate precipitant with sephacryl S-300 size exclusion 
chromatography. They reported that the activity of these fractions was 
dramatically enhanced in the presence of 1.0 M NaCl (Hamberg & Gerwick, 
1993). Although I was able to produce similar results, the loss of total activity 
was usually greater than 90%, making further purification problematic. Active 
fractions from size exclusion fractionation showed numerous bands by SDS­
PAGE. 
DEAE ion exchange chromatography was attempted. To determine the 
requirement for an anion or cation exchange resin an aliquot of a 40-80% 
ammonium sulfate cut was desalted on a sephadex G-25 column, using 50 mM 165 
NaH2PO4 buffer pH 7.2. Small aliquots (0.5 mL) were incubated with an equal 
volume of a slurry of either DEAE or carboxy methyl (CM) ion-exchange resin. 
After allowing the resin to settle the overlaying solution was assayed for 
lipoxygenase activity. Substantially more activity (> two fold) was found in the 
CM treated solution than in the DEAE treatment, indicating that the DEAE had 
effectively bound the enzyme. Therefore, fractionation on a DEAE column was 
attempted. A 0.7 X 12 cm column was packed with DEAE and equilibrated with 
50 mM NaH2PO4, pH 6.9. After loading, the material was washed with 
phosphate buffer then eluted by stepwise increases of NaC1 concentration in the 
buffer. Figure A.1 shows the results of this experiment. Although the DEAE 
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Figure A.1. DEAE ion-exchange chromatography of G. lemaneiformis 
lipoxygenase. Arrows indicate fraction at which the NaC1 concentration steps
were started. 166 
was effective at separating the lipoxygenase from some of the other proteins the 
specific activity decreased with this treatment. Less than 10% of the original 
activity was recovered. 
Hydrophobic interaction chromatography was also tried as a purification 
technique. A portion of ammonium sulfate precipitated material was brought to 
40% ammonium sulfate saturation. This solution was loaded to a phenyl­
sepharose column (0.7 X 9.0 cm) pre-equilibrated with 100 mM NaH2PO4 buffer, 
pH 7.2 at 40% ammonium sulfate saturation. After loading and washing with an 
additional 20 mL of the starting buffer, a 20% to 0% ammonium sulfate gradient 
in phosphate buffer was applied and fractions collected. Figure A.2 shows the 
results of this experiment. 
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Figure A.2. HIC chromatography of ammonium sulfate precipitated 
lipoxygenase from G. lemaneiformis. 167 
The pooled active fractions yielded a 33% recovery of total activity and 
showed a specific activity of 1.11.tmol min
-1mg-1. The specific activity of the 
ammonium sulfate precipitant was not determined in this experiment; however, 
typical values found in other experiments for this stage of purification were in 
the range of 0.04-0.06 limol min
-1mg-1. This technique appeared somewhat 
effective, although SDS-PAGE still showed numerous protein bands. 
Attempts to use isoelectric focusing for purification resulted in complete 
loss of enzyme activity. Because this technique required the protein to be in a 
low salt solution it was necessary to desalt the ammonium sulfate precipitant 
prior to application. It was found that G-25 sephadex column chromatography 
was effective for this purpose but resulted in substantial dilution. Therefore, 
dialysis was tried as a means to desalt the ammonium sulfate precipitate. The 
results of these efforts were somewhat revealing about the nature of the enzyme. 
Table A.1. Effects of DTT, FeC13, NaC1, and glycerol in stabilizing 
lipoxygenase during dialysis. 
Buffera  DTT  FeC13  NaC1  glycerol  `)/0 Tot. 
(1mM)  (50 Of)  (1 M)  (20%)  Act. 
Control  97.3 
20 mM Tris  +  3.2 
20 mM Tris  +  +  16.0 
20 mM Tris  +  +  45.0 
20 mM Tris  +  +  +  14.5 
20 mM Tris  +  +  - 0 
20 mM Tris  + +  +  +  69 
20 mM NaH2PO4  +  - - 0 
All buffers were pH 7.2, dialysis was conducted overnight at 6° C 
against 2 X 500 mL buffer changes. 168 
A series of experiments was conducted to ascertain dialysis conditions 
that would stabilize the lipoxygenase activity. In the first experiment the effects 
of FeCl3, DTT, glycerol, and NaC1 were evaluated. Table A.1 lists the dialysis 
conditions and shows the percent lipoxygenase recovery compared to the initial 
activity (calculated as total activity). 
The relatively high recovery of activity found in the glycerol treated 
solutions indicated 20% glycerol had a stabilizing effect. To further evaluate this 
effect, a series of dialysis solutions was tested using 20 mM NaH2PO4 buffer, pH 
7.2 with glycerol concentrations ranging from 0% to 40%. Table A.2 lists these 
conditions and presents the results in terms of total activity recovered. 
This experiment indicated that glycerol in a NaH2PO4 buffer had no effect 
in stabilizing the lipoxygenase but that DTT may be detrimental. Its likely that 
the results of the previous experiment simply reflected the increased viscosity of 
the dialysis buffer and that complete exchange was not effected with the 2 X 500 
mL buffer changes. 
Table A.2. Effect of glycerol (in dialysis buffer) on stability of 
lipoxygenase a. 
DTT  % Tot. 
Buffer  % glycerol  0.1 mM  Act. 
Control  N/A  N/A  94.0 
20 mM NaH2PO4  10  +  1.7 
20 mM NaH2PO4  15  +  1.9 
20 mM NaH2PO4  20  +  3.1 
20 mM NaH2PO4  40  +  6.0 
20 mM NaH2PO4  0  +  <1 
20 mM NaH2PO4  0  32.0 
a Dialysis was performed with 3 X 500 mL buffer changes at 6° C 169 
A final experiment to evaluate stabilizing conditions was conducted to 
compare the effect of DTT in various buffers and to reexamine the effects of 
FeC13, NaC1, glycerol, and MgC12 in the dialysis buffer. Table A.3 lists the 
dialysis conditions and the results in terms of total activity recovered. 
The effect of EDTA, o-phenanthroline, and DTT on the lipoxygenase 
activity was tested by incubating an aliquot of the resuspended ammonium 
sulfate precipitant with each of these reagents and assaying the activity at timed 
intervals. Incubation in 1 mM o-phenanthroline resulted in no loss of activity 
over a 4 hour period. Incubation in 25 mM EDTA for 18 hours showed no loss of 
activity. After 18 hours in 10 mM DTT the lipoxygenase showed 62% of the 
activity of the untreated controls (the control samples retained 100% activity). 
Table A.3. Reevaluation of dialysis conditions to stabilize lipoxygenasea. 
Buffer  DTT  FeC13  NaC1  glycerol  MgC12  % Tot. 
0.1mM  50p.M  1 M  (20%)  5011M  Act. 
Tris  +  <1 
Tris  <1 
NaH2PO4 +  - - - - 1.7 
NaH2PO4  2.0 
Tris  +  <1 
Tris  +  +  12.6 
Tris  +  + +  18.2 
Tris  +  1.4 
Tris  +  1.5 
Control  N/A  N/A  N/A  N/A  N/A  98.6 
a All buffers at pH 7.2, dialysis conducted at 6°C with 3 X 500 mL buffer changes. 170 
Western Blot Analysis. A sample of the 40-80% ammonium sulfate 
precipitant from G. lemaneiformis was desalted by repeated dilution and 
concentration with 20 mM NaH2PO4 buffer, pH 7.2 using an amicon centriprep 
concentrator with a 10 kDa molecular weight cutoff. This preparation was sent 
to the laboratory of Dr. Colin Funk at Vanderbilt University where it was 
subjected to western blot analysis using an antibody against the human platelet 
derived 12-lipoxygenase (Funk, 1990). Included on the blot were control samples 
of pure human 12-lipoxygenase, crude homogenates of mouse platelets 
(containing 12-lipoxygenase) and three concentrations of the algal ammonium 
sulfate preparation. Figure A.3 shows the autoradiograph from this experiment. 
Lanes 3,4, and 5 containing the algal proteins show a clear band of antibody 
binding material at approximately 45 kDa. This molecular weight is 
considerably smaller than any previously described lipoxygenase, though the 
antibody binding appears to be quite specific. 
Seasonality of lipoxygenase expression in G. lemaneiformis. During the summer 
of 1992 and 1993 a systematic examination of the level of lipoxygenase activity in 
the alga was conducted. During the first summer (1992) algae were collected on 
six occasions from May 19 to October 11. Four to six replicate extractions of 
lipoxygenase activity were made and the activity calculated on a per gram of 
tissue basis (see experimental). Table A.4 shows the results from the 1992 
collection season. 
A spike in lipoxygenase activity is evident late in September. Because 
only one sampling period showed this "spike" it was necessary to repeat the 
experiment the following summer with more frequent sampling, particularly at 
the later stages of the growth period. During 1993, samples were taken on 13 
occasions, beginning 8 April and ending 13 October (at which time the plants had 
become difficult to find). 171 
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Figure A.3 Western Blot analysis of Grasilariopsis lipoxygenase. Lanes 1&7, pure 
human platelet 12-lipoxygenase; lanes 2-4; 7, 21, 70 gg algal ammonium sulfate 
precipitant; lanes 5&6, crude mouse platelet lipoxygenase; lane 8, molecular 
weight markers. 172 
Table A.4. Seasonality of lipoxygenase activity in G. lemaneiformis 1992. 
Calendar Date  19May  1 Jul  14Ju1  27Aug  28Sep  110ct 
Julian date  140  183  196  240  272  285 
Activity/g  0.095  0.081  0.072  0.073  0.360  0.149 
S.E.M.  0.007  0.004  .012  0.024  .054  0.004 
Sample size n=  6  6  6  6  6  5 
Again a discernible increase in lipoxygenase activity was seen in the later 
part of the summer. Although not as pronounced as in the previous year, these 
data provide several sampling periods which reflect this elevated activity. 
Table A.S. Seasonality of lipoxygenase activity in G. lemaneiformis 1993. 
Calendar Date  8Apr  7May  25May  8Jun  22Jun  16Ju1  29Ju1 
Julian date  098  127  145  156  173  197  210 
Activity/g  0.044  0.067  0.078  0.086  0.078  0.083  0.113 
S.E.M.  0.003  0.010  0.001  0.014  0.012  0.005  0.013 
sample size  6  6  4  5  6  6  5 
Calendar Date  26Aug  3Sep  16Sep  23Sep  30Sep  130ct 
Julian date  238  246  259  266  273  286 
Activity/g  0.153  0.175  0.166  0.150  0.097  0.046 
S.E.M.  0.031  0.016  0.025  0.018  0.013  0.005 
sample size  6  5  4  5  6  6 173 
DISCUSSION 
Enzyme isolation. Purification of the lipoxygenase from G. lemaneiformis 
proved to be an intractable problem. Although some progress was made, 
particularly with the application of HIC chromatography, dramatic loss of 
activity accompanied every conventional technique applied except ammonium 
sulfate precipitation. The dialysis experiments were somewhat enigmatic in that 
glycerol or the presence of NaCl appeared to stabilize the enzyme in some cases 
but not in others. Overall it appears that dialysis with a 10-12,000 molecular 
weight cut off membrane results in loss of enzyme activity. From these results I 
suggest that a low molecular weight moiety of the native enzyme is lost. Since 
incubation of the active enzyme with high concentrations of EDTA or o­
phenanthroline had little effect on its activity, it would appear that the active site 
iron is not readily extractable (assuming that the G. lemaneiformis lipoxygenase 
contains iron). One possibility is that the enzyme is multimeric and dialysis 
results in loss of a low molecular weight subunit. Although the 12-lipoxygenases 
characterized to date are monomeric enzymes with molecular weights in the 
vicinity of 80-120,000 Da (Schewe et al.,1986), the mammalian 5-lipoxygenase has 
been shown to require a 5-lipoxygenase activator protein (FLAP) for full activity 
(Miller et al., 1990). Another possibility is that the enzyme is being adsorbed 
onto the dialysis membrane, although loss of a low molecular weight moiety is 
also consistant with the gel filtration results. 
The results of the western blot analysis present compelling evidence that 
the algal lipoxygenase is immunologically cross-reactive with the anti-human 
platelet 12-lipoxygenase antibody. The relatively low molecular weight is 
somewhat surprising but does not preclude the possibility of its being a 
lipoxygenase. Examination of lipoxygenases over a broad phylogenetic spectrum 174 
has revealed that they share a highly conserved region of 38 amino acids near the 
carboxyl terminal of the protein (Boyington et al., 1993). There is substantial 
variability in the N-terminal amino acid composition and length in different 
lipoxygenases (Liu & Reith, 1995). Desalting and concentration by ultrafiltration, 
in preparation for the western blot, may have resulted in loss of subunit(s) or an 
activator protein though the semi-permeable membrane. Another possibility is 
that the enzyme is subject to proteolysis during the its isolation. Resolution of 
this question will require further investigation. 
Seasonality of lipoxygenase expression in G. lemaneiformis. An intriguing 
aspect of oxylipin biosynthesis is the role these metabolites play in the ecology of 
the algae. Although a rather difficult question to address, one might start by 
examining the abundance of these compounds during the life cycle of the 
producing plants. During the initial investigations into the characteristics of 12­
lipoxygenase from the marine red alga G. lemaneiformis I made the casual 
observation that extracts of plants collected late in the year were more active than 
those from plants collected early in the growing season. These observations have 
been followed by two summers of systematic collection of G. lemaneiformis and 
rigorous quantitation of lipoxygenase activity. Analysis of lipoxygenase 
expression clearly shows that there is a significant increase of extractable enzyme 
activity on a per gram wet weight basis in late summer. Figure A.4 graphically 
depicts the results from the 1993 season. 
There are few reports on the seasonal occurrence of enzyme expression in 
marine algae. Ahern et al. (1980) examined this property of Rhodomel larix during 
his investigation of haloperoxidases from this plant. He too found that there was 
an increase in the haloperoxidase activity in mid to late summer. However, in 
the Ahern study, only six samples were taken during a twelve month period. 175 
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Figure A.4. Seasonality of lipoxygenase activity in G. lemaneiformis. Squares 
represent average lipoxygenase activity per gram of tissue 6.E.M. 
The question remains, is this seasonality due to an increase in enzyme 
expression, or simply because it is easier to extract at a particular stage of the life 
cycle? The fact that the amount of activity subsides late in the season would 
argue that it is not simply a matter of the cells becoming old and friable. There 
may be fluctuations in polyphenol production or some other general enzyme 
inhibitor during the course of the growing season. I suggest that in future 
studies of this nature concurrent analysis of a constitutive enzyme such as lactate 
dehydrogenase be conducted as a control. 176 
Recently a cDNA segment with a high degree of homology for a 
lipoxygenase gene has been cloned from gametophytes of the red alga Porphyra 
purpurea (Liu & Reith, 1995). It would be of interest to use these probes for 
northern blot analysis of G. lemaneiformis RNA. It they are cross reactive then 
quantitative analysis of gene expression could be achieved. It would also prove 
informative to quantitate the levels of 12-lipoxygenase derived oxylipins on a 
seasonal basis. 